Sentence,class,file
"Neuroimage 32 (1), 70 –78.http://dx.doi.org/10.1016/j.neuroimage.2006.03.",OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"217 (4), 449– 468. http://dx.doi.org/10.1111/j.1469-7580.",Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"127 (1), 41 –55.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1080/87565641.2010.,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/S1053-8119(03)00370-714568444 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"31 (8), 1424 –14 29. http://dx.doi.org/10.3174/ajnr.A211020448011 .",Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"Cortex 56, 30 –37.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1017/ S001216220600083116608549.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.neubiorev.2007.04.01817586047 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/ 10.1111/j.1651-2227.2010.01811.x20367617 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.ijdevneu.2010.09.,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1007/s00429-012-0496-023250390 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1111/j.1469-8749.2012.04342.x22715952 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1203/PDR.0b013e3181998baf19127204 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.bbi.2009.11.00519945527 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/ S0022-3476(99)70133-210484802 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/ 10.1016/j.jpeds.2005.06.03316291350 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.3174/ajnr.A224320930003 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.3174/ajnr.A224320930003 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.3174/ajnr.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"Neuroimage 12 (6), 601 –616.http://dx.doi.org/ 10.1006/nimg.2000.065011112393 .",OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"45 (1), 1 –10.http://dx.doi.org/10.1016/ j.pediatrneurol.2011.02.00821723452 .",OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"2), 65 –95.http://dx.doi.org/ 10.1007/s00234-013-1242-x23942765 .",Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"34 (1), 3 –19.http://dx.doi.org/10.1053/j.semperi.2009.10.00120109968 .",Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.3174/ajnr.A352823703146 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.earlhumdev.2010.01.01020153942 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.jpeds.2009.,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/ 10.1016/j.earlhumdev.2007.03.01017513071 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/ 10.1542/peds.2008-188819047222 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"86 (1), 29–33.http://dx.doi.org/10.1016/j.earlhumdev.2009.11.00420056358 .",OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.earlhumdev.2011.08.02421955502 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/S0079-6123(07)64006-017920428 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1126/science.122308222879517 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1111/j.1469-8749.2009.03398.x19694779 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/ 10.1016/j.bandc.2008.10.00519081169 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.siny.2006.07.,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1167/iovs.05- 081116877404 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1093/cercor/bhq03520237243 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.02.07321376813 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2006.04.21216797189 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"12 (1), 29 –31.http://dx.doi.org/10.1038/nn.222419029889 .",Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1126/scitranslmed.300497823427244 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.nicl.2013.11.00724371797 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1001/ archpediatrics.2011.921383271 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/S1053-8119(03)00044-212814588 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1093/cercor/1.3.2301822734 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1056/NEJMoa05379216914704 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1371/journal.pone.005187923284800 .,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
"36 (1), 22 –41.http://dx.doi.org/10.1080/ 87565641.2011.54053021253989 .",Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.1016/j.tics.2011.,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2006.01.01516545965 .,OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/main.PMC4474422.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/f3/ndt-11-1467.PMC4474453.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1467–1472Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1467Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S8538 0Systematic review of the prevalence and incidence  of Parkinson’s disease in the People’s Republic  of China Y ong-ming Zou 1 Jia Liu2 Zhi-yan Tian1 Da Lu1 Yu-ying Zhou1 1Department of Neurology, TianJin  HuangHu Hospital, TianJin, People’s  Republic of China; 2Department  of Neurology, Xuan wu Hospital,   Beijing, People’s Republic of ChinaBackground:  Parkinson’s disease (PD) is a common neurodegenerative disease, and obtaining  accurate epidemiological data for this disease is very important for policy-making in public  health.",Non-OADS,/arxiv_data1/oa_pdf/69/f3/ndt-11-1467.PMC4474453.pdf
"In the past few decades, epidemiological studies have  been carried out in many countries to clarify the characteristics of PD at the population Correspondence: Yu-ying Zhou  Department of Neurology, TianJin  HuangHu Hospital, TianJin, 300060,  People’s Republic of China email zhouyuying1962@sina.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Zou et al Running head recto: Systematic review of the prevalence and incidence of PD DOI: http://dx.doi.org/10.2147/NDT.S85380",Non-OADS,/arxiv_data1/oa_pdf/69/f3/ndt-11-1467.PMC4474453.pdf
Available  from: http://www.stats.gov.cn/tjsj/pcsj/rkpc/6rp/indexch.ht m  2.,OADS,/arxiv_data1/oa_pdf/69/f3/ndt-11-1467.PMC4474453.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/69/f3/ndt-11-1467.PMC4474453.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/f3/ndt-11-1467.PMC4474453.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/7f/ndt-11-1473.PMC4474454.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1473–1482Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1473OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8050 5Quetiapine mitigates the ethanol-induced  oxidative stress in brain tissue, but not in the liver,  of the rat Jin-hong han1,2 hong-zhao Tian2 Yang-yang lian1 Yi Yu1 cheng-biao lu2 Xin-min li3 rui-ling Zhang1 haiyun Xu4 1The second affiliated hospital of  Xinxiang Medical University, 2school  of Basic Medicine, Xinxiang Medical  University, Xinxiang, henan, People’s  republic of china; 3Department of  Psychiatry, Faculty of  Medicine and  Dentistry, University of alberta,   edmonton, aB, canada; 4The Mental  health center, shantou University  Medical college, shantou, guangdong,   People’s republic of chinaAbstract:  Quetiapine, an atypical antipsychotic, has been employed to treat alcoholic patients  with comorbid psychopathology.",Non-OADS,/arxiv_data1/oa_pdf/21/7f/ndt-11-1473.PMC4474454.pdf
"Clozapine treatment was associated  with a decrease in alcohol use in schizophrenic patients with comorbid substance use  disorders.1–3 Olanzapine treatment resulted in a reduction in the use of alcohol and  other abused substances4 and helped nonpsychotic alcohol-dependent individuals to  maintain sobriety.5 Similar benefits of quetiapine in reducing alcohol use and craving  were also reported in posttraumatic stress disorder.6,7 In a recent open-label study, que - tiapine decreased alcohol consumption, craving for alcohol, and psychiatric symptoms  intensity while maintaining a good level of tolerance.8 Moreover, in a double-blind,  placebo-controlled pilot trial, alcohol craving was significantly reduced in quetiapine- treated subjects compared with that in placebo-treated type B alcoholics (early-onset  alcoholics), although it provided no advantage over placebo in improving drinking  outcomes among type A alcoholics.9 The dopaminergic system has been described as the principal neurotransmitter  associated with reward from alcohol.10–12 The serotonergic system, which modulates correspondence: rui-ling Zhang The Second Affiliated Hospital of  Xinxiang Medical University, 388 Jianshe  road, Xinxiang, henan 453002, People’s  republic of china Tel +86 373 337 3798 email zhangruilingxx@163.co m haiyun Xu The Mental health center, shantou  University Medical college, 22 Xinling  road, shantou, guangdong 515041,  People’s republic of china Tel +86 754 8890 0728 email hyxu@stu.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Han et al Running head recto: Quetiapine mitigates ethanol-induced oxidative stress DOI: http://dx.doi.org/10.2147/NDT.S80505",Non-OADS,/arxiv_data1/oa_pdf/21/7f/ndt-11-1473.PMC4474454.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/21/7f/ndt-11-1473.PMC4474454.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/7f/ndt-11-1473.PMC4474454.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/ec/main.PMC4474475.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.05.007 2211-3355/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/ec/main.PMC4474475.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/ec/main.PMC4474475.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/2c/ec/main.PMC4474475.pdf
http://www.fns.usda.gov/cnd/Governance/Legislation/CNR_2010.htm .,Non-OADS,/arxiv_data1/oa_pdf/2c/ec/main.PMC4474475.pdf
"http://www.fns.usda.gov/ tn/team-nutrition .Fulkerson, J.A., French, S.A., Story, M., Nelson, H., Hannan, P.J., 2004.",Non-OADS,/arxiv_data1/oa_pdf/2c/ec/main.PMC4474475.pdf
"http://dx.doi.org/10.1089/chi.2015.0019 (in press, Epub ahead of print).",Non-OADS,/arxiv_data1/oa_pdf/2c/ec/main.PMC4474475.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
Direct link to deposited data Deposited data can be found here: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE35649 .2.,OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
Consent Level of consent allowed for reuse if applicable (typically for human samples )NA Sample source locationNA http://dx.doi.org/10.1016/j.gdata.2015.05.031 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
Motif analysis Peaks called by MACS were ranked as described [1].T h et o p2 0 0 peaks were used for motif analysis and the repeat masked genome sequence +/ −50 bp from the summit of these 200 peaks was downloaded from the UCSC genome browser ( http://genome.ucsc.,OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
"BMC Genomics 15 (2014) 1072, http://dx.doi.org/10.1186/1471-2164-15-1072 .",Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
"Genesis 50 (2011) 375 –383, http://dx.doi.org/10.1002/dvg.20802 .",Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
"Genesis 48 (2010) 394 –399, http://dx.doi.org/10.1002/dvg.20627 .",Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
"Genesis 28 (2000) 106 –110, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
"25 (2000) 139 –140, http://dx.doi.org/10.1038/75973 .",Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
"Genesis 50(2012) 375 –383, http://dx.doi.org/10.1002/dvg.20802 .",Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
PLoS One 6 (2011) http://dx.doi.org/10.1371/journal.pone.0028885 e28885.,Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
"Methods48 (2009) 240 –248, http://dx.doi.org/10.1016/j.ymeth.2009.03.001 .",OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
"9 (2008) R137, http://dx.doi.org/10.1186/gb-2008-9-9-r137 .",Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
"278 (2003) 27532 –27539, http://dx.doi.org/10.1074/jbc.M301461200 .",Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/18/main.PMC4474491.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/3/e1400139/DC1General MethodsFig.,Non-OADS,/arxiv_data1/oa_pdf/8b/8c/1400139.PMC4474499.pdf
"Supplementary information for this article is available online: http://emboj.embopress.org Acknowledgements We thank Kai Papenfort and Cynthia Sharma for comments, ideas, and stimu-lating discussions; Stan Gorski for editing the manuscript; K. Papenfort and H.J.",Non-OADS,/arxiv_data1/oa_pdf/84/fe/embj0034-1478.PMC4474525.pdf
"For cell counting, an automated segmenta-tion tool (maximum entropy threshold) for ImageJ (Version 1.41o;http://rsbweb.nih.gov/ij/) was used.",OADS,/arxiv_data1/oa_pdf/00/7e/embj0034-1572.PMC4474531.pdf
"Supplementary information for this article is available online: http://emboj.embopress.org Acknowledgements We thank N. Foulkes, S. Lemke, F. Loosli, and J.L.",Non-OADS,/arxiv_data1/oa_pdf/00/7e/embj0034-1572.PMC4474531.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/db/eb-6-019.PMC4474605.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpEye and Brain 2014:6 (Suppl 1) 19–27Eye and Brain Dove press submit your manuscript | www.dovepress.co m Dove press  19Original rESEarchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/EB.S5979 7Patchy distributions of myelin and vesicular  glutamate transporter 2 align with cytochrome  oxidase blobs and interblobs in the superficial  layers of the primary visual cortex Emily c rockoff1 Pooja Balaram1 Jon h Kaas1,2 1Department of Psychology,   2Department of cell and Molecular  Biology, Vanderbilt University,   nashville, Tn , USa correspondence: Emily c rockoff   Department of Psychology, 404 Wilson  hall, Vanderbilt University,   111 21st avenue South, nashville,   Tn 37240, USa   Tel +1 615 322 5548   Email emily.c.rockoff@vanderbilt.ed uAbstract:  Blobs are a modular component of the primary visual cortex (area 17) of all primates,  but not of other mammals closely related to primates.",Non-OADS,/arxiv_data1/oa_pdf/27/db/eb-6-019.PMC4474605.pdf
"Eye and Brain Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/eye-and-brain-journal  Eye and Brain is an international, peer-reviewed, open access journal   focusing on clinical and experimental research in the field of  neuro-ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/27/db/eb-6-019.PMC4474605.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/db/eb-6-019.PMC4474605.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27089 - http://dx.doi.org/10.3402/jchimp.v5.27089 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/21/b8/JCHIMP-5-27089.PMC4475253.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27089 - http://dx.doi.org/10.3402/jchimp.v5.27089",Non-OADS,/arxiv_data1/oa_pdf/21/b8/JCHIMP-5-27089.PMC4475253.pdf
"There were, however, some examples of patients in the younger age group too (overall age range 25 /C193 years, with medianPower of anecdotes on resident HVCCC curriculum Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27089 - http://dx.doi.org/10.3402/jchimp.v5.27089 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/21/b8/JCHIMP-5-27089.PMC4475253.pdf
Available from: http://www.who.int/countries/ usa/en/ [cited 19 August 2014].,OADS,/arxiv_data1/oa_pdf/21/b8/JCHIMP-5-27089.PMC4475253.pdf
Available from: http://www.choosingwisely.org/about-us/ [cited 17 August 2014].,Non-OADS,/arxiv_data1/oa_pdf/21/b8/JCHIMP-5-27089.PMC4475253.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27089 - http://dx.doi.org/10.3402/jchimp.v5.27089",Non-OADS,/arxiv_data1/oa_pdf/21/b8/JCHIMP-5-27089.PMC4475253.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27241 - http://dx.doi.org/10.3402/jchimp.v5.27241 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/cc/JCHIMP-5-27241.PMC4475254.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27241 - http://dx.doi.org/10.3402/jchimp.v5.27241",Non-OADS,/arxiv_data1/oa_pdf/dc/cc/JCHIMP-5-27241.PMC4475254.pdf
"Diagnosis criteria of three types of BrS EKG ST-segment abnormalities in the different types of Brugada syndrome Type I Type II Type III J wave amplitude ]2m m ]2m m ]2m m T wave Negative Positive or biphasicAny ST-T configuration Coved type Saddle back Either ST-segment (terminal portion)Gradually descendingElevated ]1m mElevated B1m mClinical features of Brugada syndrome Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27241 - http://dx.doi.org/10.3402/jchimp.v5.27241 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/cc/JCHIMP-5-27241.PMC4475254.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27241 - http://dx.doi.org/10.3402/jchimp.v5.27241",Non-OADS,/arxiv_data1/oa_pdf/dc/cc/JCHIMP-5-27241.PMC4475254.pdf
"Circulation 2006; 114: e385 /C1484.Clinical features of Brugada syndrome Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27241 - http://dx.doi.org/10.3402/jchimp.v5.27241 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/cc/JCHIMP-5-27241.PMC4475254.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27229 - http://dx.doi.org/10.3402/jchimp.v5.27229 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a5/02/JCHIMP-5-27229.PMC4475255.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27229 - http://dx.doi.org/10.3402/jchimp.v5.27229",Non-OADS,/arxiv_data1/oa_pdf/a5/02/JCHIMP-5-27229.PMC4475255.pdf
"CT angiogram of abdomen and pelvis (coronal view) /C1 status post-EV AR with aorto-bi-femoral graft.Mycotic aneurysm in a turtle hunter Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27229 - http://dx.doi.org/10.3402/jchimp.v5.27229 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a5/02/JCHIMP-5-27229.PMC4475255.pdf
Available from: https://public.health.oregon.gov/ DiseasesConditions/CommunicableDisease/ReportingCommunicableDisease/ReportingGuid elines/Documen ts/salmonel.pdf [cited 1 December 2014].,OADS,/arxiv_data1/oa_pdf/a5/02/JCHIMP-5-27229.PMC4475255.pdf
Avail- able from: http://www.fda.gov/forconsumers/consumerupdates/ ucm048151.htm [cited 1 December 2014].,Non-OADS,/arxiv_data1/oa_pdf/a5/02/JCHIMP-5-27229.PMC4475255.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27229 - http://dx.doi.org/10.3402/jchimp.v5.27229",Non-OADS,/arxiv_data1/oa_pdf/a5/02/JCHIMP-5-27229.PMC4475255.pdf
"AJR Am J Roentgenol 1989; 152(4): 785.Mycotic aneurysm in a turtle hunter Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27229 - http://dx.doi.org/10.3402/jchimp.v5.27229 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a5/02/JCHIMP-5-27229.PMC4475255.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"2 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038",Non-OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"A wire phantom, with the wire appearing vertical in the middle of the cylinder (arrow).Comparison of two CBCT scanners Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"4 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038",Non-OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"Axial slices of the object show the luminance intensity after receiving the X-ray signal; no artifacts were noticed(lower right panel).Comparison of two CBCT scanners Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"6 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038",Non-OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"The SD is shown as small vertical bars on thesmaller columns, while the SD of longer columns was zero:90/C3090 kV , 6 /C306 mA, 80 /C3080 kV , 7 /C307 mA.Comparison of two CBCT scanners Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"8 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038",Non-OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"The contrast resolution using four different materials in the phantom (lower left panel) was tested and the values are shown in the graph (lower right panel).Comparison of two CBCT scanners Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"10 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038",Non-OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"The radiation dose values of Scanora 3D under the following parameters: ﬁeld: 60 /C2960; voltage: 90 kV; current: 12.5 mA; and duration: 4.5 sec Place on phantom Dose (mSv) 1 0.31 2 0.103 0.164 0.155 0.166 0.187 0.09 8 0.06 9 0.0110 0.1711 0.0412 0.05Comparison of two CBCT scanners Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"12 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 28038 - http://dx.doi.org/10.3402/ljm.v10.28038",Non-OADS,/arxiv_data1/oa_pdf/0f/60/LJM-10-28038.PMC4475257.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27909 - http://dx.doi.org/10.3402/jchimp.v5.27909 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7a/68/JCHIMP-5-27909.PMC4475258.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27993 - http://dx.doi.org/10.3402/jchimp.v5.27993 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/43/2a/JCHIMP-5-27993.PMC4475259.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27993 - http://dx.doi.org/10.3402/jchimp.v5.27993",Non-OADS,/arxiv_data1/oa_pdf/43/2a/JCHIMP-5-27993.PMC4475259.pdf
"EKG showing tall peaked symmetric T waves with narrow base (EKG courtesy, www.lifeinthefastlane.com/ hyperkalemia/).Hyperkalemic manifestations and its management Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27993 - http://dx.doi.org/10.3402/jchimp.v5.27993 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/43/2a/JCHIMP-5-27993.PMC4475259.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK307/ [cited 7 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/43/2a/JCHIMP-5-27993.PMC4475259.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27993 - http://dx.doi.org/10.3402/jchimp.v5.27993",Non-OADS,/arxiv_data1/oa_pdf/43/2a/JCHIMP-5-27993.PMC4475259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27472 - http://dx.doi.org/10.3402/jchimp.v5.27472 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/15/26/JCHIMP-5-27472.PMC4475260.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27472 - http://dx.doi.org/10.3402/jchimp.v5.27472",Non-OADS,/arxiv_data1/oa_pdf/15/26/JCHIMP-5-27472.PMC4475260.pdf
"Patient population and subgroups in PDSA cycle 2.Improving antibiotic adherence in treatment of acute URI Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27472 - http://dx.doi.org/10.3402/jchimp.v5.27472 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/15/26/JCHIMP-5-27472.PMC4475260.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27472 - http://dx.doi.org/10.3402/jchimp.v5.27472",Non-OADS,/arxiv_data1/oa_pdf/15/26/JCHIMP-5-27472.PMC4475260.pdf
Available from:http://www.cdc.gov/drugresista nce/threat-report-2013/pdf/ar- threats-2013-508.pdf#page /C306 [cited 17 February 2014].,OADS,/arxiv_data1/oa_pdf/15/26/JCHIMP-5-27472.PMC4475260.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/15/26/JCHIMP-5-27472.PMC4475260.pdf
"J Community Hosp Intern Med Perspect 2014; 4: 22958, doi: http://dx.doi.org/10.3402/ jchimp.v4.22958 11.",Non-OADS,/arxiv_data1/oa_pdf/15/26/JCHIMP-5-27472.PMC4475260.pdf
"J Community Hosp Intern Med Perspect 2013; 3(2): 20744, doi: http://dx.doi.org/10.3402/jchimp.v3i1.20744 12.",Non-OADS,/arxiv_data1/oa_pdf/15/26/JCHIMP-5-27472.PMC4475260.pdf
"JAMA Intern Med 2014; 174(1): 138 /C140.Improving antibiotic adherence in treatment of acute URI Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27472 - http://dx.doi.org/10.3402/jchimp.v5.27472 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/15/26/JCHIMP-5-27472.PMC4475260.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27459 - http://dx.doi.org/10.3402/jchimp.v5.27459 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/16/2d/JCHIMP-5-27459.PMC4475261.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27459 - http://dx.doi.org/10.3402/jchimp.v5.27459",Non-OADS,/arxiv_data1/oa_pdf/16/2d/JCHIMP-5-27459.PMC4475261.pdf
"2).Late onset seroma causing cardiac tamponade Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27459 - http://dx.doi.org/10.3402/jchimp.v5.27459 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/16/2d/JCHIMP-5-27459.PMC4475261.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27459 - http://dx.doi.org/10.3402/jchimp.v5.27459",Non-OADS,/arxiv_data1/oa_pdf/16/2d/JCHIMP-5-27459.PMC4475261.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), pe rmitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27808 - http://dx.doi.org/10.3402/jchimp.v5.27808 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/36/48/JCHIMP-5-27808.PMC4475262.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27808 - http://dx.doi.org/10.3402/jchimp.v5.27808",Non-OADS,/arxiv_data1/oa_pdf/36/48/JCHIMP-5-27808.PMC4475262.pdf
"Scatter plot of intern average score with average MMI overall score.Correlation between MMI and OSCE performance Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27808 - http://dx.doi.org/10.3402/jchimp.v5.27808 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/36/48/JCHIMP-5-27808.PMC4475262.pdf
Available from: http://healthcarecomm.org/about-us/impact-of-communication-in-healthcare/ [cited 4 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/36/48/JCHIMP-5-27808.PMC4475262.pdf
Available from: https://www.partners.,Non-OADS,/arxiv_data1/oa_pdf/36/48/JCHIMP-5-27808.PMC4475262.pdf
Available from: http://www.usmle.org/step- 2-cs/ [cited 5 March 2015].Adetokunbo Oluwasanjo et al.,OADS,/arxiv_data1/oa_pdf/36/48/JCHIMP-5-27808.PMC4475262.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27808 - http://dx.doi.org/10.3402/jchimp.v5.27808",Non-OADS,/arxiv_data1/oa_pdf/36/48/JCHIMP-5-27808.PMC4475262.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27388 - http://dx.doi.org/10.3402/jchimp.v5.27388 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/91/b4/JCHIMP-5-27388.PMC4475263.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27388 - http://dx.doi.org/10.3402/jchimp.v5.27388",Non-OADS,/arxiv_data1/oa_pdf/91/b4/JCHIMP-5-27388.PMC4475263.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27445 - http://dx.doi.org/10.3402/jchimp.v5.27445 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/bf/65/JCHIMP-5-27445.PMC4475264.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27445 - http://dx.doi.org/10.3402/jchimp.v5.27445",Non-OADS,/arxiv_data1/oa_pdf/bf/65/JCHIMP-5-27445.PMC4475264.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27481 - http://dx.doi.org/10.3402/jchimp.v5.27481 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cd/0a/JCHIMP-5-27481.PMC4475265.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27481 - http://dx.doi.org/10.3402/jchimp.v5.27481",Non-OADS,/arxiv_data1/oa_pdf/cd/0a/JCHIMP-5-27481.PMC4475265.pdf
"Pre- and post-test outcome analysis ( n/C3015) Pre-test Post-test Variable (total questions) Mean SD Mean SD p-value Biophysics (12) 3.88 1.32 11.13 0.63 B0.001 Pathology (4) 0.97 0.90 3.07 0.68 B0.001 Anatomy (4) 1.60 0.92 3.28 0.50 B0.001 Total (20) 6.45 1.62 17.48 1.13 B0.001Musculoskeletal ultrasound for medical residents Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27481 - http://dx.doi.org/10.3402/jchimp.v5.27481 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cd/0a/JCHIMP-5-27481.PMC4475265.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27481 - http://dx.doi.org/10.3402/jchimp.v5.27481",Non-OADS,/arxiv_data1/oa_pdf/cd/0a/JCHIMP-5-27481.PMC4475265.pdf
Available from: http://www.cdc.gov/nchs/fastats/physician-visits.htm [cited 16 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/cd/0a/JCHIMP-5-27481.PMC4475265.pdf
Available from: http://www.cdc.gov/nchs/fastats/emergency-department.,OADS,/arxiv_data1/oa_pdf/cd/0a/JCHIMP-5-27481.PMC4475265.pdf
"J Ultrasound Med 2012; 31: 2013 /C116.Musculoskeletal ultrasound for medical residents Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27481 - http://dx.doi.org/10.3402/jchimp.v5.27481 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cd/0a/JCHIMP-5-27481.PMC4475265.pdf
"J CommunityHosp Intern Med Perspect 2015; 5: 27297, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 27481, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp Intern MedPerspect 2015; 5: 27472, doi: http://dx.doi.org/10.3402/jchimp.",OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community HospIntern Med Perspect 2015; 5: 27089, doi: http://dx.doi.org/ 10.3402/jchimp.v5.27089 6.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp InternMed Perspect 2015; 5: 27445, doi: http://dx.doi.org/10.3402/ jchimp.v5.27445 7.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community HospIntern Med Perspect 2015; 5: 27229, doi: http://dx.doi.org/ 10.3402/jchimp.v5.27229 8.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp Intern MedPerspect 2015; 5: 27241, doi: http://dx.doi.org/10.3402/jchimp.",OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 27459, doi: http://dx.doi.org/10.3402/jchimp.v5.27459 10.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp Intern MedPerspect 2015; 5: 27664, doi: http://dx.doi.org/10.3402/jchimp.",OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 27699, doi: http://dx.doi.org/10.3402/jchimp.v5.27699 12.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp Intern MedPerspect 2015; 5: 27993, doi: http://dx.doi.org/10.3402/jchimp.",OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 28573 - http://dx.doi.org/10.3402/jchimp.v5.28573 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 27388, doi: http://dx.doi.org/10.3402/jchimp.v5.27388 14.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 27909, doi: http://dx.doi.org/10.3402/jchimp.v5.2790915.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 27930, doi: http://dx.doi.org/10.3402/jchimp.v5.27930 Robert P .",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"Ferguson 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 28573 - http://dx.doi.org/10.3402/jchimp.v5.28573",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/JCHIMP-5-28573.PMC4475266.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27930 - http://dx.doi.org/10.3402/jchimp.v5.27930 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ef/2a/JCHIMP-5-27930.PMC4475267.pdf
"The numbers adjacent to the blue diamonds indicate the relative frequency of RBCs of any given volume.Lucien J. Cardinal 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27930 - http://dx.doi.org/10.3402/jchimp.v5.27930",Non-OADS,/arxiv_data1/oa_pdf/ef/2a/JCHIMP-5-27930.PMC4475267.pdf
"‘Normal distribution’ will be deﬁned in the second part of this article.Central tendency and distribution in biological systems Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27930 - http://dx.doi.org/10.3402/jchimp.v5.27930 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ef/2a/JCHIMP-5-27930.PMC4475267.pdf
"Postgrad Med 1985; 77(8): 253 /C14, 6, 61/C19.Lucien J. Cardinal 4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27930 - http://dx.doi.org/10.3402/jchimp.v5.27930",Non-OADS,/arxiv_data1/oa_pdf/ef/2a/JCHIMP-5-27930.PMC4475267.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/license s/by-nc/4.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27297 - http://dx.doi.org/10.3402/jchimp.v5.27297 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/29/JCHIMP-5-27297.PMC4475268.pdf
"GFR/C30glomerular filtration rate.Sara K. Richter and Andrew J. Crannage 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27297 - http://dx.doi.org/10.3402/jchimp.v5.27297",Non-OADS,/arxiv_data1/oa_pdf/29/29/JCHIMP-5-27297.PMC4475268.pdf
"CIN/C30contrast-induced nephropathy, SCr /C30serum creatinine, PO /C30by mouth, BID /C30two times daily, NR /C30not reported.Prevention of contrast-induced nephropathy Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27297 - http://dx.doi.org/10.3402/jchimp.v5.27297 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/29/JCHIMP-5-27297.PMC4475268.pdf
"CIN/C30contrast-induced nephropathy, NAC /C30N-acetylcysteine.Sara K. Richter and Andrew J. Crannage 4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27297 - http://dx.doi.org/10.3402/jchimp.v5.27297",Non-OADS,/arxiv_data1/oa_pdf/29/29/JCHIMP-5-27297.PMC4475268.pdf
"Outcomes Outcome N-Acetylcysteine ( n/C30151) No N-acetylcysteine ( n/C30151) p Development of CIN, n(%) 14/151 (9.3) 27/151 (17.9) 0.0428 Patients ]75 years, n(%) 4/62 (6.5) 16/75 (21.3) 0.0156 Diabetes mellitus, n(%) 8/66 (12.1) 16/88 (18.2) 0.3725 Hypertension, n(%) 11/139 (7.9) 26/145 (17.9) 0.0134 Heart failure, n(%) 3/22 (13.6) 6/19 (31.6) 0.2595 Hypotension prior to contrast, n(%) 1/4 (25.0) 1/3 (33.3) 1.0000 Increase in SCr ]0.3 mg/dL, n(%) 17 (11.3) 15 (9.9) 0.8520 Absolute change in BUN (mg/dL) 0.61 1.17 0.6366Percent change in BUN (%) 3.3 13.7 0.0307 CIN/C30contrast-induced nephropathy, BUN /C30blood urea nitrogen, SCr /C30serum creatinine.Prevention of contrast-induced nephropathy Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27297 - http://dx.doi.org/10.3402/jchimp.v5.27297 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/29/JCHIMP-5-27297.PMC4475268.pdf
"CIN/C30contrast-induced nephropathy, NAC /C30N-acetylcysteine.Sara K. Richter and Andrew J. Crannage 6 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27297 - http://dx.doi.org/10.3402/jchimp.v5.27297",Non-OADS,/arxiv_data1/oa_pdf/29/29/JCHIMP-5-27297.PMC4475268.pdf
"N Engl J Med 2006; 354: 2773/C182.Prevention of contrast-induced nephropathy Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27297 - http://dx.doi.org/10.3402/jchimp.v5.27297 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/29/JCHIMP-5-27297.PMC4475268.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27699 - http://dx.doi.org/10.3402/jchimp.v5.27699 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/82/88/JCHIMP-5-27699.PMC4475269.pdf
"Parasternal short axis images at the level of the ventricles shows multiple trabeculae and intertrabecular recesses in inferior, lateral, walls, middle and apical portions of theseptum, and apex of the left ventricle.Ewelina Maria Biskup 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27699 - http://dx.doi.org/10.3402/jchimp.v5.27699",Non-OADS,/arxiv_data1/oa_pdf/82/88/JCHIMP-5-27699.PMC4475269.pdf
"Ventricular short axis at the lower mid to apical regions showing heavy trabeculation in both ventricles.Presyncope /C1not an orthostatic problem Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27699 - http://dx.doi.org/10.3402/jchimp.v5.27699 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/82/88/JCHIMP-5-27699.PMC4475269.pdf
"doi: 10.3909/ ricm0531.Ewelina Maria Biskup 4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27699 - http://dx.doi.org/10.3402/jchimp.v5.27699",Non-OADS,/arxiv_data1/oa_pdf/82/88/JCHIMP-5-27699.PMC4475269.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting al l non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27664 - http://dx.doi.org/10.3402/jchimp.v5.27664 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cb/68/JCHIMP-5-27664.PMC4475270.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27664 - http://dx.doi.org/10.3402/jchimp.v5.27664",Non-OADS,/arxiv_data1/oa_pdf/cb/68/JCHIMP-5-27664.PMC4475270.pdf
"Conventional angiography of the head and neck showing moyamoya-like conversion of the lenticulostriate arteries giving a classic ‘puff of smoke’ appearance.Smoke in the air Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27664 - http://dx.doi.org/10.3402/jchimp.v5.27664 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cb/68/JCHIMP-5-27664.PMC4475270.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 27664 - http://dx.doi.org/10.3402/jchimp.v5.27664",Non-OADS,/arxiv_data1/oa_pdf/cb/68/JCHIMP-5-27664.PMC4475270.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/30/34/atr-04-02-20977.PMC4475336.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Undoubtedly , prehospital care has an important role in  the management of trauma victims and their outcome.",Non-OADS,/arxiv_data1/oa_pdf/ca/9c/atr-04-02-29422.PMC4475337.pdf
Available from: http://emsold.mui.ac.ir/ ems-115-tarikh-667.html.,Non-OADS,/arxiv_data1/oa_pdf/ca/9c/atr-04-02-29422.PMC4475337.pdf
Available from: http://115.lums.ac.ir/index.php?module=web_ directory&wd_id=1630.,OADS,/arxiv_data1/oa_pdf/ca/9c/atr-04-02-29422.PMC4475337.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3c/cc/atr-04-02-28465.PMC4475338.pdf
Available from:  http://ec.europa.eu/transport/road_safety/specialist/knowl - edge/pedestrians/index_en.htm.,Non-OADS,/arxiv_data1/oa_pdf/3c/cc/atr-04-02-28465.PMC4475338.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b1/0e/atr-04-02-24622.PMC4475339.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/be/d1/atr-04-02-27123.PMC4475340.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ae/9d/atr-04-02-20969.PMC4475341.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/00/a4/atr-04-02-27046.PMC4475342.pdf
"GO analysis of DEGs was performed using the Database for Annotation, Visualization, and IntegratedDiscovery (DAVID) (http://david.abcc.ncifcrf.gov/) (Huang et al, 2009a,b).",OADS,/arxiv_data1/oa_pdf/d2/5c/embj0034-1630.PMC4475398.pdf
The chi-square test was used for Supplementary FigS5F following the instructions on the GraphPad Software website(http://graphpad.com/quickcalcs/chisquared1.cfm).,OADS,/arxiv_data1/oa_pdf/d2/5c/embj0034-1630.PMC4475398.pdf
"Supplementary information for this article is available online: http://emboj.embopress.org Acknowledgements We thank Dr Oliver Mühlemann, University of Bern, Switzerland for the NMDreporter.",Non-OADS,/arxiv_data1/oa_pdf/d2/5c/embj0034-1630.PMC4475398.pdf
33. http://www.genomichealth.com/Pipeline/ProstateCancer.,Non-OADS,/arxiv_data1/oa_pdf/12/4c/pros0075-1206.PMC4475421.pdf
Supplementary material for this article is available on the Journal of  Biomolecular Screening Web site at http://jbx.sagepub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/e5/c4/10.1177_1087057115579637.PMC4475453.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/12/11/10.1177_2058460115589338.PMC4475512.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/ehv086.PMC4475571.pdf
"Materials and Methods    Search strategies and s tudy selection   PubMed (http://www.ncbi.nlm.nih.gov/pubmed),  Embase ( http://www.elsevier.co m/online -tools/ - embase), Web of Science (http://thomsonreuters .",OADS,/arxiv_data1/oa_pdf/dc/e2/IJBMS-18-423.PMC4475649.pdf
"com/thomson -reuters -web -of-science/), Ovid Med - line (http://gateway.ovid.com)  were  used to search   for endometriosis miRNA expression profiling  studies pu blished from January 2003 to October  201 4 (last accessed on 20 October 201 4), by means  of the key word s: endometriosis AND micro RNA.",OADS,/arxiv_data1/oa_pdf/dc/e2/IJBMS-18-423.PMC4475649.pdf
"Therefore, we used GeneCodis web tool  (http://genecodis.dacya.ucm.es/) (9, 10) to predict  the biological process (GO process) and to perform  pathway enrichment analysis (KEGG and Panther  pathways) of all miRNAs that were identified as  consistently expressed miRNAs in the eligible  references.",OADS,/arxiv_data1/oa_pdf/dc/e2/IJBMS-18-423.PMC4475649.pdf
The haplotypes was deducted and analyzed using  Haploview software package (available at:  http://www.broad.mit.edu/mpg/haploview/).,OADS,/arxiv_data1/oa_pdf/46/20/IJBMS-18-465.PMC4475654.pdf
"Also, tertiary structures were predicted using  online ligand -binding site prediction server  (http://www.sbg.bio.ic.ac.uk) (16).",OADS,/arxiv_data1/oa_pdf/38/3c/IJBMS-18-499.PMC4475659.pdf
PCR amplification of GroEL (1641 bp) gene     Characterization of epitopes   Final B and T -cell predicted e pitopes were  evaluated using the VaxiJen 2.0 server  (http://www.ddg - pharmfac.net/vaxijen/VaxiJen/ -  VaxiJen.html ) for the alignment -independent  prediction of protective antigens.,OADS,/arxiv_data1/oa_pdf/38/3c/IJBMS-18-499.PMC4475659.pdf
"I n addition,  enzymatic degradation sites, Mass (Da) and pI were  determined using the Protein Digest server  (http://db.Systemsbiology.net:8080/ proteomics Tool kit/proteinD igest.html).",OADS,/arxiv_data1/oa_pdf/38/3c/IJBMS-18-499.PMC4475659.pdf
"Validation bioinformatics analysis approach    In order  to validate  B and T cell prediction  software applications used in the present study,  three antigens whose epitopes were determined  experimentally  (http://www.iedb.org ), were  selected and their epitopes were predicted u sing the  bioinformatics tools used in the present study .",OADS,/arxiv_data1/oa_pdf/38/3c/IJBMS-18-499.PMC4475659.pdf
Available at: http://www.heart.org/HEARTORG/   Conditions/Cholesterol/WhyCholesterolMatters/Athero sclerosis_UCM_305 564_Article.jsp.,Non-OADS,/arxiv_data1/oa_pdf/2c/91/IJBMS-18-514.PMC4475661.pdf
Available at:  http://www.abcam.com.,Non-OADS,/arxiv_data1/oa_pdf/2c/91/IJBMS-18-514.PMC4475661.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"In the vicinity of capillaries, tumour cell may slow down and enter a stage of inactivity, active intravasation or dormancy.The potential of exosome as personalized diagnostic marker Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"show that miR-21 and miR-29a in tumour-derived exosome can reach, bind toand activate the Toll-like receptor (TLR) such as murine TLR7 and human TLR8 in the intracellular endosomesThe potential of exosome as personalized diagnostic marker Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"Next- generation sequencing can provide thousands of geneThe potential of exosome as personalized diagnostic marker Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"Molecules in EV from body ﬂuids of patients with cancer as potential markers for personalized medicine Caner type Material Body fluids Biomarkers Potential application References Prostate cancer Protein Plasma, serum Survivin Monitoring (93) Protein Plasma PSA Diagnosis/prognosis (88) Protein Urine PSA Diagnosis/monitoring (89) Protein Urine b-catenin Screening (94) Protein Urine PCA-3, TMPRSS2:ERG Diagnosis/monitoring (86) miRNA Plasma, serum and urine miR-107, miR-141, miR-375, miR-574-3p Diagnosis/prognosis (95) miRNA Serum miR-141 Diagnosis/prognosis (96) miRNA Serum 15 miRNAs Diagnosis/monitoring (97)Vesicle Serum Platelet microparticle number Prognosis (98) Vesicle Plasma Microvesicle number Diagnosis/prognosis (99) Ovarian cancer Protein Plasma Claudin-4 Screening (100) Protein Plasma TGF-beta1, MAGE3/6 Prediction/monitoring (12) Protein Serum L1CAM, CD24, ADAM10, EMMPRIN Diagnosis/prognosis (101)Protein Serum IgG recognized exosome antigen Diagnosis Protein Ascites CD24, EpCAM Diagnosis (102) Protein Ascites MMP2, MMP9, uPA Diagnosis (103) miRNA Serum 12 miRNAs Screening (104) Vesicle Serum EpCAM( /C27)exosome number Screening (104) Lung cancer Protein Serum EGRF Prognosis (91) Protein Urine LRG1 Diagnosis (105) Protein Pleural effusion SNX25, BTG1, PEDF , thrombospondin Diagnosis (106) miRNA Serum miR-486, miR-30d, miR-1, miR-499 Diagnosis/prognosis (107) miRNA Plasma 6 miRNAs Diagnosis (108)miRNA Plasma let-7f, miR-30e-3p, miR-223, miR-301 Diagnosis (109) miRNA Plasma miR-205, miR-19a, miR-19b, miR-30b, miR-20aMonitoring (130) miRNA Plasma 10 miRNAs Screening (108) miRNA Plasma 12 miRNAs Screening/prognosis (110) Vesicle Plasma EpCAM( /C27)exosome number Screening/prognosis (110) Vesicle Plasma Microvesicle number Prognosis (131) Glioblastoma Protein Plasma EGFR, EGFRvIII, PDPN, IDH1R132H Monitoring (111) Protein Serum EGFRvIII Prognosis (112) miRNA Serum miR-21 Diagnosis/prognosis (113) miRNA Serum RNU6-1, miR-320, miR-574-3p Diagnosis (114) miRNA Cerebrospinal fluid miR-21 Diagnosis (115) Breast cancer miRNA Blood, milk, ductal fluids miR-16, miR-1246, miR-451, miR-720 Prognosis (116) miRNA Serum miR-200a, miR-200c, miR-205 Diagnosis (117) Protein CD24, EpCAM (117) Protein Serum HER-2 Monitoring (118) miRNA Serum miR-21 Prognosis (41) Pancreatic cancer miRNA Serum miR-17-5p, miR-21 Diagnosis (90) DNA Serum KRAS Companion diagnosis/prognosis(92) Protein Plasma EGFR Diagnosis (119) mRNA Saliva Apbb1ip, ASPN, Daf2, FoxP1, Bco31781, Gng2Diagnosis (120) Colorectal cancer Protein Ascites Claudin-3 Diagnosis (121) miRNA Serum 7 miRNAs Diagnosis (122) Vesicle Plasma Microvesicle number Diagnosis/prognosis (123) Melanoma Protein Plasma Caveolin-1 Diagnosis/prognosis (124) Protein Plasma TYRP2, VLA-4, HSP70, HSP90‘ Prognosis (68)The potential of exosome as personalized diagnostic marker Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"2014;32:983 /C197.The potential of exosome as personalized diagnostic marker Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"Identiﬁcation of double-stranded genomic DNAThe potential of exosome as personalized diagnostic marker Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522 13 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"2012;10:e1001450.The potential of exosome as personalized diagnostic marker Citation: Journal of Extracellular Vesicles 2015, 4: 27522 - http://dx.doi.org/10.3402/jev.v4.27522 15 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/62/b9/JEV-4-27522.PMC4475684.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"Electrophoretic separation wasA novel role for peptidylarginine deiminases Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"To further identify the localisation of PAD2 and PAD4 enzymes during BzATP stimulation and Cl-am inhibition, PC3 cells were pretreated with 10 mM Cl-am (30 min at 378C), stimulated with BzATP and labelled with PAD2 or PAD4 antibody followed by isotype-matched AlexaFluorA novel role for peptidylarginine deiminases Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"** PB0.005 and *** PB0.001 were considered statistically signiﬁcant (one-way ANOV A).A novel role for peptidylarginine deiminases Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"Scale bars: 100 mm.A novel role for peptidylarginine deiminases Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"The ‘‘OK’’ column simplifies information about data quality and confidence score (2 /C3095%, 1 /C3050%).A novel role for peptidylarginine deiminases Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"The pharmacological inhibition of PADs with the pan- PAD-inhibitor chloramidine (Cl-am) abrogates the release of MVs and when combined with the anticancer drug methotrexate (MTX) works synergistically to induce increased cytotoxic effects and apoptosis of PC3 tumour cells.A novel role for peptidylarginine deiminases Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"2013;2.19671, doi: http://dx.doi.org/10.3402/jev.v2i0.19671 54.",Non-OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"The identiﬁcation of new biomarkersfor identifying and monitoring kidney disease and theirA novel role for peptidylarginine deiminases Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192 15 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"16 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26192 - http://dx.doi.org/10.3402/jev.v4.26192",OADS,/arxiv_data1/oa_pdf/01/d8/JEV-4-26192.PMC4475687.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/fe/TORMJ-9-70.PMC4475688.pdf
[5] Available at: http://www.ehealthme.com/ds/chantix/tardive  dyskinesia  [6] Tardive Dyskinesia: summary of a Task Force Report of the  American Psychiatric Association.,Non-OADS,/arxiv_data1/oa_pdf/c1/32/TONEUJ-9-7.PMC4475689.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/52/TORJ-9-21.PMC4475690.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/18/TORJ-9-27.PMC4475692.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/be/main.PMC4475693.pdf
"For example, on the N terminus of the ZP-N domain of both ZP1 and ZP4 homologues, there is an additional ZP-N domain (the N-terminal domain) followed by a trefoil domain, although the N-terminal and trefoil domains of ZP1 but not of ZP4 possess a free http://dx.doi.org/10.1016/j.fob.2015.05.005 2211-5463/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/59/be/main.PMC4475693.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ZP, zona pellucida; IHP, internal hydrophobic patch; EHP, external hydrophobic patch; TGFR, transforming growth factor- breceptor; Trx, thioredoxin; His 6, hexahistidine; EGF, epidermal growth factor; DTT, dithiothreitol; CBB, Coomassie Brilliant Blue; RT, room temperature; DIC, differential interferencecontrast; MBP, maltose binding protein; THP, Tamm–Horsfall protein ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/59/be/main.PMC4475693.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.05.005 .",OADS,/arxiv_data1/oa_pdf/59/be/main.PMC4475693.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.02.008,Non-OADS,/arxiv_data1/oa_pdf/00/e3/main.PMC4475694.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,4 2–48 This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/e3/main.PMC4475694.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,4 2–48 This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/e3/main.PMC4475694.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,4 2–48 This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/e3/main.PMC4475694.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,4 2–48 This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/e3/main.PMC4475694.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,4 2–48 This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/e3/main.PMC4475694.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,4 2–48 This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/00/e3/main.PMC4475694.pdf
These New Microbe and New Infect 2015; 6:35–39 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.04.001,Non-OADS,/arxiv_data1/oa_pdf/bc/6f/main.PMC4475695.pdf
"(B) Tabular presentation of serum levels vitamin D 3(ng/ml), pro- and anti-in ﬂammatory cytokines (pg/ml) among leprosy reaction patients and healthy controls.36 New Microbes and New Infections , Volume 6 Number C, --- 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,3 5–39 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/bc/6f/main.PMC4475695.pdf
"Vitamin D receptor expression and leprosy reaction 37 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,3 5–39 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/bc/6f/main.PMC4475695.pdf
"(C) Tabular representation of bacillary index, reaction types and VDR expression levels among patients with leprosy.38 New Microbes and New Infections , Volume 6 Number C, --- 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,3 5–39 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/bc/6f/main.PMC4475695.pdf
"Vitamin D receptor expression and leprosy reaction 39 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,3 5–39 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/bc/6f/main.PMC4475695.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
Long term longitudinal studies have speci ﬁcally identi ﬁedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.05.004 2213-2317/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ACh, acetylcholine; ADMA, asymmetric dimethylarginine; AU, ar- bitrary units; AUC, area under the curve; BP, blood pressure; cGMP, cyclic guani- dine monophosphate; DeXA, Dual energy X-ray absorptiometry; eNOS, endothelialnitric oxide synthase; HOMA-IR, homeostatic model assessment of insulin re-sistance; IL-6, interleukin-6; IL-10, interleukin-10; iNOS, inducible nitric oxidesynthase; IPGTT, intraperitoneal glucose tolerance test; IPITT, intraperitoneal in-sulin tolerance test; MAP, Mean arterial pressure; NADPH, nicotinamide adeninedinucleotide phosphate; NO, nitric oxide; NOS, nitric oxide synthase; NaCl, sodiumchloride; NaNO 3, sodium nitrate; NO3−, nitrate; PE, phenylephrine; SDMA, sym- metric dimethylarginine; SEM, standard error of measure; SNP, sodium ni- troprusside; T3, triiodothyronine; T4, thyroxine nCorresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Speijers, J. Meulenbelt, Health implications of exposure to environmental nitrogenous compounds, Toxicological Reviews 22 (1) (2003) 41–51,http://dx.doi.org/10.2165/00139709-200322010-00005 14579546 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Tannenbaum, P. Correa, Nitrate and gastric cancer risks, Nature 317 (6039) (1985) 675 –676, http://dx.doi.org/10.1038/317675b0 4058577 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Gladwin, The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics, Nature Reviews Drug Discovery 7 (2) (2008) 156 –167, http://dx.doi.org/10.1038/nrd2466 18167491 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Lundberg, et al., Nitrate, bacteria and human health, Nature Reviews Mi- crobiology 2 (7) (2004) 593 –602, http://dx.doi.org/10.1038/nrmicro929 15197394 .",OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Lundberg, Novel aspects of dietary nitrate and human health, Annual Review of Nutrition 33 (2013) 129 –159, http://dx.doi.org/10.1146/an- nurev-nutr-071812-161159 23642194 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Webb, et al., Acute blood pressure lowering, vasoprotective, and anti- platelet properties of dietary nitrate via bioconversion to nitrite, Hypertension 51 (3) (2008) 784 –790, http://dx.doi.org/10.1161/HYPERTENSIONA- HA.107.103523 18250365 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[9] G. Richardson, et al., The ingestion of inorganic nitrate increases gastric S- nitrosothiol levels and inhibits platelet function in humans, Nitric Oxide 7 (1) (2002) 24 –29,http://dx.doi.org/10.1016/S1089-8603(02)00010-1 12175816 .M.P.",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[10] A. Rodriguez-Mateos, et al., Interactions between cocoa ﬂavanols and in- organic nitrate: additive effects on endothelial function at achievable dietary amounts, Free Radical Biology and Medicine 80 (2015) 121 –128, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[11] F.J. Larsen, et al., Dietary inorganic nitrate improves mitochondrial ef ﬁciency in humans, Cell Metabolism 13 (2) (2011) 149 –159, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[12] M. Govoni, et al., The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash, Nitric Oxide 19 (4) (2008) 333 –337, http://dx.doi.org/10.1016/j.niox.2008.08.003 18793740 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[14] J. Petersson, et al., Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by an antiseptic mouthwash, Free Radical Biology and Medicine 46 (8) (2009) 1068 –1075, http://dx.doi.org/10.1016/j.free- radbiomed.2009.01.011 19439233 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[15] L.A. Bazzano, et al., Intake of fruit, vegetables, and fruit juices and risk of diabetes in women, Diabetes Care 31 (7) (2008) 1311 –1317, http://dx.doi.org/ 10.2337/dc08-0080 18390796 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Park, et al., Fruit, vegetable, and ﬁsh consumption and heart rate varia- bility: the veterans administration normative aging study, American Journal of Clinical Nutrition 89 (3) (2009) 778 –786, http://dx.doi.org/10.3945/ ajcn.2008.26849 19158214 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Aly, et al., Potential testicular toxicity of sodium nitrate in adult rats, Food and Chemical Toxicology 48 (2) (2010) 572 –578, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Chen, C. Gairola, Effect of nitrate and nitrite in drinking water on rats, Toxicology Letters 6 (3) (1980) 199 –206, http://dx.doi.org/10.1016/ 0378-4274(80)90192-7 7404601 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Hong, Dietary vitamin E and selenium and toxicity of nitrite and nitrate, Toxicology 180 (2) (2002) 195 –207, http://dx.doi.org/10.1016/ S0300-483X(02)00391-8 12324194 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[23] X. Gao, et al., NADPH oxidase in the renal microvasculature is a primary target for blood pressure-lowering effects by inorganic nitrate and nitrite, Hy- pertension 65 (1) (2015) 161 –170, http://dx.doi.org/10.1161/HYPERTENSIO- NAHA.114.04222 25312440 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[24] M.J. Mulvany, W. Halpern, Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats, CirculationResearch 41 (1) (1977) 19 –26,http://dx.doi.org/10.1161/01.RES.41.1.19 862138 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Brown, et al., Simultaneous determination of 6 L-arginine metabolites in human and mouse plasma by using hydrophilic-interaction chromatography and electrospray tandem mass spectrometry, Clinical Chemistry 57 (5) (2011) 701–709, http://dx.doi.org/10.1373/clinchem.2010.155895 21406573 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[26] A.A. Chaoui, et al., Effects of inorganic nitrates on thyroid gland activity and morphology in female rats, Therapie 59 (4) (2004) 471 –475, http://dx.doi.org/ 10.2515/therapie:2004079 15559551 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[31] F.J. Larsen, et al., Dietary nitrate reduces resting metabolic rate: a randomized, crossover study in humans, American Journal of Clinical Nutrition 99 (4)(2014) 843 –850, http://dx.doi.org/10.3945/ajcn.113.079491 24500154 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[32] F.J. Larsen, et al., Effects of dietary nitrate on oxygen cost during exercise, Acta Physiologica (Oxford) 191 (1) (2007) 59 –66,http://dx.doi.org/10.1111/j.1748- 1716.2007.01713.x 17635415 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[33] M. Carlström, et al., Cross-talk between nitrate –Nitrite-NO and NO synthase pathways in control of vascular NO homeostasis, Antioxidants and Redox Signaling (2014) , http://dx.doi.org/10.1089/ars.2013.5481 24224525 .",OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[36] J.J. van Vliet, et al., Twenty-four-hour duplicate diet study 1994; nitrate and nitrite: method development and intake per person per day, Cancer Letters 114 (1 –2) (1997) 305 –307, http://dx.doi.org/10.1016/S0304-3835(97)04688-0 9103317 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Endocrine Disorders 8 (2008) 1, http://dx.doi.org/10.1186/1472-6823-8-1 18211669 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[39] P. Iglesias, et al., Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function, Clinical Endocrinology (Oxford) 59 (5) (2003) 621 –629, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[40] H. Li, et al., Clinical evaluation of various thyroid hormones on thyroid func- tion, International Journal of Endocrinology 2014 (2014) 618572, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"Agnihothri, et al., Moderate weight loss is suf ﬁcient to affect thyroid hormone homeostasis and inhibit its peripheral conversion, Thyroidology 24 (1) (2014) 19 –26,http://dx.doi.org/10.1089/thy.2013.0055 23902316 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[43] M. Pourhassan, et al., Impact of body composition during weight change on resting energy expenditure and homeostasis model assessment index in overweight nonsmoking adults, American Journal of Clinical Nutrition 99 (4) (2014) 779 –791, http://dx.doi.org/10.3945/ajcn.113.071829 24500156 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[44] G. Jahreis, et al., Effect of chronic dietary nitrate and different iodine supply on porcine thyroid function, somatomedin-C-level and growth, Experimental and Clinical Endocrinology 88 (2) (1986) 242 –248, http://dx.doi.org/10.1055/s- 0029-1210603 3556413 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[46] A. Zaki, et al., Impact of nitrate intake in drinking water on the thyroid gland activity in male rat, Toxicology Letters 147 (1) (2004) 27 –33,http://dx.doi.org/ 10.1016/j.toxlet.2003.10.010 14700525 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[48] L. Kedzierski, et al., Decreased IL-10 and IL-13 production and increased CD44hi T cell recruitment contribute to Leishmania major immunity induced by non-persistent parasites, European Journal of Immunology 38 (11) (2008) 3090 –3100, http://dx.doi.org/10.1002/eji.200838423 18924210 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[50] M. Hirotani, et al., Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis, Journal of Neuroimmunology 221 (1 –2) (2010) 95 –100, http://dx.doi.org/10.1016/j.jneuroim.2010.02.012 20227772 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[51] C. Jädert, et al., Decreased leukocyte recruitment by inorganic nitrate and nitrite in microvascular in ﬂammation and NSAID-induced intestinal injury, Free Radical Biology and Medicine 52 (3) (2012) 683 –692, http://dx.doi.org/ 10.1016/j.freeradbiomed.2011.11.018 22178413 .",Non-OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
"[52] T. Yang, et al., Inorganic nitrite attenuates NADPH oxidase-derived superoxide generation in activated macrophages via a nitric oxide-dependent mechanism, Free Radical Biology and Medicine 83 (2015) 159 –166, http://dx.doi.org/ 10.1016/j.freeradbiomed.2015.02.016 25724690 .M.P.",OADS,/arxiv_data1/oa_pdf/74/74/main.PMC4475696.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/27/main.PMC4475776.pdf
"Further, CaA and its derivative, caffeic acid phenethyl ester (CAPE), suppress the angio- genesis of human renal carcinoma cells by blocking http://dx.doi.org/10.1016/j.fob.2015.05.009 2211-5463/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4f/27/main.PMC4475776.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: CaA, 3,4-dihydroxycinnamic acid; CSCs, cancer stem cells; DNMT, DNA methyltransferases; HCC, hepatocellular carcinoma; miR-148a,microRNA-148a; qMSP, quantitative methylation-speciﬁc polymerase chain reac-tion; SAM, S-adenosylmethionine; TGF b, transforming growth factor beta; TNBC, triple-negative breast cancer ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/4f/27/main.PMC4475776.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.05.009 .",OADS,/arxiv_data1/oa_pdf/4f/27/main.PMC4475776.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/be/main.PMC4475777.pdf
"In this report, we found that co-stimulation http://dx.doi.org/10.1016/j.fob.2015.05.008 2211-5463/ /C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/0e/be/main.PMC4475777.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: LC-SFAs, long-chain saturated fatty acids; MC-SFAs, medium-chain saturated fatty acids; ROS, reactive oxygen species; SFAs, saturatedfatty acids; TG, triacylglycerol ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/0e/be/main.PMC4475777.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.nicl.2015.05.0082213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"Functional connectivity We analyzed functional brain connectivity from the MEG data by computing a phase synchronization (PS) measure: the phase-locking value (PLV) ( Lachaux et al., 1999 ;Mormann, 2000 ), using HERMES tool- box, available at http://hermes.ctb.upm.es/ (Niso et al., 2013 ).",OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/ 10.1016/j.neuron.2012.05.00122632718 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.clinph.2013.06.00323810635 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"4), 28 –31.http://dx.doi.org/10.1111/j.1528-1167.2011.",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"5, 93. http://dx.doi.org/10.3389/fneur.",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"104 (11), 118701. http://dx.doi.org/10.1103/ PhysRevLett.104.11870120366507 .",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1111/ j.1528-1167.2007.01030.x17381440 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.eplepsyres.2011.04.01121601428 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"106 (3), 357– 369. http://dx.do i.org/10.1016/j.eplepsyres.2013.06.",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/ S0920-1211(00)00167-411074183 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/ 10.1016/j.yebeh.2007.01.01617347053 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.yebeh.2013.02.00423510795 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"28, S74 –S80.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"11, 103. http://dx.doi.org/10.1186/ 1471-2202-11-10320731854 .",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1097/WCO.0b013e32835ee5b823406911 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"30, 38 –42.http://dx.doi.org/10.1016/j.yebeh.2013.09.005 .",OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2013.04.08723643999 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"Science 315 (5814), 972 –97 6.http://dx.doi.org/10.1126/science.113680017218491 .513 G. Niso et al.",OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1162/neco.2009.05-08-78519191593 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"NeuroImage 65, 349– 363. http://dx.doi.org/10.1016/ j.neuroimage.2012.10.00123046981 .",OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.09.03617977022 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1007/ s11517-011-0778-321533620 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1089/brain.2014.030625411715 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.seizure.2014.07.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.eplepsyres.2014.05.00324907181 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.clinph.2012.06.01322832101 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.clinph.2009.10.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"E 71 (5 Pt 2), 056204. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1111/j.1528-1157.1989.tb05316.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.yebeh.2008.08.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1007/s00422-011-0456- 422095173 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"247, 314 –327.http://dx.doi.org/ 10.1016/j.expneurol.2013.01.02923384663 .",OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1177/107385841142275422235060 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1002/(SICI)1097-0193(1999)8:4 b194::AID- HBM4 N3.0.CO;2-C10619414 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"792 (1), 24 –40.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"2011 (11), 11018. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1371/journal.pcbi.100039519492086 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0333-10.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1093/brain/awl241 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1509-04.200415371508 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.cortex.2011.11.01222176870 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"2011, 156869. http://dx.doi.org/10.1155/2011/15686921253357 .",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.4250-04.200515829648 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.yebeh.2006.11.01217258506 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"34, 127– 128. http://dx.doi.org/ 10.1016/j.yebeh.2014.03.00724713435 .",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1097/00007611-195407000- 00024 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1111/j.1528-1167.2007.01482.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.expneurol.2009.02.00119232346 .,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"Chaos 24 (3), 033112. http://dx.doi.org/ 10.1063/1.489056825273192 .",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1111/j.1528- 1167.2009.02127.x19490045 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1103/PhysRevLett.76.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1111/j.1528-1157.2000.tb00158.x10714400 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1212/ 01.WNL.0000086903.69738.DC14557556 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1016/j.yebeh.2004.01.00715145302 .514 G. Niso et al.,OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1038/nrn380125186238 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"97 (12), 124905. http://dx.doi.org/10.1063/ 1.1935742 .",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1088/0031-9155/51/7/00816552102 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"Methods 236, 51 –57.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1209/epl/i2006-10147-0 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1111/j.1528-1167.2006.00828.x17201708 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1371/journal.pone.000808119956634 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1371/journal.pone.005976423565166 .,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
"Epilepsia 52 (1), 84 –93  .http://dx.doi.org/10.1111/j.1528-1167.",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4475779.pdf
For more infor-mation see the following link: http://www.formulaction.com/ stability-turbiscan-lab.html.,Non-OADS,/arxiv_data1/oa_pdf/32/6d/MC-11-391.PMC4475780.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/59/main.PMC4475784.pdf
This is an open access article under the CC BY-NC-ND 4.0 license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/9b/main.PMC4475785.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.12.0012213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/34/9b/main.PMC4475785.pdf
This is an open access article under the CC BY-NC-ND 4.0 license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/9b/main.PMC4475785.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/d6/main.PMC4475786.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.02.005 2213-3232/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/d6/main.PMC4475786.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/d6/main.PMC4475786.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Papilio glaucus Mitochondrial genome Illumina sequencing Phylogeny Introduction The order Lepidoptera contains approximately 160,000 described and half a million estimated species (Kristensen et al., 2007 ), and it represents one of the most diverse and fascinating group of insects.",Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
E-mail address: grishin@chop.swmed.edu (N.V. Grishin) http://dx.doi.org/10.1016/j.mgene.2015.05.002 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
"Sequence assembly Sequencing reads were processed sequentially by MIRABAIT ( Chevreux et al., 1999 ) to remove contamina- tion from sequence adapters, by Fastq_quality_trimmer ( http://hannonlab.cshl.ed/fastx_toolkit/ )t ot r i ml o w - quality regions at both ends and by QUAKE to correct errors ( Cong et al., 2015; Kelley et al., 2010 ).",OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.mgene.2015.05.002 .,OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
Mitochondrial DNA http://dx.doi.org/10.3109/19401736.2014.905843 .80 J. Shen et al.,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
Mitochondrial DNA http://dx.doi.org/10.3109/19401736.2014.898278 .,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
Mitochondrial DNA http://dx.doi.org/10.3109/19401736.2013.855909 .,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
Mitochondrial DNA http://dx.doi.org/10.3109/19401736.2014.905842 .,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
http://hannonlab.cshl.edu/fastx_toolkit/ .,OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
Mitochondrial DNA http://dx.doi.org/10.3109/19401736.2013.855751 .,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
Mitochondrial DNA http://dx.doi.org/10.3109/19401736.2014.905853 .,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
Mitochondrial DNA http://dx.doi.org/10.3109/19401736.2013.840610 .,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
Mitochondrial DNA http://dx.doi.org/10.3109/19401736.2014.900673 .,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/main.PMC4475787.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/3f/main.PMC4475807.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 235–240 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.016 1319-0164 ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/4b/3f/main.PMC4475807.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/3f/main.PMC4475807.pdf
Statistical Year Book 2013 < http://dsc.gov.ae/EN/Pub- lications/Pages/PublicationsList.aspx?Publicatio- nId=1&Year=2013 > (accessed 12.07.14).,OADS,/arxiv_data1/oa_pdf/4b/3f/main.PMC4475807.pdf
An Online Sample Size Calculator < http://www.rao- soft.com/samplesize.html > (accessed 25.06.14).,Non-OADS,/arxiv_data1/oa_pdf/4b/3f/main.PMC4475807.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/01/main.PMC4475810.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 230–234 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.002 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/04/01/main.PMC4475810.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/01/main.PMC4475810.pdf
http://dx.doi.org/10.1016/j.jsps.2013.07.008,OADS,/arxiv_data1/oa_pdf/26/19/main.PMC4475812.pdf
Data for the present study were retrieved from the Scopus international multidisciplinary bibliographical database [ http://www.sco- pus.com/search/ ] for the last ten years (2001–2010).,Non-OADS,/arxiv_data1/oa_pdf/26/19/main.PMC4475812.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 250–256 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.011 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/96/64/main.PMC4475813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/64/main.PMC4475813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/64/main.PMC4475813.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 257–265 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.10.002 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4d/a9/main.PMC4475816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/a9/main.PMC4475816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/a9/main.PMC4475816.pdf
Available from: http://www.qu.edu.qa/pharmacy/mis- sion_vision.php (retrieved 25.01.14.).,Non-OADS,/arxiv_data1/oa_pdf/4d/a9/main.PMC4475816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/7e/main.PMC4475818.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 241–249 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.008 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5f/7e/main.PMC4475818.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/7e/main.PMC4475818.pdf
"Software Two quantitative models for taspoglutide PD indexes were developed and estimated on the available digitalized measures,using Monolix 4.3 software ( http://software.monolix.org ) (Bouazza et al., 2012; Laouenan et al., 2013 ).",OADS,/arxiv_data1/oa_pdf/5f/7e/main.PMC4475818.pdf
"Prediction distributiongraphics were obtained using the Monolix 4.3 software, and other graphics were obtained from R 2.15 ( http://www.R-pro- ject.org ) and RStudio 0.97 ( http://www.rstudio.com ) program.",OADS,/arxiv_data1/oa_pdf/5f/7e/main.PMC4475818.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.jsps.2014.",OADS,/arxiv_data1/oa_pdf/5f/7e/main.PMC4475818.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/5f/main.PMC4475819.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 276–289 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.001 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bd/5f/main.PMC4475819.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/5f/main.PMC4475819.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 290–302 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.004 1319-0164 ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/e3/cf/main.PMC4475820.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/cf/main.PMC4475820.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/cf/main.PMC4475820.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.04.002,Non-OADS,/arxiv_data1/oa_pdf/ba/f4/main.PMC4475829.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,2 3 –25 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ba/f4/main.PMC4475829.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,2 3 –25 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ba/f4/main.PMC4475829.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.05.003,Non-OADS,/arxiv_data1/oa_pdf/60/a4/main.PMC4475830.pdf
Consensus sequences were assembled from both orientations and the allelic pro ﬁle was matched using the Multi Locus Sequence Typing database (http://www.mlst.net/ ).,OADS,/arxiv_data1/oa_pdf/60/a4/main.PMC4475830.pdf
"Consensus sequences were matched from both forward and reverse sequences, and the repeat units were identi ﬁed using the Ridom database ( http://spa.ridom.de/ ).",OADS,/arxiv_data1/oa_pdf/60/a4/main.PMC4475830.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1 5–20 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/60/a4/main.PMC4475830.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1 5–20 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/60/a4/main.PMC4475830.pdf
"In France, 21.2% of MSSA and 46.3% of MRSA were resistant to erythromycin according to national surveynetworks reports in 2008 (Rapport d ’activité ONERBA, 2009, http://www.onerba.org/IMG/pdf/ONERBA_rap2009-10_CH6- 2.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/60/a4/main.PMC4475830.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1 5–20 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/60/a4/main.PMC4475830.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1 5–20 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/60/a4/main.PMC4475830.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1 5–20 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/60/a4/main.PMC4475830.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.04.009,Non-OADS,/arxiv_data1/oa_pdf/e6/b0/main.PMC4475831.pdf
Institutional review board approval was not required for this study according to the research guidelines ofthe Japanese government ( http://www.niph.go.jp/wadai/ ekigakurinri/guidelines.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/e6/b0/main.PMC4475831.pdf
expasy.org/translate/ ) and CLUSTALW2.1 ( http://www.ddbj.,Non-OADS,/arxiv_data1/oa_pdf/e6/b0/main.PMC4475831.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e6/b0/main.PMC4475831.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e6/b0/main.PMC4475831.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e6/b0/main.PMC4475831.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e6/b0/main.PMC4475831.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e6/b0/main.PMC4475831.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e6/b0/main.PMC4475831.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.04.008,Non-OADS,/arxiv_data1/oa_pdf/26/9b/main.PMC4475833.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/26/9b/main.PMC4475833.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/26/9b/main.PMC4475833.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/26/9b/main.PMC4475833.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/26/9b/main.PMC4475833.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/26/9b/main.PMC4475833.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/26/9b/main.PMC4475833.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 315–326 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.012 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f8/3a/main.PMC4475836.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/3a/main.PMC4475836.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/3a/main.PMC4475836.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.jsps.2014.",OADS,/arxiv_data1/oa_pdf/f8/3a/main.PMC4475836.pdf
http://dx.doi.org/10.3109/10717544.10712014.,Non-OADS,/arxiv_data1/oa_pdf/f8/3a/main.PMC4475836.pdf
http://dx.doi.org/10.1016/j.jsps.2013.11.002,OADS,/arxiv_data1/oa_pdf/43/2f/main.PMC4475840.pdf
Biotech.. http://dx.doi.org/10.1155/2012/ 941232 .,OADS,/arxiv_data1/oa_pdf/43/2f/main.PMC4475840.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 327–329 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.08.005 1319-0164 ª2014 King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/f8/85/main.PMC4475842.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 308–314 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.010 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6c/55/main.PMC4475851.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/55/main.PMC4475851.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/55/main.PMC4475851.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 266–275 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.018 1319-0164 ª2014 The Author.",Non-OADS,/arxiv_data1/oa_pdf/da/5b/main.PMC4475852.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/5b/main.PMC4475852.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/5b/main.PMC4475852.pdf
"Educational Outcomes, 2013, American Association of Colleges of Pharmacy, Centre for the Advancement of Pharmacy Education <http://www.accp.org/documents/CAPEoutcomes071213.pdf > (accessed 13.09.14).",Non-OADS,/arxiv_data1/oa_pdf/da/5b/main.PMC4475852.pdf
©2015PublishedbyElsevierLtdonbehalf of AustralianSocietyforParasitology.Thisisanopenaccess articleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/24/main.PMC4475855.pdf
http://dx.doi.org/10.1016/j.ijppaw.2015.02.002 2213-2244/© 2015 Published by Elsevier Ltd on behalf of Australian Society for Parasitology.,Non-OADS,/arxiv_data1/oa_pdf/b2/24/main.PMC4475855.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 330–332 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.02.010",Non-OADS,/arxiv_data1/oa_pdf/e4/a2/main.PMC4475857.pdf
Article ID 820183. http://dx.doi.org/10.1155/2013/820183 .,Non-OADS,/arxiv_data1/oa_pdf/e4/a2/main.PMC4475857.pdf
http://dx.doi.org/10.1016/ j.ajme.2013.03.005 .,OADS,/arxiv_data1/oa_pdf/e4/a2/main.PMC4475857.pdf
http://dx.doi.org/10.1016/j.jep.2013.11.028 .,OADS,/arxiv_data1/oa_pdf/e4/a2/main.PMC4475857.pdf
http://dx.doi.org/ 10.1089/acm.2013.0353 .,Non-OADS,/arxiv_data1/oa_pdf/e4/a2/main.PMC4475857.pdf
2013. http://dx.doi.org/10.1155/2013/ 608430 .,Non-OADS,/arxiv_data1/oa_pdf/e4/a2/main.PMC4475857.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/a0/main.PMC4475860.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2015) 23, 303–307 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2014.11.015 1319-0164 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ce/a0/main.PMC4475860.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/a0/main.PMC4475860.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
285Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.05.008 2213-2317/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: 5-hmC, 5-hydroxymethylcytosine; 5-mC, 5-methylcytosine; AP-1, activator protein 1; Ape-1, apurinic/apyrimidinic endonuclease 1; AREs, AU-ric h ele- ments; BER, base excision repair; COPD, chronic obstructive pulmonary disorder; DNMT, DNA methyltransferase; GAPDH, glyceraldehyde-3-phosphat e dehydrogenase; GPx- 1, glutathione peroxidase-1; Grx, glutaredoxin; HAT, histone acetyltransferase; HDAC, histone deacetylase; HIF-1 α, hypoxia inducible factor-1 α; HO-1, heme oxygenase-1; HuR, mRNA-binding protein in the 3 ′-untranslated region; JmjC, Jumonji C domain-containing histone demethylases; Keap1, kelch-like ECH-associated protein 1; MMP, matrix metalloproteinase; NF- κB, nuclear factor- κB; NER, nucleotide excision repair; Nox, member of the NADPH oxidase family; Nrf2, nuclear factor erythroid related factor 2; OxyR, transcription factor (hydrogen peroxide-inducible genes activator); PETN, pentaerithrityl tetranitrate; PHD, prolylhydroxylase; RNS , reactive nitrogen species; ROS, reactive oxygen species; SOD, superoxide dismutase; Trx, thioredoxin nCorrespondence to: Universitätsmedizin der Johannes Gutenberg-Universität Mainz, II.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"References [1] T. Lindahl, Instability and decay of the primary structure of DNA, Nature 362 (6422) (1993) 709 –715, http://dx.doi.org/10.1038/362709a0 8469282 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"66 (2015) 379 –398, http://dx.doi.org/10.1146/ annurev-physchem-040513-103605 25580626 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"6 (9) (2014)a016428, http://dx.doi.org/10.1101/cshperspect.a016428 25104768 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Tsai, DNA damage and its links to neurodegen- eration, Neuron 83 (2) (2014) 266 –282, http://dx.doi.org/10.1016/j.neu- ron.2014.06.034 25033177 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"24 (7) (1999) 271 –275, http://dx.doi.org/10.1016/S0968-0004(99)01413- 9 10390616 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"USA 100 (22) (2003) 12871 –12876, http://dx.doi.org/10.1073/ pnas.2135498100 14566050 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"91 (1) (2015) 140 –155, http://dx.doi.org/10.1111/php.12368 25327445 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"339 (2) (1995) 73 –89,http://dx.doi.org/10.1016/ 0165-1110(95)90004-7 7791803 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"39 (4 –5) (2002) 331 –457, http://dx.doi.org/10.1080/ 10408360290795547 12385502 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"28 (2015) 14 –20,http://dx.doi.org/10.1016/j.dnar- ep.2015.01.009 25703834 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"78 (2015) 17 –25,http://dx.doi.org/ 10.1016/j.fct.2015.01.014 25640527 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"7 (6) (2014) 812 –823, http://dx.doi.org/10.1016/j.tranon.2014.10.005 25500092 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"94(3) (2015) 212 –219, http://dx.doi.org/10.1016/j.bcp.2015.01.012 25667043 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"43 (2) (2015) 1081 –1089, http://dx.doi.org/10.1093/nar/gku1332 25550433 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"15 (1) (2015) 89 –97,http://dx.doi.org/10.1097/ ACI.0000000000000135 25486379 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"27 (1) (2013) 379 –390, http://dx.doi.org/10.1096/fj.12- 218685 23024373 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"327 (1 –2) (2012) 26 –47,http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"329 (1) (2014) 116 –123, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"206 (5) (2014) 589 –598, http://dx.doi.org/10.1083/jcb.201403096 25154395 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"24 (2015) 15 –20,http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Complementation of the DNA repair defect in xeroderma pigmentosum group G cells by a human cDNA related to yeast RAD2, Nature 363 (6425)(1993) 182 –185, http://dx.doi.org/10.1038/363182a0 8483504 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Acta 442 (2015) 102 –109, http://dx.doi.org/10.1016/j.cca.2015.01.014 25619773 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"84 (1) (2015) , http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"5 (2014) 287, http://dx.doi.org/10.3389/fgene.2014.00287 25191341 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"17 (2014) 30 –38,http://dx.doi.org/10.1016/j.dnar- ep.2014.02.019 24680220 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"329 (1) (2014) 69 –77,http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"(2015) , http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"(2014) , http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"16 (1) (2015) 35 –45,http://dx.doi.org/10.1007/ s11154-014-9305-9 25540093 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"24 (3) (2014) 329 –342, http://dx.doi.org/10.11613/ BM.2014.035 25351351 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Semenza, Hypoxia-inducible factors in physiology and medicine, Cell 148 (3) (2012) 399 –408, http://dx.doi.org/10.1016/j.cell.2012.01.021 22304911 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"5 (2014) 423, http://dx.doi.org/ 10.3389/fgene.2014.00423 25538732 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"[42] J. Mothes, D. Busse, B. Kofahl, J. Wolf, Sources of dynamic variability in NF- κB signal transduction: a mechanistic model, BioEssays 37 (4) (2015) 452 –462, http://dx.doi.org/10.1002/bies.201400113 25640005 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Mohamed, G. McFadden, NFkB inhibitors: strategies from poxviruses, Cell Cycle 8 (19) (2009) 3125 –3132, http://dx.doi.org/10.4161/cc.8.19.9683 19738427 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"26 (3) (2012) 203 –234, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"17 (4) (1992) 221 –237, http://dx.doi.org/10.3109/ 10715769209079515 14 73734 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"566 (2015) 76 –84,http://dx.doi.org/ 10.1016/j.abb.2014.12.012 25528168 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"91 (2015) 104 –114, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Cell 30 (4) (2008) 393 –402, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"27 (3) (2007) 912 –925, http://dx.doi.org/10.1128/ MCB.01223-06 17101781 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Giaccia, D. Mansuy, J. Pouysségur, M. Yaniv, F. Mechta-Grigoriou, JunD reduces tumorangiogenesis by protecting cells from oxidative stress, Cell 118 (6) (2004) 781 –794, http://dx.doi.org/10.1016/j.cell.2004.08.025 15369676 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Ratcliffe, The FIH hy- droxylase is a cellular peroxide sensor that modulates HIF transcriptional activity, EMBO Rep. 13 (3) (2012) 251 –257, http://dx.doi.org/10.1038/em- bor.2012.9 22310300 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"535 (1 –3) (2003) 106 –112, http://dx.doi.org/10.1016/ S0014-5793(02)03887-5 12560087 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"47 (4) (2009) 458 –467, http://dx.doi.org/10.1016/j.free- radbiomed.2009.05.019 19477267 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"2012 (2012) 842632, http://dx.doi.org/10.1155/2012/842632 22506100 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"16 (1) (2002) 6 –21,http://dx.doi.org/10.1101/gad.947102 11782440 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"34 (3) (2014) 249 –257, http://dx.doi.org/10.1055/s-0034- 1386763 25192503 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Merbs, J. Qian, Character- ization of tissue-speci ﬁc differential DNA methylation suggests distinct modes of positive and negative gene expression regulation, BMC Genomics 16 (2015) 49, http://dx.doi.org/10.1186/s12864-015-1271-4 25652663 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"[65] T. Kouzarides, Chromatin modi ﬁcations and their function, Cell 128 (4) (2007) 693 –705, http://dx.doi.org/10.1016/j.cell.2007.02.005 17320507 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Today 14 (19 –20) (2009) 942 –948, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"17 (3) (2007) 195 –211, http://dx.doi.org/10.1038/sj.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"585 (13) (2011) 2024 –2031, http://dx.doi.org/10.1016/j.febslet.2010.11.010 21074527 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Angrand, The control of histone lysine methylation in epige- netic regulation, Biochimie 89 (1) (2007) 1 –20,http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"14 (10A) (2004) 1902 –1910, http://dx.doi.org/10.1101/gr.2722704 15364901 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"(2015) , http://dx.doi.org/ 10.1038/jhh.2014.132 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Doudna, A three-dimensional view of the molecular machinery of RNA interference, Nature 457 (7228) (2009) 405 –412, http://dx.doi.org/ 10.1038/nature07755 19158786 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell 116 (2) (2004) 281 –297, http://dx.doi.org/10.1016/S0092-8674(04)00045-5 14744438 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"37 (5) (2003) 471 –480, http://dx.doi.org/10.1080/Y.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"FitzGerald, Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS, Circulation 108 (16) (2003) 1912 –1916, http://dx.doi.org/10.1161/01.CIR.0000093660.86242.BB 14568884 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"[79] H. Sies, Oxidative Stress: Oxidants and Antioxidants, Academic Press, Lon- don, UK (1991) http://dx.doi.org/10.1113/expphysiol.1997.sp004024 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"20 (22) (2014) 3579 –3594, http://dx.doi.org/10.2174/ 13816128113196660748 24180381 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"111 (2) (2003) 163 –169, http://dx.doi.org/10.1172/JCI17638 12531868 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"FitzGerald, Oxidative stress and cardiovascular injury: Part II: animal and human studies, Circulation 108 (17) (2003) 2034 –2040, http://dx.doi.org/10.1161/01.CIR.0000093661.90582.c4 14581381 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"43 (4) (2011) 259 –272, http://dx.doi.org/10.3109/ 07853890.2010.543920 21284528 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"297 (8) (2007) 842 –857, http://dx.doi.org/10.1001/jama.297.8.842 17327526 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Simonetti, C. Gluud, Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta- analysis, Lancet 364 (9441) (2004) 1219 –1228, http://dx.doi.org/10.1016/ S0140-6736(04)17138-9 15464182 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"17 (32) (2010) 3827 –3841, http://dx.doi.org/10.2174/092986710793205444 20858217 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Drug Targets 11 (12) (2010) 1517 –1531, http://dx.doi.org/10.2174/1389450111009011517 20704549 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"14 (11) (2002) 879 –897, http://dx.doi.org/10.1016/S0898-6568(02)00053-0 12220615 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"15 (8) (2011) 2335 –2381, http://dx.doi.org/10.1089/ars.2010.3534 21194351 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Stamler, Nitrosative stress: activation of the transcription factor OxyR, Cell 86 (5) (1996) 719 –729, http://dx.doi.org/10.1016/S0092-8674(00)80147-6 8797819 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"285 (11) (2010) 8463 –8471, http://dx.doi.org/10.1074/jbc.M109.051714 20061377 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"20 (2) (2014) 339 –352, http://dx.doi.org/10.1089/ars.2012.4776 22794181 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"389 (3) (2008) 243 –255, http://dx.doi.org/ 10.1515/BC.2008.022 18177264 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"28 (23) (2008) 7139 –7155, http://dx.doi.org/10.1128/MCB.01145-08 18809573 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"65 (6) (2004) 1440 –1451, http://dx.doi.org/10.1124/mol.65.6.1440 15155837 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"29 (10) (2009) 2622 –2635, http://dx.doi.org/10.1128/MCB.01495-08 19289500 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"23 (6) (2004) 1313 –1324, http://dx.doi.org/10.1038/sj.emboj.7600163 15014438 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"13 (4) (2010) 489 –509, http://dx.doi.org/ 10.1089/ars.2009.3021 20210649 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"12 (11) (2010) 1247 –1269, http://dx.doi.org/10.1089/ ars.2009.2698 19764832 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"2 (4) (2000) 811 –820, http://dx.doi.org/10.1089/ ars.2000.2.4-811 11213485 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Acta 1780 (11) (2008) 1304 –1317, http://dx.doi.org/10.1016/j.bba- gen.2008.06.003 18621099 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"33 (6) (2005) 1375 –1377, http://dx.doi.org/10.1042/BST20051375 16246122 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"14 (2) (2005) 149 –153, http://dx.doi.org/10.1097/00041552-200503000-00010 15687841 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"USA 94 (8) (1997) 3633 –3638, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"283 (45) (2008) 30632 –30641, http://dx.doi.org/10.1074/jbc.M801401200 18776186 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"18 (20) (1999) 5609 –5621, http://dx.doi.org/10.1093/emboj/18.20.5609 10523305 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Pharmacol.51 (2 –3) (2009) 133 –139, http://dx.doi.org/10.1016/j.vph.2009.05.005 19524065 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"274 (39) (1999) 27891 –27897, http://dx.doi.org/10.1074/ jbc.274.39.27891 10488136 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"261 (3) (1999) 859 –863, http://dx.doi.org/10.1006/ bbrc.1999.1125 10441516 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"3 (4) (2001)671 –683, http://dx.doi.org/10.1089/15230860152543014 11554453 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"10 (2009) 86, http://dx.doi.org/10.1186/1471- 2199-10-86 19715578 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"27 (24) (1999) 4679 –4686, http://dx.doi.org/10.1093/nar/27.24.4679 10572166 .Y.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"281 (19) (2006)13596 –13603, http://dx.doi.org/10.1074/jbc.M512787200 16537541 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Tang, L. Liu, Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyl-transferase and increased sensitivity to genotoxic diethylnitrosamine, Car- cinogenesis 32 (7) (2011) 973 –977, http://dx.doi.org/10.1093/carcin/bgr041 21385828 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"15 (2) (2011) 551 –589, http://dx.doi.org/10.1089/ars.2010.3492 20919933 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"53 (11) (2012) 2178 –2187, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"18 (15) (2013) 1920 –1936, http://dx.doi.org/10.1089/ars.2012.4926 23480168 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"13 (10) (2012) 679 –692, http://dx.doi.org/ 10.1038/nrg3270 22945394 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"36 (1) (2003) 95–109, http://dx.doi.org/10.5483/BMBRep.2003.36.1.095 12542980 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"1) (2008) S42 –S45, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"10 (4) (2008) 799 –811, http://dx.doi.org/10.1089/ars.2007.1938 18220485 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Targets 15 (4) (2011) 439 –456, http://dx.doi.org/10.1517/ 14728222.2011.555400 21284573 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"64 (2013) 4 –11,http://dx.doi.org/10.1016/j.free- radbiomed.2013.07.025 23880293 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"18 (10) (2011) 1628 –1639, http://dx.doi.org/ 10.1038/cdd.2011.42 21527937 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"17 (12) (2011) 1627 –1635, http://dx.doi.org/ 10.1038/nm.2512 22101765 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Barr, S.G. Gray, The role of epigenetics in resistance to cisplatin chemotherapy in lung cancer, Cancers (Basel) 3 (1) (2011) 1426 –1453, http://dx.doi.org/10.3390/cancers3011426 24212667 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"352 (1 –2) (2011) 181 –188, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"(2014) , http://dx.doi.org/ 10.1089/ars.2014.6025 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"18 (15)(2013) 1937 –1945, http://dx.doi.org/10.1089/ars.2012.4895 23126619 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"33 (2) (2012) 403 –412, http://dx.doi.org/ 10.1007/s13277-012-0322-6 22274925 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"79 (2015) 197 –205, http://dx.doi.org/10.1016/j.freeradbiomed.2014.12.008 25526894 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Park, G. Jung, Epigenetic changes induced by reactive oxygen species in hepato-cellular carcinoma: methylation of the E-cadherin promoter, Gastro- enterology 135 (6) (2008) 2128 –2140, http://dx.doi.org/10.1053/j.gas- tro.2008.07.027 18801366 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"299 (3) (2010) G697 –G706, http://dx.doi.org/10.1152/ajpgi.00186.2010 20576920 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"74 (2014) 99–107, http://dx.doi.org/10.1016/j.freeradbiomed.2014.06.017 24973648 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"56 (2013) 17 –27,http://dx.doi.org/ 10.1016/j.freeradbiomed.2012.11.018 23219873 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"14 (3) (2011)391 –401, http://dx.doi.org/10.1089/ars.2010.3302 20586612 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"16 (4) (2015)258 –264, http://dx.doi.org/10.1038/nrm3931 25549891 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Drug Discov.13 (9) (2014) 673 –691, http://dx.doi.org/10.1038/nrd4360 25131830 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"58 (2013) 87 –97,http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"52 (5) (2012) 819 –837, http://dx.doi.org/10.1016/j.freeradbiomed.2011.11.009 22178977 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"13 (7) (2010)1023 –1032, http://dx.doi.org/10.1089/ars.2010.3251 20392170 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"24 (9) (2010) 3145 –3159, http://dx.doi.org/10.1096/fj.09-151308 20385619 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"285 (23)(2010) 17417 –17424, http://dx.doi.org/10.1074/jbc.M109.089250 20385560 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"24 (5) (2011) 651 –662, http://dx.doi.org/10.1021/ tx100355a 21449565 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"33 (7) (2013) 1601 –1611, http://dx.doi.org/ 10.1161/ATVBAHA.113.300972 23640483 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"[160] A. Monfort, A. Wutz, Breathing-in epigenetic change with vitamin C, EMBO Rep. 14 (4) (2013) 337 –346, http://dx.doi.org/10.1038/embor.2013.29 23492828 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Esteban, G. Pan, D. Pei, The histone demethylases Jhdm1a/1b enhance somatic cellreprogramming in a vitamin-C-dependent manner, Cell Stem Cell 9 (6) (2011) 575 –587, http://dx.doi.org/10.1016/j.stem.2011.10.005 22100412 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"53 (5) (2012) 1041 –1047, http://dx.doi.org/10.1016/j.freeradbiomed.2012.07.020 22841757 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"28 (24) (2008) 7451 –7464, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"18 (18) (2013) 2429 –2443, http://dx.doi.org/10.1089/ ars.2012.5107 23311711 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Avvedimento, DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene ex-pression, Science 319 (5860) (2008) 202 –206, http://dx.doi.org/10.1126/sci- ence.1147674 18187655 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"environmental regulation of 5-hydroxymethylcytosine by oxidative stress, Epigenetics 6 (7) (2011) 853 –856, http://dx.doi.org/10.4161/epi.6.7.16461 21617369 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"32 (14) (2004) 4100 –4108, http://dx.doi.org/10.1093/nar/gkh739 15302911 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"67 (3) (2007) 946 –950, http://dx.doi.org/10.1158/0008-5472.CAN-06- 3123 17283125 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"67 (12) (2007) 5583 –5586, http://dx.doi.org/10.1158/ 0008-5472.CAN-07-0846 17575120 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Sowers, In- corporation of 5-chlorocytosine into mammalian DNA results in heritable gene silencing and altered cytosine methylation patterns, Carcinogenesis 30(5) (2009) 886 –893, http://dx.doi.org/10.1093/carcin/bgp060 19279184 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"10 (5) (2013) 256 –266, http://dx.doi.org/10.1038/nrclinonc.2013.42 23546521 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Acta 1846 (1) (2014) 201 –215, http://dx.doi.org/10.1016/j.bbcan.2014.07.004 25026313 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"7 (04) (2005) 1 –20,http://dx.doi.org/10.1017/S146239940500904X .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"360 (22) (2009) 2289 –2301, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"30 (21) (2012) 2670 –2677, http://dx.doi.org/10.1200/ JCO.2011.38.9429 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"10 (3) (2009) 223 –232, http://dx.doi.org/10.1016/S1470-2045(09)70003-8 19230772 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"282 (1) (2009) 116 –123, http://dx.doi.org/10.1016/j.canlet.2009.03.010 19345479 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"93 (9) (2002) 1047 –1056, http://dx.doi.org/10.1111/j.1349-7006.2002.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"373 (1) (2008) 151 –154, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"61 (2013) 197 –205, http://dx.doi.org/10.1016/j.free- radbiomed.2013.04.013 23602908 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"(2015) , http://dx.doi.org/10.1165/ rcmb.2014-0260OC .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Domann, Epigenetic reprogramming governs EcSOD expression during human mam- mary epithelial cell differentiation, tumorigenesis and metastasis, Oncogene 33 (3) (2014) 358 –368, http://dx.doi.org/10.1038/onc.2012.582 23318435 .",OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"USA 99 (13) (2002) 8921 –8926, http://dx.doi.org/10.1073/ pnas.132556899 12070353 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Barnes, Treatment effects of low-dose theophylline combined with an inhaled cor- ticosteroid in COPD, Chest 137 (6) (2010) 1338 –1344, http://dx.doi.org/ 10.1378/chest.09-2363 20299628 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"1215 (2011) 109 –116, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"15 (4) (2014) 401 –408, http://dx.doi.org/ 10.2174/1389201015666140711114450 25022271 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"[191] S.A. Gatz, L. Wiesmüller, Take a break –resveratrol in action on DNA, Car- cinogenesis 29 (2) (2008) 321 –332, http://dx.doi.org/10.1093/carcin/bgm276 18174251 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"17 (2) (2012) 327 –339, http://dx.doi.org/10.1089/ars.2012.4600 22404530 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"van den Brink, J.C. Hardwick, Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness ’via the bone morphogenetic protein pathway, Gut 60 (11) (2011) 1544 –1553, http://dx.doi.org/10.1136/gut.2011.237495 21551187 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Cancer 135 (11) (2014) 2528 –2536, http://dx.doi.org/10.1002/ijc.28672 24346863 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"93 (3) (2015) 343 –351, http://dx.doi.org/10.1016/j.bcp.2014.11.013 25482567 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"[197] S. Schuhmacher, P. Wenzel, E. Schulz, M. Oelze, C. Mang, J. Kamuf, T. Gori, T. Jansen, M. Knorr, S. Karbach, M. Hortmann, F. Mäthner, A. Bhatnagar, U. Förstermann, H. Li, T. Münzel, A. Daiber, Pentaerythritol tetranitrate im- proves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1, Hypertension 55 (4) (2010) 897 –904, http://dx.doi.org/10.1161/ HYPERTENSIONAHA.109.149542 20157049 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"[198] S. Schuhmacher, M. Oelze, F. Bollmann, H. Kleinert, C. Otto, T. Heeren, S. Steven, M. Hausding, M. Knorr, A. Pautz, K. Reifenberg, E. Schulz, T. Gori, P. Wenzel, T. Münzel, A. Daiber, Vascular dysfunction in experimental dia- betes is improved by pentaerithrityl tetranitrate but not isosorbide-5- mononitrate therapy, Diabetes 60 (10) (2011) 2608 –2616, http://dx.doi.org/ 10.2337/db10-1395 21844097 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"Genomics 38 (2) (2009) 176 –185, http://dx.doi.org/10.1152/physiolgenomics.00035.2009 19417013 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"[200] Z. Wu, D. Siuda, N. Xia, G. Reifenberg, A. Daiber, T. Münzel, U. Förstermann, H. Li, Maternal treatment of spontaneously hypertensive rats with pentaer- ythritol tetranitrate reduces blood pressure in female offspring, Hyperten- sion 65 (1) (2015) 232 –237, http://dx.doi.org/10.1161/HYPERTENSIONA- HA.114.04416 25385760 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"32 (10) (2012) 2435 –2443, http://dx.doi.org/ 10.1161/ATVBAHA.112.254011 22859492 .",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
"13 (9A) (2009) 2800 –2821, http://dx.doi.org/10.1111/j.1582-4934.2009.00845.x 19602054 .Y.",Non-OADS,/arxiv_data1/oa_pdf/e1/7d/main.PMC4475862.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/j.nicl.2014.08.017 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"Despite these operational disadvantages, surface-based methods, especially FreeSurfer ( http://surfer.nmr.mgh.",Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
Non-corrected tissue probability maps: Test one Cortical thickness was measured us ing Laplacian and DiRecT methods with the tissue probability map from FSL5.0.1 ( http://fsl.fmrib.ox.ac.uk/ fsl/fslwiki) using default parameters without boundary correction.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
Acknowledgement The authors would like to thank the Victorian Life Sciences Compu- tation Initiative in the University of Melbourne ( http://www.vlsci.org.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/j.media.2009.07.00319648050 .,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"Human Brain Mapping 30, 3188– 3199. http://dx.doi.org/10.1002/hbm.2074019219850 .",Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1161/STROKEAHA.110.59032321148444 .,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.10.06523123680 .,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"3), 61 –75.http://dx.doi.org/10.3233/JAD-2011-000421971451 .",Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/j.jns.2012.07.01922858417 .,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.07.04422846659 .,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1006/ nimg.1998.03959931268 .,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"Neuroimage 45, 867 –87 9. http://dx.doi.org/10.1016/j.neuroimage.",OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1212/WNL.0b013e3182749f3923054230 .,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"IEEE Transactions on Medical Imaging 20, 70 –80.http://dx.doi.org/10.1109/ 42.90642611293693 .",OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1038/nrneurol.,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1371/journal.pone.003823422675527 .,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"Neuroimage 32, 180– 194.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"Journal of Alzheimer 3s Disease: JAD 30, 857– 874. http://dx.doi.org/10.3233/JAD-2012-11206022466003 .",Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"Gender difference anal- ysis of cortical thickness in healthy young adults with surface-based methods.Neuroimage 31, 31 –38.http://dx.doi.org/10.1016/ j.neuroimage.2005.11.04216426865 .",OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.09.,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"Human Brain Mapping 11, 12 –32.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"Neuroimage 27, 210– 221. http://dx.doi.org/10.1016/ j.neuroimage.2005.03.03615896981 .",OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.2010.07.,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"Journal of Comparative Neurology 384, 312 –3209215725 http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/S1474-4422(09)70236-419782001.,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1177/ 08830738990140020710073431 .,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/ j.neurobiolaging.2007.,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1093/cercor/bhh03215054051 .,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1002/hbm.2099121086550 .,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
"Neurology 12, 822 –838.http://dx.doi.org/10.1016/S1474-4422(13)70124-823867200 .",Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
http://dx.doi.org/10.1109/ TMI.2003.81777514552586 .,Non-OADS,/arxiv_data1/oa_pdf/c8/33/main.PMC4475863.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
Although it is believed that oxidative stress contributes to skeletal muscle dysfunctionContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.05.006 2213-2317/ &2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: 1D, one-dimensional; 2D, bi-dimensional; ATP, adenosine tripho- sphate; CK, creatine kinase; DNP, 2 –4-dinitrophenylhydrazone; DNPH, 2,4-dini- trophenylhydrazine; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GPD1,Glycerol-3-phosphate dehydrogenase [NAD þ], cytoplasmic; HSP70, Heat shock 70 kDa protein; IEF, Isoelectric focusing; MM-CK, muscle-type creatine kinase; MS,mass spectrometry; MyBPC, myosin-binding protein C; PCr –CK, phosphocreatine – creatine kinase; RA, rectus abdominis ; RMI, relative modi ﬁcation index; ROS, re- active oxygen species; ZASP, LIM domain-binding protein 3 nCorresponding author at: Sorbonne Universités, UPMC Univ Paris 06, UMR 8256, Biological adaptation and ageing-IBPS, F-75005 Paris, France.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"2012 (2012) 982794, http://dx.doi.org/10.1155/2012/982794 22175016 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"Baraibar, M. Gueugneau, S. Duguez, G. Butler-Browne, D. Bechet, B. Friguet, Expression and modi ﬁcation proteomics during skeletal muscle ageing, Biogerontology 14 (3) (2013) 339 –352, http://dx.doi.org/10.1007/ s10522-013-9426-7 23624703 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"102 (6) (2007) 2389 –2397, http://dx.doi.org/10.1152/ japplphysiol.01202.2006 17289908 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"589 (9) (2011) 2147 –2160, http://dx.doi.org/10.1113/jphysiol.2010.203232 21320887 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"15 (9) (2011) 2519 –2528, http://dx.doi.org/10.1089/ars.2011.3973 21457104 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"Care 15 (3)(2012) 240 –245, http://dx.doi.org/10.1097/MCO.0b013e328352b4c2 22466926 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"14 (2) (2011) 196 –207, http://dx.doi.org/10.1016/j.cmet.2011.05.014 21803290 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"45 (6) (2008)826 –838, http://dx.doi.org/10.1016/j.freeradbiomed.2008.06.006 18598756 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"101 (6) (2006)1581 –1587, http://dx.doi.org/10.1152/japplphysiol.00426.2006 16840579 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"48 (7) (2013) 620 –625, http://dx.doi.org/10.1016/j.exger.2012.10.007 23127722 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"Baraibar, R. Ladouce, B. Friguet, Proteomic quanti ﬁcation and identi ﬁca- tion of carbonylated proteins upon oxidative stress and during cellular aging, J.Proteomics 92 (2013) 63 –70,http://dx.doi.org/10.1016/j.jprot.2013.05.008 .",OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"56 (11) (2001) B459 –B467, http://dx.doi.org/10.1093/gerona/56.11.B459 11682566 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"52 (9) (2012) 1692 –1697, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"39 (9) (2004) 1391 –1400, http://dx.doi.org/10.1016/j.exger.2004.06.002 15489062 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"33 (3) (2000) 287 –293, http://dx.doi.org/10.1080/ 10715760000301451 10993482 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"40 (12) (2005) 959 –965, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"2012 (2012) 1 –8,http://dx.doi.org/10.1155/2012/919832 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"72 (1976) 248 –254, http://dx.doi.org/10.1016/0003-2697(76)90527- 3 942051 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"186 (1990) 464 –478, http://dx.doi.org/ 10.1016/0076-6879(90)86141-H 1978225 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"51 (8) (2011) 1522 –1532, http://dx.doi.org/10.1016/j.freeradbiomed.2011.06.032 21810466 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"Ahmed, A. Rogowska-Wrzesinska, P. Roepstorff, A.-L. Bulteau, B. Friguet, Protein modi ﬁcation and replicative senescence of WI-38 human embryonic ﬁbroblasts, Aging Cell 9 (2) (2010) 252 –272, http://dx.doi.org/10.1111/j.1474- 9726.2010.00555.x 20102351 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"1 (6) (2006) 2856 –2860, http://dx.doi.org/10.1038/nprot.2006.468 17406544 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"22 (4)(2001) 345 –351, http://dx.doi.org/10.1023/A:1013122805060 11808774 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"520 (2) (1999) 463 –471, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"[32] B. Ramamurthy, L. Larsson, Detection of an aging-related increase in advanced glycation end products in fast- and slow-twitch skeletal muscles in the rat,Biogerontology 14 (3) (2013) 293 –301, http://dx.doi.org/10.1007/s10522-013- 9430-y 23681254 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"2011 (2011) 636403, http://dx.doi.org/10.1155/2011/636403 22028592 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"466 (3) (2014) 445 –450, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"33 (10) (2012) 1435 –1438, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"27 (8) (2013) 3217 –3228, http://dx.doi.org/10.1096/fj.13-228882 23657818 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"50 (4) (2011) 613 –620, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"83 (6) (1998)580 –593, http://dx.doi.org/10.1161/01.RES.83.6.580 9742053 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"108 (6) (2011) 751–764, http://dx.doi.org/10.1161/CIRCRESAHA.110.231670 21415409 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"[41] D. Capitanio, M. Vasso, C. Fania, M. Moriggi, A. Viganò, P. Procacci, V. Magnaghi, C. Gel ﬁ, Comparative proteomic pro ﬁle of rat sciatic nerve and gastrocnemius muscle tissues in ageing by 2-D DIGE, Proteomics 9 (7) (2009) 2004 –2020, http://dx.doi.org/10.1002/pmic.200701162 19333999 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"5 (6) (2006) 1344 –1353, http://dx.doi.org/10.1021/ pr050414x 16739986 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"101 (6) (2006) 1581 –1587, http://dx.doi.org/10.1152/japplphysiol.00426.2006 16840579 .S.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"[45] P. Doran, K. O ’Connell, J. Gannon, M. Kavanagh, K. Ohlendieck, Opposite pa- thobiochemical fate of pyruvate kinase and adenylate kinase in aged rat skeletal muscle as revealed by proteomic DIGE analysis, Proteomics 8 (2) (2008) 364 –377, http://dx.doi.org/10.1002/pmic.200700475 18050275 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"30 (4) (2012) 723 –733, http://dx.doi.org/10.3892/ ijmm.2012.1056 22797148 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"505 (2) (2011) 144–154, http://dx.doi.org/10.1016/j.abb.2010.10.013 20965144 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"I, UBMB Life 54 (6) (2002) 323 –333, http://dx.doi.org/10.1080/ 15216540290114676 12665242 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"91 (4) (2011) 1447 –1531, http://dx.doi.org/10.1152/physrev.00031.2010 22013216 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"19 (9) (2005) 1143 –1145, http://dx.doi.org/10.1096/fj.04-3084fje 15831715 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"Maier, G. Butler-Browne, D. Béchet, Proteomics of muscle chronological ageing in post-menopausal women, BMC Genomics 15 (1) (2014) 1165, http://dx.doi.org/10.1186/1471- 2164-15-1165 25532418 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"334 (17) (1996) 1100 –1104, http://dx.doi.org/10.1056/ NEJM199604253341705 8598869 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"284 (49) (2009) 34331 –34341, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"457 (4) (2015) 1–6,http://dx.doi.org/10.1016/j.bbrc.2015.01.043 25603051 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"118 (3) (2015) 386 –394, http://dx.doi.org/10.1152/ japplphysiol.00840.2014 25429098 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"384 (1) (2000) 143–153, http://dx.doi.org/10.1006/abbi.2000.2107 11147825 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"110 (3) (2013) 297 –302, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"Open 3 (12) (2014) 1224 –1227, http://dx.doi.org/10.1242/bio.20149548 25432515 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"Genome 25 (9 – 10) (2014) 464 –472, http://dx.doi.org/10.1007/s00335-014-9519-x 24777203 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"4 (10) (2008) 568 –577, http://dx.doi.org/10.1038/ncpneuro0913 18833216 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"86 (10) (2007) 629 –640, http://dx.doi.org/ 10.1016/j.ejcb.2007.07.003 17761354 .",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
"[69] A. Lombardi, E. Silvestri, F. Ciof ﬁ, R. Senese, A. Lanni, F. Goglia, P. de Lange, M. Moreno, De ﬁning the transcriptomic and proteomic pro ﬁles of rat ageing skeletal muscle by the use of a cDNA array, 2D- and blue native-PAGE ap- proach, J. Proteomics 72 (4) (2009) 708 –721, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/31/91/main.PMC4475901.pdf
Available from: http://www.ojp.usdoj.gov/bjs/cvict.htm.,OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.childstats.gov.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.ojp.usdoj.gov/bjs/pub/pdf/iscs07.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.mehrnews.com.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.SID.ir.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.SID.ir.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.SID.ir.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.SID.ir.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.SID.ir.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.SID.ir.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.ncjrs.gov/pdffiles1/jr000243f.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
":  Youth aggression and violence International Journal of Preventive Medicine, School health (Special issue 2) December 2014 S96Available from: https://www.fatherhood.org/father_ factor.asp.",Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.jamaica-gleaner.com/gleaner/20070923/news/news1.html.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available from: http://www.gse.harvard.edu/news/features/ﬁ schersummary.html.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
Available  from: http://www.self-esteem-nase.org/research.shtml.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/IJPVM-5-83.PMC4476012.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comDear Editor, We read with interest and some perplexity the article  by the Italian surgeon, Sergio Canavero, on the  subject of head transplantation commonly known as  HEAVEN surgery shorthand for its more full name,  “head anastomosis venture” and GEMINI spinal cord  fusion (SCF) procedure.",Non-OADS,/arxiv_data1/oa_pdf/10/9e/SNI-6-103.PMC4476134.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/103/158785 Access this article online Quick Response Code: Website:    www.surgicalneurologyint.com DOI:    10.4103/2152-7806.158785,Non-OADS,/arxiv_data1/oa_pdf/10/9e/SNI-6-103.PMC4476134.pdf
"Surgical Neurology International 2015, 6:103  http://www.surgicalneurologyint.com/content/6/1/103to serious psychological problems, namely insanity and  finally death.",Non-OADS,/arxiv_data1/oa_pdf/10/9e/SNI-6-103.PMC4476134.pdf
Available from: http://www.forbes.com/sites/arthurcaplan/2015/02/26/ doctor‑seeking‑to‑perform‑head‑transplant‑is‑out‑of‑his‑mind/.,Non-OADS,/arxiv_data1/oa_pdf/10/9e/SNI-6-103.PMC4476134.pdf
"Surgical Neurology International 2015, 6:103  http://www.surgicalneurologyint.com/content/6/1/103an intense pre- and post-operative neurorehabilitation  program.",Non-OADS,/arxiv_data1/oa_pdf/10/9e/SNI-6-103.PMC4476134.pdf
"Surgical Neurology International 2015, 6:103  http://www.surgicalneurologyint.com/content/6/1/103Finally, the scientist who introduced PEG to the field  has recently caught on to the power of PEG - along with  peripheral nerve bridges - in providing a long-sought cure  for spinal paralysis.",Non-OADS,/arxiv_data1/oa_pdf/10/9e/SNI-6-103.PMC4476134.pdf
"An illusory transformation of  the whole body is possible including the substitution of  the real body by a virtual body (Slater M, http://cbc.upf.",Non-OADS,/arxiv_data1/oa_pdf/10/9e/SNI-6-103.PMC4476134.pdf
"Surgical Neurology International 2015, 6:103  http://www.surgicalneurologyint.com/content/6/1/103It is called the plasticity principle that together with  the relativistic brain hypothesis[11] will allow humans to  transcend biology within our lifetime.",Non-OADS,/arxiv_data1/oa_pdf/10/9e/SNI-6-103.PMC4476134.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Causes of cerebrospinal fluid (CSF) leakage are primarily traumatic  or iatrogenic in origin.",Non-OADS,/arxiv_data1/oa_pdf/a9/6b/SNI-6-106.PMC4476136.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/106/158898 Copyright: © 2015 Hayashi Y.,Non-OADS,/arxiv_data1/oa_pdf/a9/6b/SNI-6-106.PMC4476136.pdf
"Surgical Neurology International 2015, 6:106  http://www.surgicalneurologyint.com/content/6/1/106CASE REPORT A 38‑year‑old male presented with progressing high  fever, headache, and vomiting for 2 days.",Non-OADS,/arxiv_data1/oa_pdf/a9/6b/SNI-6-106.PMC4476136.pdf
"Surgical Neurology International 2015, 6:106  http://www.surgicalneurologyint.com/content/6/1/106accumulation in the sphenoid sinus or intracranial  air on CT scan was not found for 5 years after  discharge [Figure 4].",Non-OADS,/arxiv_data1/oa_pdf/a9/6b/SNI-6-106.PMC4476136.pdf
"Surgical Neurology International 2015, 6:106  http://www.surgicalneurologyint.com/content/6/1/106It might be impossible to draw conclusions from one  case, but workup for patients with meningitis of unknown  etiology is described below.",Non-OADS,/arxiv_data1/oa_pdf/a9/6b/SNI-6-106.PMC4476136.pdf
"Surgical Neurology International 2015, 6:106  http://www.surgicalneurologyint.com/content/6/1/106through the clivus: Report of two cases.",Non-OADS,/arxiv_data1/oa_pdf/a9/6b/SNI-6-106.PMC4476136.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comThis is the third volume of the monumental A History  of Medicine series  by the medical historian and classical  scholar Plinio Prioreschi M.D., PhD.",Non-OADS,/arxiv_data1/oa_pdf/28/9d/SNI-6-104.PMC4476137.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/104/158789 Copyright: © 2015 Faria MA.,Non-OADS,/arxiv_data1/oa_pdf/28/9d/SNI-6-104.PMC4476137.pdf
"Surgical Neurology International 2015, 6:104  http://www.surgicalneurologyint.com/content/6/1/104Pederasty was accepted but with young male slaves  only.",Non-OADS,/arxiv_data1/oa_pdf/28/9d/SNI-6-104.PMC4476137.pdf
"Surgical Neurology International 2015, 6:104  http://www.surgicalneurologyint.com/content/6/1/104Galen discovered the sources of paraplegia, quadriplegia,  and hemiplegia based on animal studies.",Non-OADS,/arxiv_data1/oa_pdf/28/9d/SNI-6-104.PMC4476137.pdf
"Surgical Neurology International 2015, 6:104  http://www.surgicalneurologyint.com/content/6/1/104One can realistically surmise that the Roman state of  health and the military tradition was consistent with  Juvenal’s shortened aphorism, quoted by Prioreschi mens  sana in corpore sano – “Pray the gods for healthy minds  in healthy bodies and for a stout heart that does not fear  death.”[16] Chapter VIII, “Physicians, Education, Ethics, Hospital,  and Public Health” as noted by the title deals sequentially  and succinctly with those issues.",Non-OADS,/arxiv_data1/oa_pdf/28/9d/SNI-6-104.PMC4476137.pdf
"Surgical Neurology International 2015, 6:104  http://www.surgicalneurologyint.com/content/6/1/104Also in this chapter Prioreschi discusses the widespread  ancient practice of copying other writers’ works, not only  in medical treatises but also in history and literature  tracts, a practice that today we refer to as plagiarism.",Non-OADS,/arxiv_data1/oa_pdf/28/9d/SNI-6-104.PMC4476137.pdf
Available from: http://www.surgicalneurologyint.,Non-OADS,/arxiv_data1/oa_pdf/28/9d/SNI-6-104.PMC4476137.pdf
Available from:  http://www.surgicalneurologyint.com.,Non-OADS,/arxiv_data1/oa_pdf/28/9d/SNI-6-104.PMC4476137.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Aneurysms arising from the posterior communicating artery (PCoA)  itself are rare in which aneurysms usually located in the proximal portion of the  PCoA.",Non-OADS,/arxiv_data1/oa_pdf/ed/73/SNI-6-101.PMC4476138.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/101/158515 Copyright: © 2015 Takeda M. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/ed/73/SNI-6-101.PMC4476138.pdf
"Surgical Neurology International 2015, 6:101  http://www.surgicalneurologyint.com/content/6/1/101Collateral flow to the bilateral PCA and right superior  cerebellar artery through the right PCoA was seen.",Non-OADS,/arxiv_data1/oa_pdf/ed/73/SNI-6-101.PMC4476138.pdf
"Surgical Neurology International 2015, 6:101  http://www.surgicalneurologyint.com/content/6/1/101aneurismal fundus projects to the laterally within  the carotid cistern and most of the aneurysms are  unrelated to perforating arteries.",Non-OADS,/arxiv_data1/oa_pdf/ed/73/SNI-6-101.PMC4476138.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comRecently, an important letter to the editor[48] was  published in Surgical Neurology International (SNI )  in response to my editorial, “The road being paved  to neuroethics: A path leading to bioethics or to  neuroscience medical ethics?”[22] In that article, I made several statements regarding ethics, morality, and religion,  that to the letter writer seemed either inappropriate or  outright incorrect.",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/105/158894 Copyright: © 2015 Faria MA.,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105topic in which no less than philosophy and history  become judges of important moral assertions.",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105The editorial in question repeatedly suggests that  morals are derived from religious principles.",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105The mission statement of World Neurosurgery , the  official journal of the World Federation of Neurosurgical  Societies, includes the wording, to “serve as a forum for  scientific, clinical, educational, social, cultural, economic,  and political ideas and issues for global neurosurgery...",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105colleagues.",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105happened first, as previously mentioned, when the pagan  Greco-Roman world of the Roman Empire adopted  the Judeo-Christian religion and ethics in the form of  Christianity in the 4th century A.D.",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105virtues such as intelligence, prudence, and wisdom.",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105inherited this dual inextricably entwined intellectual and  devotional legacy.",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105establishing tyranny.",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105others living lives of quiet desperation in primitive as well  as modern society.",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105or religion to exercise virtue, are the happy few.",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.ccel.org/ccel/aquinas/summa.,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.surgicalneurologyint.com/text.,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.haciendapub.com/articles/ god-or-man-final-arbiter-moral-law-russell-l-blaylock-md	 [Last	accessed	 on	 2014 Dec 08].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.surgicalneurologyint.com/text.,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.fordham.,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: https://archive.org/details/39002086108496.med.yale.,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.haciendapub.com/medicalsentinel/ medical‑sentinel‑breath‑fresh‑air [Last accessed on 2014 Dec 08].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available  from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/146/142323  [Last accessed on 2014 Dec 8].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.surgicalneurologyint.com/text.,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology International 2015, 6:105  http://www.surgicalneurologyint.com/content/6/1/105surgicalneurologyint.com/text.asp?2013/4/1/16/106578 [Last accessed on  2014 Dec 8].",Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.haciendapub.com/articles/stalin‑ communists‑and‑fatal‑statistics [Last accessed on 2014 Dec 08].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.haciendapub.com/medicalsentinel/ cuban‑psychiatry‑perversion‑medicine [Last accessed on 2014 Dec 8].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.surgicalneurologyint.com/text.,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.haciendapub.com/ randomnotes/religion‑opiate‑people [Last accessed on 2014 Dec 08].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.surgicalneurologyint.com/ text.asp?2013/4/1/91/115162 [Last accessed on 2014 Dec 8].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.thelancet.com/gaza‑letter ‑2014.,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available  from: http://www.haciendapub.com/medicalsentinel/history‑ medicine [Last  accessed on 2014 Dec 08].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.lifetree.org/newsletter/2010‑11‑02.html  [Last accessed on 2015 Mar 10].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.worldneurosurgery.org/content/aims [Last  accessed on 2015 Mar 03].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://www.surgicalneurologyint.com/text.,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
Available from: http://surgicalneurologyint.com/ readercomments.asp?issn=2152‑ 7806;year=2015;volume=6;issue=1;spage= 28;epage=28;aulast=Zrinzo;aid=SurgNeurolInt_2015_6_1_28_151609 [Last  accessed on 2015 Mar 3].,Non-OADS,/arxiv_data1/oa_pdf/37/73/SNI-6-105.PMC4476139.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Surgical treatment of the intracranial pial arteriovenous fistula Warley Carvalho da Silva Martins, Lucas Alverne Freitas de Albuquerque,   Carlos Batista Alves de Souza Filho, Marcos Dellaretti, Atos Alves de Sousa Department of Neurosurgery, Santa Casa de Misericordia Hospital, Belo Horizonte, Minas Gerais, Brazil  E‑mail: *Warley Carvalho da Silva Martins ‑ medicalwarley@yahoo.com.br; Lucas Alverne Freitas de Albuquerque ‑ lucasalverne@gmail.com;   Carlos Batista Alves de Souza Filho ‑ carlosbatistafilho@gmail.com; Marcos Dellaretti ‑ mdellaretti@mac.com; Atos Alves de Sousa ‑ sousatos@hotmail.com   *Corresponding author Received: 21 March 14  Accepted: 16 December 14  Published: 10 June 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.158518  Quick Response Code: Abstract Background:  Pial arteriovenous fistula (PAVF) is a rare vascular condition  comprising of one or more arterial vessels that are in direct communication with  the draining veins.",Non-OADS,/arxiv_data1/oa_pdf/52/1c/SNI-6-102.PMC4476140.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/102/158518 Copyright: © 2015 da Silva Martins WC.,Non-OADS,/arxiv_data1/oa_pdf/52/1c/SNI-6-102.PMC4476140.pdf
"Surgical Neurology International 2015, 6:102  http://www.surgicalneurologyint.com/content/6/1/102Computer tomography (CT) showed a lesion in the  frontal region that suggested an AVM.",Non-OADS,/arxiv_data1/oa_pdf/52/1c/SNI-6-102.PMC4476140.pdf
"Surgical Neurology International 2015, 6:102  http://www.surgicalneurologyint.com/content/6/1/102AVM.",Non-OADS,/arxiv_data1/oa_pdf/52/1c/SNI-6-102.PMC4476140.pdf
"Surgical Neurology International 2015, 6:102  http://www.surgicalneurologyint.com/content/6/1/102treatment, 74 (68.5%) had angiographic evidence of  complete obliteration.",Non-OADS,/arxiv_data1/oa_pdf/52/1c/SNI-6-102.PMC4476140.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/2b/msv051.PMC4476151.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/12/msv052.PMC4476152.pdf
Supplementary Material Supplementary tables S1–S5 and ﬁgures S1–S8 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/1f/12/msv052.PMC4476152.pdf
"http://macclade.org , Sunderland (MA): Sinauer Associates, Inc. Makino T, Hokamp K, McLysaght A.",Non-OADS,/arxiv_data1/oa_pdf/1f/12/msv052.PMC4476152.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/msv057.PMC4476156.pdf
Picard v1.117 ( http://broadinstitute.github.io/picard ) “SamToFastq” command was then used to extract resulting reads from the BAM ﬁle.,OADS,/arxiv_data1/oa_pdf/42/f4/msv057.PMC4476156.pdf
Molecular Phylogenetic Analysis Using the Maximum-Likelihood Method Protein sequences homologous to the each ORF of the region C protein were identiﬁed by a BL ASTP search of the National Center for Biotechnology Information and GRYC (GenomeResources for Yeast Chromosomes http://gryc.inra.fr/index.,OADS,/arxiv_data1/oa_pdf/42/f4/msv057.PMC4476156.pdf
Supplementary Material Supplementary ﬁgures S1–S4 and table S1 and S2are available atMolecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/42/f4/msv057.PMC4476156.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/cd/msv060.PMC4476159.pdf
"( http://tree.bio.ed.ac.uk/ software/ﬁgtree/ , last accessed March 18, 2015) and poorly supported nodes were collapsed manually.",OADS,/arxiv_data1/oa_pdf/1c/cd/msv060.PMC4476159.pdf
"Additional data are availab le from TreeBASE (study 16473 http://purl.org/phylo/tree base/phylows/study/TB2:S16473 , last accessed March 18, 2015), including all nucleotide se- quences, alignments, and tree ﬁles used in this study.",OADS,/arxiv_data1/oa_pdf/1c/cd/msv060.PMC4476159.pdf
Supplementary Material Supplementary ﬁgures S1–S7 and tables S1–S3 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/1c/cd/msv060.PMC4476159.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/bf/msv061.PMC4476160.pdf
Materials and Methods Sequence Analysis of the FBti0019386 Flanking Regions Single nucleotide polymorphism (SNP) data were down- loaded from the DGRP2 webpage ( https://www.hgsc.bcm.,OADS,/arxiv_data1/oa_pdf/35/bf/msv061.PMC4476160.pdf
Strains with ( N= 65) and without ( N=3 8 ) FBti0019386 insertion were ﬁltered using vcftools v_0.1.10 (http://vcftools.sourceforge.net/ ).,OADS,/arxiv_data1/oa_pdf/35/bf/msv061.PMC4476160.pdf
"Detection of HP1a Protein Binding in FBti0019386 Sequence We downloaded all available raw data from modEncode HP1a protein ChIP-Seq experiments: Embryos (ID 3391 and 3392),third instar larvae (ID 4936), and adult heads (ID 5592) (http://data.modencode.org ).",OADS,/arxiv_data1/oa_pdf/35/bf/msv061.PMC4476160.pdf
Supplementary Material Supplementary tables S1–S9 and ﬁgures S1–S3 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/35/bf/msv061.PMC4476160.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/3b/msv070.PMC4476163.pdf
"Fragments in the appropriate ori- entation were subseq uently recombined into the destination vectors pEarleyGate104 and pEarleyGate101 (obtained from TAIR; http://www.arabidopsis.org/ , last accessed March 23, 2015), allowing for C- and N-terminal fusions with YFP, re- spectively.",OADS,/arxiv_data1/oa_pdf/64/3b/msv070.PMC4476163.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/02/msv108.PMC4476165.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/6b/main.PMC4476185.pdf
http://dx.doi.org/10.1016/j.shaw.2015.03.001Safety and Health at Work 6 (2015) 143 e145,Non-OADS,/arxiv_data1/oa_pdf/10/6b/main.PMC4476185.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.qM.H.W.F.-D. is the principal investigator of this study.",Non-OADS,/arxiv_data1/oa_pdf/d0/03/main.PMC4476186.pdf
http://dx.doi.org/10.1016/j.shaw.2014.12.003Safety and Health at Work 6 (2015) 90 e96,Non-OADS,/arxiv_data1/oa_pdf/d0/03/main.PMC4476186.pdf
34 p. Available from:http://www.cpwr.com/publications/chart-book-hazards-and-exposures .,OADS,/arxiv_data1/oa_pdf/d0/03/main.PMC4476186.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/52/main.PMC4476187.pdf
http://dx.doi.org/10.1016/j.shaw.2014.12.002Safety and Health at Work 6 (2015) 146 e150,Non-OADS,/arxiv_data1/oa_pdf/3f/52/main.PMC4476187.pdf
Available from: http://factsreports.revues.org/45 .,Non-OADS,/arxiv_data1/oa_pdf/3f/52/main.PMC4476187.pdf
Available from: http://www.ghanaweb.com/ GhanaHomePage/NewsArchive/artikel.php?ID ¼197916 .,Non-OADS,/arxiv_data1/oa_pdf/3f/52/main.PMC4476187.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
http://dx.doi.org/10.1016/j.shaw.2015.02.001Safety and Health at Work 6 (2015) 104 e113,Non-OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
Available from: http://www.census.gov/ compendia/statab/2012/tables/12s1063.pdf .,OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
2011 [cited 2014 Dec 3] Available from: http://www.fmcsa.dot.gov/ regulations/hours-of-service .,OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
Available from: http://www.fmcsa.dot.gov/sites/ fmcsa.dot.gov/ ﬁles/docs/Ef ﬁcacy-of-HOS-Restart-Rule-Report.pdf .,OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
2013 [cited 2014 Dec 3] Available from: http://www.mrb.fmcsa.,OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
Available from: http://deepblue.lib.umich.edu/bitstream/handle/2027.42/90952/ 102856.pdf?sequence ¼1&isAllowed ¼y.,OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
Available from: http://www.sleepfoundation.org/alert/you- cant-catch-sleep .,Non-OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
Available from: http://www.sleepfoundation.org/article/sleep-topics/napping .,Non-OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
Available from: https://www.fhwa.dot.gov/ohim/onh00/bar8.htm .,Non-OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
Available from: http://www.bls.gov/ooh/transportation-and-material-moving/heavy-and-tractor-trailer-truck-drivers.,Non-OADS,/arxiv_data1/oa_pdf/e8/71/main.PMC4476188.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/54/main.PMC4476190.pdf
http://dx.doi.org/10.1016/j.shaw.2014.12.001Safety and Health at Work 6 (2015) 139 e142,Non-OADS,/arxiv_data1/oa_pdf/4c/54/main.PMC4476190.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/47/main.PMC4476191.pdf
http://dx.doi.org/10.1016/j.shaw.2015.02.005Safety and Health at Work 6 (2015) 85 e89,Non-OADS,/arxiv_data1/oa_pdf/de/47/main.PMC4476191.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/10/main.PMC4476192.pdf
http://dx.doi.org/10.1016/j.shaw.2015.01.001Safety and Health at Work 6 (2015) 120 e127,Non-OADS,/arxiv_data1/oa_pdf/6d/10/main.PMC4476192.pdf
Available from: http://www.hse.gov.uk/statistics/lfs/swit3w12.xls .,OADS,/arxiv_data1/oa_pdf/6d/10/main.PMC4476192.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/cf/main.PMC4476194.pdf
http://dx.doi.org/10.1016/j.shaw.2014.12.004Safety and Health at Work 6 (2015) 114 e119,Non-OADS,/arxiv_data1/oa_pdf/a1/cf/main.PMC4476194.pdf
2012 [cited 2013 Jul 22].Available from: http://www.mhlw.go.jp/bunya/koyoukintou/josei-jitsujo/11.,Non-OADS,/arxiv_data1/oa_pdf/a1/cf/main.PMC4476194.pdf
Available from: http://www.mhlw.go.jp/toukei/itiran/ roudou/saigai/anzen/kenkou07/dl/kenkou07.pdf [In Japanese].,Non-OADS,/arxiv_data1/oa_pdf/a1/cf/main.PMC4476194.pdf
Available from: http://www.stat.,OADS,/arxiv_data1/oa_pdf/a1/cf/main.PMC4476194.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/04/main.PMC4476195.pdf
http://dx.doi.org/10.1016/j.shaw.2015.01.002Safety and Health at Work 6 (2015) 134 e138,Non-OADS,/arxiv_data1/oa_pdf/0c/04/main.PMC4476195.pdf
Available: http://www.who.int/pbd/deafness/facts/en/ .,Non-OADS,/arxiv_data1/oa_pdf/0c/04/main.PMC4476195.pdf
Available from: http://apps.who.int/iris/handle/10665/66040#sthash.3WHayG0y.dpuf .,OADS,/arxiv_data1/oa_pdf/0c/04/main.PMC4476195.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/11/main.PMC4476196.pdf
http://dx.doi.org/10.1016/j.shaw.2015.01.003Safety and Health at Work 6 (2015) 97 e103,Non-OADS,/arxiv_data1/oa_pdf/c9/11/main.PMC4476196.pdf
Available from: https://www.atsb.gov.au/media/36879/ Safety_climate_factors.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c9/11/main.PMC4476196.pdf
Available from: http://www.hse.gov.uk/research/otopdf/1999/oto99063.pdf .,OADS,/arxiv_data1/oa_pdf/c9/11/main.PMC4476196.pdf
Available from: http://www.lboro.ac.uk/media/wwwlboroacuk/content/sbe/ downloads/OffshoreSafetyClimateAssessment.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c9/11/main.PMC4476196.pdf
[cited 2014 Apr 14] Available from: https://www.encorewiki.org/display/ wnzhao/ TheþMinimum þSample þSizeþinþFactorþAnalysis .,Non-OADS,/arxiv_data1/oa_pdf/c9/11/main.PMC4476196.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/26/main.PMC4476197.pdf
http://dx.doi.org/10.1016/j.shaw.2015.03.002Safety and Health at Work 6 (2015) 128 e133,Non-OADS,/arxiv_data1/oa_pdf/90/26/main.PMC4476197.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/ca/main.PMC4476198.pdf
http://dx.doi.org/10.1016/j.shaw.2015.02.002Safety and Health at Work 6 (2015) 151 e155,Non-OADS,/arxiv_data1/oa_pdf/ba/ca/main.PMC4476198.pdf
Available from: http://www.bls.gov/news.release/ archives/osh2_11262013.htm .,OADS,/arxiv_data1/oa_pdf/ba/ca/main.PMC4476198.pdf
Available from: http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm6016a3.htm .,OADS,/arxiv_data1/oa_pdf/ba/ca/main.PMC4476198.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/4b/main.PMC4476202.pdf
http://dx.doi.org/10.1016/j.shaw.2014.11.001Safety and Health at Work 6 (2015) 77 e84,Non-OADS,/arxiv_data1/oa_pdf/f5/4b/main.PMC4476202.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/a1/63/MJIRI-29-198.PMC4476210.pdf
"29.198.15 April2015http://mjiri.iums.ac.irSpinal cord injury (SCI) is a problem that affects different aspects of the victim’s life, particularly the health -related quality of life (HRQOL) (2 -6), and imposes a relatively high burden of the disease (7).",Non-OADS,/arxiv_data1/oa_pdf/a1/63/MJIRI-29-198.PMC4476210.pdf
"29.198.15 April2015 http://mjiri.iums.ac.irhealth perceptions (GH), vitality (VT), s o- cial functioning (SF), role limitation due to emotional problems (RE) and mental health (MH).",Non-OADS,/arxiv_data1/oa_pdf/a1/63/MJIRI-29-198.PMC4476210.pdf
"29.198.15 April2015http://mjiri.iums.ac.irveterans (13.79±3.243 compared to 8.86± 5.321, respectively, p= 0.001).",OADS,/arxiv_data1/oa_pdf/a1/63/MJIRI-29-198.PMC4476210.pdf
"29.198.15 April2015 http://mjiri.iums.ac.ireach group was interviewed by a different set of interviewers, imposing the risk of bias in data collection.",Non-OADS,/arxiv_data1/oa_pdf/a1/63/MJIRI-29-198.PMC4476210.pdf
"29.198.15 April2015http://mjiri.iums.ac.irtempt to match the two groups of veterans and non-veterans based on age, time since injury an d injury severity (complete SCI) resulted in a relatively small sample size, which could lead to the observed insignif i- cant differences.",Non-OADS,/arxiv_data1/oa_pdf/a1/63/MJIRI-29-198.PMC4476210.pdf
"29.198.15 April2015 http://mjiri.iums.ac.irA.H, Ghodsi.M, Montazeri A, Rahimi movaghar V. Health-related quality of life among individuals with long-standing spinal cord injury: a compar ative study of veterans and non -veterans.",Non-OADS,/arxiv_data1/oa_pdf/a1/63/MJIRI-29-198.PMC4476210.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.MD, Associate Professor, Pediatric Gastroenterology division Ali -Asghar Children’s Hospital, Iran University of Medical Sciences, Tehran, Iran.talachian.e@iums.ac.ir 2.",Non-OADS,/arxiv_data1/oa_pdf/74/b6/MJIRI-29-207.PMC4476211.pdf
29.207.27 April2015http://mjiri.iums.ac.irovertreatment of diarrhea with antibiotics is a main reason for drug resistance in deve l- oping countries and increases the need for alternative treatments and preventive met h- ods(5).,Non-OADS,/arxiv_data1/oa_pdf/74/b6/MJIRI-29-207.PMC4476211.pdf
29.207.27 April2015 http://mjiri.iums.ac.irng/mL (50 nmol/L) as deficient and a hig h- er level of 25(OH)D up to 30 ng/mL (75 nmol/L) as insufficient (12-14).,Non-OADS,/arxiv_data1/oa_pdf/74/b6/MJIRI-29-207.PMC4476211.pdf
"29.207.27 April2015http://mjiri.iums.ac.irrheal illness may cause vitamin A deficie n- cy(18,19).",Non-OADS,/arxiv_data1/oa_pdf/74/b6/MJIRI-29-207.PMC4476211.pdf
29.207.27 April2015 http://mjiri.iums.ac.irbelieve a level between 20 and 30 ng/mL still signifies a mild level of deficiency (i n- sufficiency) as it is associated with a rise in PTH level.,Non-OADS,/arxiv_data1/oa_pdf/74/b6/MJIRI-29-207.PMC4476211.pdf
"29.207.27 April2015http://mjiri.iums.ac.irning, and implementation.",Non-OADS,/arxiv_data1/oa_pdf/74/b6/MJIRI-29-207.PMC4476211.pdf
29.207.27 April2015 http://mjiri.iums.ac.ir38.,Non-OADS,/arxiv_data1/oa_pdf/74/b6/MJIRI-29-207.PMC4476211.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _____________________ _______________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/32/8b/MJIRI-29-202.PMC4476212.pdf
"29.202.20 April2015http://mjiri.iums.ac.ircell damage to or inflammatory responses into the muscle cells (2,4).",Non-OADS,/arxiv_data1/oa_pdf/32/8b/MJIRI-29-202.PMC4476212.pdf
"29.202.20 April2015  http://mjiri.iums.ac.ircess of research subjects and the anthrop o- metric indices and aerobic power, sample size for each group in creased to 9.",Non-OADS,/arxiv_data1/oa_pdf/32/8b/MJIRI-29-202.PMC4476212.pdf
29.202.20 April2015http://mjiri.iums.ac.irdividual characteristics and hemodynamic parameters in both groups before the exe r- cise protocol are shown in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/32/8b/MJIRI-29-202.PMC4476212.pdf
29.202.20 April2015  http://mjiri.iums.ac.irdamage as evidenced by an increase in the plasma levels of enzymes.,Non-OADS,/arxiv_data1/oa_pdf/32/8b/MJIRI-29-202.PMC4476212.pdf
"29.202.20 April2015http://mjiri.iums.ac.irexhaustive exercise may increase the pla s- ma levels of CoQ10 oxidative phosphoryl a- tion, accelerates the electron transfer (adenosine triphosphate production), i n- creases availability to another sources of carbohydrates, increases fatty acid meta bo- lism (less reliant anaerobic pathways) and lower subsequent accumulation of plasma lactate(20,21).",Non-OADS,/arxiv_data1/oa_pdf/32/8b/MJIRI-29-202.PMC4476212.pdf
29.202.20 April2015 http://mjiri.iums.ac.ir2008;88(4):1243 -76.,Non-OADS,/arxiv_data1/oa_pdf/32/8b/MJIRI-29-202.PMC4476212.pdf
29.202.20 April2015http://mjiri.iums.ac.irinflammatory myopathies.,Non-OADS,/arxiv_data1/oa_pdf/32/8b/MJIRI-29-202.PMC4476212.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _________________________________________ ___________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/0d/7f/MJIRI-29-203.PMC4476213.pdf
"29.203.21 April2015http://mjiri.iums.ac.iresis was supported by previous observ a- tionsin which KIT expression in melanoma was strong in the in situ and junctional components of invasive lesions, while KIT expression was lost once the melanoma b e- came invasive and metastatic (3,4).",Non-OADS,/arxiv_data1/oa_pdf/0d/7f/MJIRI-29-203.PMC4476213.pdf
"29.203.21 April2015  http://mjiri.iums.ac.ir0 out of 50, regressive changes 1 out of 50 (2%).",Non-OADS,/arxiv_data1/oa_pdf/0d/7f/MJIRI-29-203.PMC4476213.pdf
"29.203.21 April2015http://mjiri.iums.ac.irtwo uveal melanoma cases showed more than 95% of tumor cells positive for KIT, whereas ano ther case was negative for KIT staining (Fig.",Non-OADS,/arxiv_data1/oa_pdf/0d/7f/MJIRI-29-203.PMC4476213.pdf
29.203.21 April2015 http://mjiri.iums.ac.irThe aim of this study was to further clari- fyc-Kit alterations in patients with cutan e- ous and mucosal melanomas and their m e- tastasis.Our results are in keeping with those recent studies showing thatsome types of melanoma hassignificant expre s- sion of KIT which can be detected by IHC.,Non-OADS,/arxiv_data1/oa_pdf/0d/7f/MJIRI-29-203.PMC4476213.pdf
29.203.21 April2015http://mjiri.iums.ac.irnoma.Semin Cutan Med Surg.,Non-OADS,/arxiv_data1/oa_pdf/0d/7f/MJIRI-29-203.PMC4476213.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ________________________________________________________________________________ ____________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/4f/de/MJIRI-29-200.PMC4476214.pdf
29.200.18 April2015http://mjiri.iums.ac.ircine uses radioisotopes for diagnostic and therapeutic cases through oral or injection.,Non-OADS,/arxiv_data1/oa_pdf/4f/de/MJIRI-29-200.PMC4476214.pdf
29.200.18April2015 http://mjiri.iums.ac.irsame time.,Non-OADS,/arxiv_data1/oa_pdf/4f/de/MJIRI-29-200.PMC4476214.pdf
29.200.18 April2015http://mjiri.iums.ac.irtid break (chb) with mean±SD frequencies of 3±0.84 per 100 cells and 3.1±1.40 per 100 cells respectively in the nuclear med i- cine workers versus controls with a mean±SD frequency of 1.86±0.69 and 1.29±0.84 for chg and chb respectively.,OADS,/arxiv_data1/oa_pdf/4f/de/MJIRI-29-200.PMC4476214.pdf
29.200.18April2015  http://mjiri.iums.ac.irevaluated in these personnel using film badge.,Non-OADS,/arxiv_data1/oa_pdf/4f/de/MJIRI-29-200.PMC4476214.pdf
29.200.18 April2015http://mjiri.iums.ac.irHistory of work experience had no corr e- lation with chromosome damages.,Non-OADS,/arxiv_data1/oa_pdf/4f/de/MJIRI-29-200.PMC4476214.pdf
29.200.18April2015 http://mjiri.iums.ac.ir15.,Non-OADS,/arxiv_data1/oa_pdf/4f/de/MJIRI-29-200.PMC4476214.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/07/0e/MJIRI-29-193.PMC4476215.pdf
29.193.14 March 2015http://mjiri.iums.ac.irtypes of ischemic stroke observed.,Non-OADS,/arxiv_data1/oa_pdf/07/0e/MJIRI-29-193.PMC4476215.pdf
"29.193.14 March 2015 http://mjiri.iums.ac.irSurgical Procedure We carefully performed transient, global ischemia.",Non-OADS,/arxiv_data1/oa_pdf/07/0e/MJIRI-29-193.PMC4476215.pdf
29.193.14 March 2015http://mjiri.iums.ac.irprogram.,Non-OADS,/arxiv_data1/oa_pdf/07/0e/MJIRI-29-193.PMC4476215.pdf
"29.193.14 March 2015 http://mjiri.iums.ac.irchemia-reperfusion stimulates an infla m- matory reaction and apoptosis, and it is the main pathophys iologic mechanisms ofDND(19).",Non-OADS,/arxiv_data1/oa_pdf/07/0e/MJIRI-29-193.PMC4476215.pdf
29.193.14 March 2015http://mjiri.iums.ac.irtissue following reperfusion (20).,Non-OADS,/arxiv_data1/oa_pdf/07/0e/MJIRI-29-193.PMC4476215.pdf
29.193.14 March 2015 http://mjiri.iums.ac.ircurs within selectively vulnerable areas such as the CA1 pyramidal neurons ( as our study) and 2 vessel occlusion (common c a- rotid artery occlusion) is a suitable model to evaluate histopathology consequences from brain ischemia (37).,Non-OADS,/arxiv_data1/oa_pdf/07/0e/MJIRI-29-193.PMC4476215.pdf
29.193.14 March 2015http://mjiri.iums.ac.ir2006;295(5):547 -53.,Non-OADS,/arxiv_data1/oa_pdf/07/0e/MJIRI-29-193.PMC4476215.pdf
29.193.14 March 2015 http://mjiri.iums.ac.irvere ischemia and reperfusion.,Non-OADS,/arxiv_data1/oa_pdf/07/0e/MJIRI-29-193.PMC4476215.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran(MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/MJIRI-29-199.PMC4476216.pdf
29.199.18 April2015http://mjiri.iums.ac.irthe Punicaceae family.,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/MJIRI-29-199.PMC4476216.pdf
29.199.18 April2015 http://mjiri.iums.ac.ir36-Item Short F orm Health Survey (SF-36) Questionnaire (17)was used to measure physical and mental components of health related QoL (HRQoL) from ba seline to a f- ter completion of the treatment course.,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/MJIRI-29-199.PMC4476216.pdf
29.199.18 April2015 http://mjiri.iums.ac.irStatistical analysis All statistical analyses were performed using SPSS version 11.5.,OADS,/arxiv_data1/oa_pdf/c5/a9/MJIRI-29-199.PMC4476216.pdf
"29.199.18 April2015  http://mjiri.iums.ac.irHemorrhage PBAC mean (SD) score was reduced in theTA and PG groups, respectively from 304.4 (192.7) and 304.9 (176.1) before treatment, to 143.1 (96) and 164 (100.2) in the third treatment cycle ( p< 0.001), with no statistically significant difference b e- tween the groups after treatment.",Non-OADS,/arxiv_data1/oa_pdf/c5/a9/MJIRI-29-199.PMC4476216.pdf
"29.199.18 April2015http://mjiri.iums.ac.irFurthermore, we compared the improv e- ment of QoL after the intervention between and within the groups.",Non-OADS,/arxiv_data1/oa_pdf/c5/a9/MJIRI-29-199.PMC4476216.pdf
29.199.18 April2015 http://mjiri.iums.ac.irLimitations A placebo -controlled arm to demonstrate the efficacy of our regimens could confirm the observed effects.,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/MJIRI-29-199.PMC4476216.pdf
29.199.18 April2015http://mjiri.iums.ac.irrhagia and normal menstrual blood loss.,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/MJIRI-29-199.PMC4476216.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/99/MJIRI-29-191.PMC4476217.pdf
29.191.14 March2015http://mjiri.iums.ac.irdamage after I/R injury.,Non-OADS,/arxiv_data1/oa_pdf/cd/99/MJIRI-29-191.PMC4476217.pdf
29.191.14 March2015 http://mjiri.iums.ac.irdays before sham ope ration) + sham o p- eration; 3) SIMV20 (Simvastatin 20mg/kg/day for 7 days before sham o p- eration) + sham operation; 4) Untreated left kidney ischemia (45 min) and repe r- fusion (24 h)  (I/R); 5) SIMV10 (Simvastatin 10mg/kg/day for 7 days b e- fore I/R) + I/R; 6) S IMV20 (Simvastatin 20 mg/kg/day for 7 days before I/R) + I/R;7) glibenclamide (5mg/kg i.p.,Non-OADS,/arxiv_data1/oa_pdf/cd/99/MJIRI-29-191.PMC4476217.pdf
"29.191.14 March2015 http://mjiri.iums.ac.irWestern blotting The kidney sections for western blo t- ting were immersed in a lysis buffer (i n- cluding sodium dodecyl sulfate 2.5%, glycerol 10%, Tris-HCl 62.5mM and pH 6.8) and then placed in a thermomixer at 95° for eight minutes.",Non-OADS,/arxiv_data1/oa_pdf/cd/99/MJIRI-29-191.PMC4476217.pdf
"29.191.14 March2015  http://mjiri.iums.ac.irlevels (53.3 ± 7.44mg/dl, p<0.01; Fig .",Non-OADS,/arxiv_data1/oa_pdf/cd/99/MJIRI-29-191.PMC4476217.pdf
29.191.14 March2015 http://mjiri.iums.ac.irWestern blot Western blot analysis revealed that simvastatin in all applied doses did not alter the expression of Bcl -2 and Bax proteins.,Non-OADS,/arxiv_data1/oa_pdf/cd/99/MJIRI-29-191.PMC4476217.pdf
29.191.14 March2015  http://mjiri.iums.ac.irsimvastatin on Bax protein level in I/R - injured ki dney tissue of animals treated with simvastatin at doses 10 and 20mg/kg and 5mg/kg glibenclamide.,Non-OADS,/arxiv_data1/oa_pdf/cd/99/MJIRI-29-191.PMC4476217.pdf
29.191.14 March2015 http://mjiri.iums.ac.irthe tissue after I/R injury which was i m- proved in groups pretreated with simva s- tatin.,Non-OADS,/arxiv_data1/oa_pdf/cd/99/MJIRI-29-191.PMC4476217.pdf
29.191.14 March2015 http://mjiri.iums.ac.irassociated with the membrane depolar i- zation and influx of Ca2+ ions and d e- creasemitochondrial membrane pote n- tial(14).,Non-OADS,/arxiv_data1/oa_pdf/cd/99/MJIRI-29-191.PMC4476217.pdf
29.191.14 March2015http://mjiri.iums.ac.ir11.,Non-OADS,/arxiv_data1/oa_pdf/cd/99/MJIRI-29-191.PMC4476217.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.PhD, Assistant Professor, Dep artmentof Basic Sciences, National Nutrition and Food Technology Research Institute, Faculty of Nutrition and Food Technology, Shahid B eheshti University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/9a/46/MJIRI-29-192.PMC4476218.pdf
29.192.14March2015http://mjiri.iums.ac.irstroke and myocardial infarction (2).Sev- eral causes have been described to be ass o- ciated with the increased risk of acquiring atherosclerosis.,Non-OADS,/arxiv_data1/oa_pdf/9a/46/MJIRI-29-192.PMC4476218.pdf
29.192.14 March 2015 http://mjiri.iums.ac.irthem.,Non-OADS,/arxiv_data1/oa_pdf/9a/46/MJIRI-29-192.PMC4476218.pdf
29.192.14March2015http://mjiri.iums.ac.irsearch demonstrated that patients with more than 75% stenosis of coronary artery had higher level of plasm a oxysterol.,Non-OADS,/arxiv_data1/oa_pdf/9a/46/MJIRI-29-192.PMC4476218.pdf
29.192.14 March 2015 http://mjiri.iums.ac.irrisk of developing atherosclerosis (33).,Non-OADS,/arxiv_data1/oa_pdf/9a/46/MJIRI-29-192.PMC4476218.pdf
29.192.14March2015http://mjiri.iums.ac.irCholesterol oxidation products in the vascular remodeling due to atherosclerosis.,Non-OADS,/arxiv_data1/oa_pdf/9a/46/MJIRI-29-192.PMC4476218.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/fb/93/MJIRI-29-209.PMC4476219.pdf
"29.209.5May2015http://mjiri.iums.ac.ir9 countries showed that even in mothers with normal plasma glucose values (a c- cording to the ADA index), there is still a strong correlation between diabetes co m- plications and plasma glucose levels.",Non-OADS,/arxiv_data1/oa_pdf/fb/93/MJIRI-29-209.PMC4476219.pdf
29.209.5May2015 http://mjiri.iums.ac.ir(n= 90).,Non-OADS,/arxiv_data1/oa_pdf/fb/93/MJIRI-29-209.PMC4476219.pdf
"29.209.5May2015http://mjiri.iums.ac.irFBS test, 1h OGTT, and 2h OGTT were 52, 48, and 24, respectively.",OADS,/arxiv_data1/oa_pdf/fb/93/MJIRI-29-209.PMC4476219.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/76/76/MJIRI-29-197.PMC4476220.pdf
"Parvovirus B19 infection in fetal mortality 2 MJIRI,Vol.29.197.7April2015http://mjiri.iums.ac.irfor replication.",Non-OADS,/arxiv_data1/oa_pdf/76/76/MJIRI-29-197.PMC4476220.pdf
"3 MJIRI,Vol.29.197.7April2015 http://mjiri.iums.ac.irmers and probe at a concentration of 30 and 100 nM, respectively.",OADS,/arxiv_data1/oa_pdf/76/76/MJIRI-29-197.PMC4476220.pdf
"Parvovirus B19 infection in fetal mortality 4 MJIRI,Vol.29.197.7April2015http://mjiri.iums.ac.irtermination of the frequency of parvovirus B19 infection in fetal losses f rom 100 sa m- ples, 6 samples (6%) of dead fetuses were infected with B19V.",Non-OADS,/arxiv_data1/oa_pdf/76/76/MJIRI-29-197.PMC4476220.pdf
"5 MJIRI,Vol.29.197.7April2015 http://mjiri.iums.ac.ir5.Cooling LL, Koerner TA, Naides SJ.",Non-OADS,/arxiv_data1/oa_pdf/76/76/MJIRI-29-197.PMC4476220.pdf
"Parvovirus B19 infection in fetal mortality 6 MJIRI,Vol.29.197.7April2015http://mjiri.iums.ac.ir83(4):679 -84.",Non-OADS,/arxiv_data1/oa_pdf/76/76/MJIRI-29-197.PMC4476220.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/3c/MJIRI-29-201.PMC4476221.pdf
"29.201.20 April2015http://mjiri.iums.ac.irBesides hormonal, iatrogenic and systemic causes, other pathologies such as endom e- trial polyps, sub mucosal fibroids, hype r- plasia and endometrial carcinoma should always be considered as potential progn o- sis.",Non-OADS,/arxiv_data1/oa_pdf/e4/3c/MJIRI-29-201.PMC4476221.pdf
29.201.20 April2015 http://mjiri.iums.ac.irendometrial cavity floor.,Non-OADS,/arxiv_data1/oa_pdf/e4/3c/MJIRI-29-201.PMC4476221.pdf
"29.201.20 April2015http://mjiri.iums.ac.irsive, costly and time -consuming method of hysterosco py.",Non-OADS,/arxiv_data1/oa_pdf/e4/3c/MJIRI-29-201.PMC4476221.pdf
"29.201.20 April2015 http://mjiri.iums.ac.ir5.Dijkhuizen FP ,Mol BW ,Bongers MY ,Bröl- mann HA ,Heintz AP .Cost-effectiveness oftrans- vaginalsonography and saline infused sonography in theevaluation ofmenorrhagia .Int J Gynaecol Obstet.2003;83(1):45 -52.",Non-OADS,/arxiv_data1/oa_pdf/e4/3c/MJIRI-29-201.PMC4476221.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.Assistant Professor, Colorectal Research Center, Iran university of Medical Sciences, Rasool -e-AkramHospital, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
"29.195.6 April2015http://mjiri.iums.ac.irpopulation infected with this organism, predominantly live in Asia.",Non-OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
"29.195.6 April2015 http://mjiri.iums.ac.irlactation, history of previous H. pylori eradication, taking antibiotics  and/or  no n- steroid anti -inflammatory drugs (NSAID) or bismuth during the previous 4 weeks, concomitant use of alcohol, anticoagulant, monoamine oxidase inhibitors (MAOIs), sympathomi metics and/or corticosteroid, history of gastric surgery, known case of neoplasms and severe underlying disease such as; liver, renal, pulmonary or cardiac disease, G6PD deficiency and history of drug allergy to any mentioned medication in this study .",Non-OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
"29.195.6 April2015http://mjiri.iums.ac.irGeiger–Muller counter (Heliprobe Analy s- er, Kibion AB) , and radioactivity of sa m- ples was automatically measured after 250 seconds.",OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
29.195.6 April2015 http://mjiri.iums.ac.ircompliance and one lost follow -up due to appendectomy).,Non-OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
29.195.6 April2015 http://mjiri.iums.ac.irPP eradication rates are shown in Table 5.,Non-OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
"29.195.6 April2015 http://mjiri.iums.ac.irAlso, the rate of metronidazole resistance has been increased in many countries.",Non-OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
29.195.6 April2015http://mjiri.iums.ac.irtreatment and adding another drug such as bismuth in combination with amoxicillin and PPI can be a reasonable approach to reduce the side effects and to increase the effectiveness of furazolidone (40).,Non-OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
"29.195.6 April2015 http://mjiri.iums.ac.irReferences 1.Graham DY, Lu H, Yamaoka Y.",Non-OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
29.195.6 April2015http://mjiri.iums.ac.irA multicenter clinical study.,Non-OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
29.195.6 April2015 http://mjiri.iums.ac.irpylori eradication using tetracycline and furazol i- done versus amoxicillin and azithromycin in lanzoperazole based triple therapy: an open ra ndom- ized clinical trial.,Non-OADS,/arxiv_data1/oa_pdf/cf/ab/MJIRI-29-195.PMC4476222.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/54/ce/MJIRI-29-194.PMC4476223.pdf
29.194.18 March2015http://mjiri.iums.ac.irof the patients had normal blood pressure .,Non-OADS,/arxiv_data1/oa_pdf/54/ce/MJIRI-29-194.PMC4476223.pdf
29.194.18 March2015 http://mjiri.iums.ac.irpressure was controlled.,Non-OADS,/arxiv_data1/oa_pdf/54/ce/MJIRI-29-194.PMC4476223.pdf
29.194.18 March2015http://mjiri.iums.ac.ircontrol reduces the complications of di s- ease and will lead to reducedhealth care costs.,Non-OADS,/arxiv_data1/oa_pdf/54/ce/MJIRI-29-194.PMC4476223.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences __________________________________________________________________________________________ __________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/24/c2/MJIRI-29-204.PMC4476224.pdf
29.204.21 April2015http://mjiri.iums.ac.irdrink alcohol to protect and promote health and prevent diseases (4).,Non-OADS,/arxiv_data1/oa_pdf/24/c2/MJIRI-29-204.PMC4476224.pdf
29.204.21 April2015 http://mjiri.iums.ac.irand Palutzian & Ellison spiritual health questionnaire.,Non-OADS,/arxiv_data1/oa_pdf/24/c2/MJIRI-29-204.PMC4476224.pdf
"29.204.21 April2015http://mjiri.iums.ac.irsuch as father´s or mother's educational level, occupation and age (p>0.05).",Non-OADS,/arxiv_data1/oa_pdf/24/c2/MJIRI-29-204.PMC4476224.pdf
"29.204.21 April2015 http://mjiri.iums.ac.irthe theory of planned behavior and scores of responsibility for health, spiritual health andinterpersonal relations.",Non-OADS,/arxiv_data1/oa_pdf/24/c2/MJIRI-29-204.PMC4476224.pdf
29.204.21 April2015http://mjiri.iums.ac.irperceived behavioral control scores of st u- dents.,Non-OADS,/arxiv_data1/oa_pdf/24/c2/MJIRI-29-204.PMC4476224.pdf
29.204.21 April2015 http://mjiri.iums.ac.ir11.,Non-OADS,/arxiv_data1/oa_pdf/24/c2/MJIRI-29-204.PMC4476224.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ___________________________________________________________________ _________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/13/ea/MJIRI-29-205.PMC4476225.pdf
"29.205.22April2015http://mjiri.iums.ac.irlemsassociated with MS are fatigue, d e- pression, muscular spasms, pain, overactive bladder, and sexual impairments.",Non-OADS,/arxiv_data1/oa_pdf/13/ea/MJIRI-29-205.PMC4476225.pdf
29.205.22 April2015 http://mjiri.iums.ac.irstudy aims to examine whether a large cli n- ical trial for this purpose is feasible.,Non-OADS,/arxiv_data1/oa_pdf/13/ea/MJIRI-29-205.PMC4476225.pdf
29.205.22April2015http://mjiri.iums.ac.iripants.,Non-OADS,/arxiv_data1/oa_pdf/13/ea/MJIRI-29-205.PMC4476225.pdf
29.205.22 April2015 http://mjiri.iums.ac.irexercises were performed using stationar y bikes and treadmills.,Non-OADS,/arxiv_data1/oa_pdf/13/ea/MJIRI-29-205.PMC4476225.pdf
29.205.22April2015http://mjiri.iums.ac.irresearcher could control for the confoun d- ing variables by comparing the posttest r e- sults of each patient with his/her own p re- test results.,OADS,/arxiv_data1/oa_pdf/13/ea/MJIRI-29-205.PMC4476225.pdf
29.205.22 April2015 http://mjiri.iums.ac.iressential questions are: what are the most effective exercises?,Non-OADS,/arxiv_data1/oa_pdf/13/ea/MJIRI-29-205.PMC4476225.pdf
"29.205.22 April2015 http://mjiri.iums.ac.ir33.Rao S. A manual for the brief, repeatable battery of neuropsychological tests in multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/13/ea/MJIRI-29-205.PMC4476225.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.PhD, Research Exp ert, Development of Research & Technology Center, Deputy of Research & Technology, Ministry of Health and Medical Education, Tehran, Iran, and Non Communicable Disease Research Center, Endocrine & Metabolism Research Institute, Tehran Univ ersity of MedicalScience, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/1b/70/MJIRI-29-210.PMC4476226.pdf
"29.210.5May2015http://mjiri.iums.ac.irproductive life (2, 3).Undoubtedly, unive r- sity students, like other young groups, are at riskofsexually transmitted infections and related problems.",Non-OADS,/arxiv_data1/oa_pdf/1b/70/MJIRI-29-210.PMC4476226.pdf
"29.210.5May2015 http://mjiri.iums.ac.irtraining course was given by six trainers who were gynecologists, maternal and child health specialists, general practitioners, psychiatrics and psychologists.",Non-OADS,/arxiv_data1/oa_pdf/1b/70/MJIRI-29-210.PMC4476226.pdf
29.210.5May2015http://mjiri.iums.ac.irstratified sampling.,OADS,/arxiv_data1/oa_pdf/1b/70/MJIRI-29-210.PMC4476226.pdf
29.210.5May2015  http://mjiri.iums.ac.irHIV/AIDS.,Non-OADS,/arxiv_data1/oa_pdf/1b/70/MJIRI-29-210.PMC4476226.pdf
29.210.5May2015http://mjiri.iums.ac.irthan the others (64.7% vs. 44.8%; p= 0.02).,OADS,/arxiv_data1/oa_pdf/1b/70/MJIRI-29-210.PMC4476226.pdf
29.210.5May2015 http://mjiri.iums.ac.iruniversities.,Non-OADS,/arxiv_data1/oa_pdf/1b/70/MJIRI-29-210.PMC4476226.pdf
29.210.5May2015http://mjiri.iums.ac.irEastern Mediterranean Health Journal 2004; 10(1/2):72 -81.,Non-OADS,/arxiv_data1/oa_pdf/1b/70/MJIRI-29-210.PMC4476226.pdf
Available from: http://www.un.org/millennium goals/aids.shtml.,Non-OADS,/arxiv_data1/oa_pdf/1b/70/MJIRI-29-210.PMC4476226.pdf
Available from:http://www.unfpa.org/public/cache/offonce/ home/sitemap/icpd/International -Conference -on- Populatio n-and-Development/ICPD -Summary.,Non-OADS,/arxiv_data1/oa_pdf/1b/70/MJIRI-29-210.PMC4476226.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.MD, MPH, PhD, Assistant Professor of Epidemiology, Department of Epidemiology and Biostatistics, School of Public Health, T ehran Uni- versity of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/f8/5e/MJIRI-29-206.PMC4476227.pdf
29.206.26 April2015http://mjiri.iums.ac.irprograms (4).,OADS,/arxiv_data1/oa_pdf/f8/5e/MJIRI-29-206.PMC4476227.pdf
29.206.26 April2015 http://mjiri.iums.ac.irresearchers with the affiliation of that ce n- ter.,Non-OADS,/arxiv_data1/oa_pdf/f8/5e/MJIRI-29-206.PMC4476227.pdf
29.206.26 April2015http://mjiri.iums.ac.irbooks in 2011 ( Fig.1).,Non-OADS,/arxiv_data1/oa_pdf/f8/5e/MJIRI-29-206.PMC4476227.pdf
"29.206.26 April2015 http://mjiri.iums.ac.irindex which shows the quality and impact of scientific productions had a median of 11.The median g -index, hg -index, and A - index were 17.5, 14.3, and 22.9 respectiv e- ly and the median R -index, e-index, and impact index were 16.5, 11.2, and 1.6, r e- spectively (Table 4 and 5).",OADS,/arxiv_data1/oa_pdf/f8/5e/MJIRI-29-206.PMC4476227.pdf
29.206.26 April2015http://mjiri.iums.ac.irwas 7.7±10.4 and the mean±SD number of the sessions of the research council was 33.7±19.5.,OADS,/arxiv_data1/oa_pdf/f8/5e/MJIRI-29-206.PMC4476227.pdf
"29.206.26 April2015 http://mjiri.iums.ac.irsimilar inv estigation has been performed on evaluation of scientific output of several research centers but a study on the 36 -year scientific products of Pasteur Institute of Iran in the Web of Science revealed that 823 papers were published by the institute until the end of 2009, indicating the high speed of science production between 2005 and 2009 (28).",Non-OADS,/arxiv_data1/oa_pdf/f8/5e/MJIRI-29-206.PMC4476227.pdf
29.206.26 April2015http://mjiri.iums.ac.irrelationship with paper publication.,Non-OADS,/arxiv_data1/oa_pdf/f8/5e/MJIRI-29-206.PMC4476227.pdf
29.206.26 April2015 http://mjiri.iums.ac.irgrounds for improving the quality and quantity of their performance.,Non-OADS,/arxiv_data1/oa_pdf/f8/5e/MJIRI-29-206.PMC4476227.pdf
29.206.26 April2015http://mjiri.iums.ac.irjournals.,Non-OADS,/arxiv_data1/oa_pdf/f8/5e/MJIRI-29-206.PMC4476227.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/26/b6/MJIRI-29-208.PMC4476228.pdf
"29.208.28 April2015http://mjiri.iums.ac.irIn Iran, a community -based study r e- vealed that lifetime prevalence of suicidal thoughts, plans and attempts were 12.7, 6.2 and 3.3 percent respectively (3).",Non-OADS,/arxiv_data1/oa_pdf/26/b6/MJIRI-29-208.PMC4476228.pdf
"29.208.28 April2015http://mjiri.iums.ac.irpsychologist for 70 subjects, 35 cases with major depression (according to DSM -IV criteria) and 35 without mental disorders.",Non-OADS,/arxiv_data1/oa_pdf/26/b6/MJIRI-29-208.PMC4476228.pdf
29.208.28 April2015http://mjiri.iums.ac.irIn urban areas the screening was pe r- formed among the referrals in HCs every day and the suspected cases were referred to GPs in the same center for any manag e- ment.,Non-OADS,/arxiv_data1/oa_pdf/26/b6/MJIRI-29-208.PMC4476228.pdf
"29.208.28 April2015http://mjiri.iums.ac.irStatistical Analysis The data were analyzed using SPSS for windows, version 16 (SPSS Inc., Chicago, IL).",OADS,/arxiv_data1/oa_pdf/26/b6/MJIRI-29-208.PMC4476228.pdf
29.208.28 April2015http://mjiri.iums.ac.irSecondary Outcomes 1.Suicide attempt.,Non-OADS,/arxiv_data1/oa_pdf/26/b6/MJIRI-29-208.PMC4476228.pdf
"29.208.28 April2015http://mjiri.iums.ac.irHowever, in Savojbolagh the program was not successful and the rate of suicide rose from 1.6 to 3.4 per 100’000 population (in the intervention period) in the corr e- spondence period.",Non-OADS,/arxiv_data1/oa_pdf/26/b6/MJIRI-29-208.PMC4476228.pdf
29.208.28 April2015http://mjiri.iums.ac.ir1996; 11:181 -8.,Non-OADS,/arxiv_data1/oa_pdf/26/b6/MJIRI-29-208.PMC4476228.pdf
33.Statistical Center of Iran [http://www.amar.org.ir/].,Non-OADS,/arxiv_data1/oa_pdf/26/b6/MJIRI-29-208.PMC4476228.pdf
"http://www.ama - assn.org/ama/pub/category/1736.htmlStatistical 34.Bruce M L, Ten Have T R, Reynolds C F, Katz I, Schulberg H C, Mulsant B H, and et al.",Non-OADS,/arxiv_data1/oa_pdf/26/b6/MJIRI-29-208.PMC4476228.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/65/f6/MJIRI-29-196.PMC4476229.pdf
29.196.7April2015http://mjiri.iums.ac.irment: shortage of acute psychiatric beds.,Non-OADS,/arxiv_data1/oa_pdf/65/f6/MJIRI-29-196.PMC4476229.pdf
29.196.7April2015 http://mjiri.iums.ac.irtable.,Non-OADS,/arxiv_data1/oa_pdf/65/f6/MJIRI-29-196.PMC4476229.pdf
29.196.7April2015http://mjiri.iums.ac.irtients were only looked after by their fam i- lies.,Non-OADS,/arxiv_data1/oa_pdf/65/f6/MJIRI-29-196.PMC4476229.pdf
29.196.7April2015 http://mjiri.iums.ac.ireffects checklist and updating medical AMD 4.Providing a data sheet to register the collected data for eac h patient and tracking them 5.Having the AMD reviewed by the s u- pervisor in every supervision session 6.Having the patients’ data sheets r e- viewed by the main investigator periodica l- ly 7.Contacting the participants or their caregivers every 2 to 3 months to trace the activities being performed regularly by each case manager .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/MJIRI-29-196.PMC4476229.pdf
"29.196.7April2015http://mjiri.iums.ac.irOutcome Measures The psychological status was not signif i- cantly different among the three groups b e- fore the intervention, validating the ra n- domization of the participants.",Non-OADS,/arxiv_data1/oa_pdf/65/f6/MJIRI-29-196.PMC4476229.pdf
"29.196.7April2015 http://mjiri.iums.ac.irmean difference of the utility score at bas e- line and after 12 months was 0.056 (95% CI:-0.13-0.24), 0.15 (95% CI: -0.01-0.32) and-0.068 (95% CI: -0.24-0.10) in the ge n- eral practitioner, nurse and control groups, respectively.",Non-OADS,/arxiv_data1/oa_pdf/65/f6/MJIRI-29-196.PMC4476229.pdf
29.196.7April2015http://mjiri.iums.ac.ircurrent medications and link them to a ps y- chiatrist to manage their problems in a more appropriate way.,Non-OADS,/arxiv_data1/oa_pdf/65/f6/MJIRI-29-196.PMC4476229.pdf
29.196.7April2015 http://mjiri.iums.ac.ir8.,Non-OADS,/arxiv_data1/oa_pdf/65/f6/MJIRI-29-196.PMC4476229.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f5/2b/main.PMC4476268.pdf
"The idea  of  modeling  the  correct  kind  of  ELA  is irrelevant, since  there  is  no  single  type  of  exposure,  and the remarkable  plasticity  exhibited  by  the  brain  is  largely http://dx.doi.org/10.1016/j.dcn.2014.07.001 1878-9293/©  2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/f5/2b/main.PMC4476268.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/2b/main.PMC4476268.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/8a/ahmt-6-101.PMC4476312.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdolescent Health, Medicine and Therapeutics 2015:6 101–113Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  101OriginAl reseArcHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S8433 2Factors that influence the preventive care offered  to adolescents accessing Public Oral Health  services, nsW, Australia Angela V Masoe1 Anthony s Blinkhorn2 Jane Taylor1 Fiona A Blinkhorn1 1School of Health Sciences, Faculty  of Health and Medicine, Oral Health,   University of Newcastle, Ourimbah,   nsW, Australia; 2Department of  Population Oral Health, Faculty  of Dentistry, University of Sydney,   Westmead, nsW, Australia correspondence: Angela V Masoe   Oral Health, PO Box 729,   Queanbeyan 2620, nsW, Australia   Tel +61 2 6128 9852   email a ngela.masoe@gsahs.health.nsw.",Non-OADS,/arxiv_data1/oa_pdf/0d/8a/ahmt-6-101.PMC4476312.pdf
Available from: http://www.who.int/kms/ about/strategy/kms_strategy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/8a/ahmt-6-101.PMC4476312.pdf
Available from: http://www.health.nsw.gov.au/oralhealth/ Documents /oral-health-2020.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/8a/ahmt-6-101.PMC4476312.pdf
Available from:  http://www.health.nsw.gov.au/statehealthplan/Publications/NSW-State- Health-Plan-Towards-2021.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/8a/ahmt-6-101.PMC4476312.pdf
"Available from: http://www0.health.nsw.gov.au/policies/ pd/2013/pdf/PD2013_025.pd f. Accessed May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0d/8a/ahmt-6-101.PMC4476312.pdf
"Available from:  http://www0.health.nsw.gov.au/policies/pd/2009/pdf/PD2009_046.pd f.  Accessed May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0d/8a/ahmt-6-101.PMC4476312.pdf
"Available from:  http://www.health.nsw.gov.au/environment/water/Documents/PD2006- 076-Use-of-Fluorides-in-NSW .pd f. Accessed May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0d/8a/ahmt-6-101.PMC4476312.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/0d/8a/ahmt-6-101.PMC4476312.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/8a/ahmt-6-101.PMC4476312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/90/nihms-700217.PMC4476383.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/j.abrep.2015.03.006 2352-8532/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
"Cognitive Behaviour Therapy ,41,5 1 –62.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/S0306-4603(01)00241-6 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1037/0021-843X.111.1.180 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1080/14622200500259788 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/ S0306-4603(01)00238-6 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1037/0022-006X.63.6.1005 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1037/0022-006X.58.3.310 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1037/1064-1297.3.2.174 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1046/j.1360-0443.1999.94226910.x .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/j.janxdis.2008.01.005 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/S0140-6736(08)60871-5 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1097/00004583-200002000-00021 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1111/j.1360-0443.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1093/ntr/ntr332 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1037/a0024133 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1037/a0024133 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/ 10.1001/jama.284.20.2606 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
"Journal of Psychopathology and Behavioral Assessment ,29(2), 69 –79.http://dx.doi.org/10.1007/s10862-006- 9028-7 .",Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/0887-6185(92)90036-7 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/ 10.1037/a0018009 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
"Journal of Anxiety Disorders , 18(1), 7 –18.http://dx.doi.org/10.1016/j.janxdis.2003.07.003 .",Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/ 10.1016/j.janxdis.2006.11.003 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
"The American Journal on Addictions ,18(1), 93 –99.http://dx.doi.org/10.1080/10550490802408985 .",Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/S0006-3223(02)01475-0 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/S0887- 6185(02)00175-5 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/ 0306-4603(94)90032-9 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
"Addictive Behaviors ,19,3 3 –39.http://dx.doi.org/10.1016/0306- 4603(94)90049-3 .",Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/0005-7967(86) 90143-9 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1037/0021-843X.108.3.532 .32 C.P.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/j.jpsychires.2006.07.009 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1891/ jcop.17.2.179.57431 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1037/0022-3514.54.6.1063 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1093/ntr/nts208 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/S1077- 7229(03)80052-4 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1016/j.addbeh.2004.02.017 .,OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1093/ntr/ntn037 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.1080/ 14622200701540812 .,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/56/fe/main.PMC4476409.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/4f/main.PMC4476410.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2015.05.001 2352-2895/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/4f/main.PMC4476410.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 2 (2015) 44 e50,Non-OADS,/arxiv_data1/oa_pdf/8c/4f/main.PMC4476410.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/90/cvv153.PMC4476413.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/15/8d/cia-10-969.PMC4476422.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 969–977Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  969OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8308 6Development, validation, and administration of   a treatment-satisfaction questionnaire for  caregivers of dependent type 2 diabetic patients Judit garcía-Aparicio José-Ignacio herrero- herrero los Montalvos Internal Medicine  Department, University hospital   of salamanca, salamanca, spainBackground:  Satisfaction with treatment is considered a relevant factor for assessing results  in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/15/8d/cia-10-969.PMC4476422.pdf
"Some, like the Diabetes Treatment  Satisfaction Questionnaire,2 are specific, while others, such as the Diabetes-Specific  Quality-of-Life Scale3 and the Diabetes Quality of Life Clinical Trial Questionnaire,4  come under the category of quality-of-life assessments.Correspondence: José-Ignacio herrero- herrero servicio de Medicina Interna “los  Montalvos”, Complejo Asistencial  Universitario de salamanca (hospital los  Montalvos), salamanca 37192, spain Tel +34 923 330 164 Fax +34 923 330 418 email jherreroh@saludcastillayleon.e s Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: García-Aparicio and Herrero-Herrero Running head recto: Satisfaction questionnaire for caregivers of diabetics DOI: http://dx.doi.org/10.2147/CIA.S83086",Non-OADS,/arxiv_data1/oa_pdf/15/8d/cia-10-969.PMC4476422.pdf
"Clinical Interventions in Aging Publish	your	work	in	this	journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/15/8d/cia-10-969.PMC4476422.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/15/8d/cia-10-969.PMC4476422.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/92/cia-10-963.PMC4476423.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 963–967Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  963OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8314 1rates and predictors of uncontrolled bronchial  asthma in elderly patients from western romania Iosif Marincu1 stefan Frent1 Mirela Cleopatra T omescu2 stefan Mihaicuta1 1Department of Infectious Diseases,   Pulmonology, epidemiology and  Parasitology, 2Department of Internal  Medicine I, Victor Babes University  of Medicine and Pharmacy, Timisoara,   romaniaPurpose:  Bronchial asthma (BA) is a chronic inflammatory disorder of the airways, featuring  variable and often reversible airflow limitations.",Non-OADS,/arxiv_data1/oa_pdf/ba/92/cia-10-963.PMC4476423.pdf
"For an accu - rate assessment, guidelines recommend the evaluation of daily and nightly symptoms,  quantification of daily activity impairment (at work in adults and at school in children) Correspondence: Mirela Cleopatra  Tomescu Department of Internal Medicine I,  Victor Babes University of Medicine and  Pharmacy, Bd revolutiei din 1989 nr 12,  Timisoara 300024, romania Tel +40 722 979 516 Fax +40 256 220 636 email tomescu.mirela@umft.r o Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Marincu et al Running head recto: Predictors of uncontrolled bronchial asthma in elderly from Romania DOI: http://dx.doi.org/10.2147/CIA.S83141",Non-OADS,/arxiv_data1/oa_pdf/ba/92/cia-10-963.PMC4476423.pdf
Available from: http://www.ginasthma.,Non-OADS,/arxiv_data1/oa_pdf/ba/92/cia-10-963.PMC4476423.pdf
"Available from: http://www.asparad.ro/Statistica/BOLI  PROFESIONALE 2011.pd f. Accessed June 9, 2015.",OADS,/arxiv_data1/oa_pdf/ba/92/cia-10-963.PMC4476423.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ba/92/cia-10-963.PMC4476423.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ba/92/cia-10-963.PMC4476423.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/e2/dddt-9-3099.PMC4476424.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3099–3108Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3099Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8556 7Phase ii study of reintroduction of oxaliplatin  for advanced colorectal cancer in patients  previously treated with oxaliplatin and irinotecan:  re-OPen study correspondence: Mitsukuni suenaga Department of gastroenterology, cancer  institute hospital of Japanese Foundation  for cancer research, 3-8-31 ariake,  Koto-ku, Tokyo 135-8550, Japan Tel +813 3520 0111 Fax +813 3570 0343 email m.suenaga@jfcr.or.j p Mitsukuni suenaga1 nobuyuki Mizunuma1 satoshi Matsusaka1 eiji shinozaki1 Masato Ozaka1 Mariko Ogura1 T oshiharu Yamaguchi2 1Department of gastroenterology,   2Department of gastroenterological  surgery, cancer institute hospital  of Japanese Foundation for cancer  research, T okyo, JapanBackground:  The effectiveness of reintroducing oxaliplatin in patients with metastatic colorectal  cancer refractory to standard chemotherapy has not been verified.",Non-OADS,/arxiv_data1/oa_pdf/98/e2/dddt-9-3099.PMC4476424.pdf
"Keywords:  reintroduction, oxaliplatin, FOLFOX, advanced colorectal cancer, salvage-line Introduction Colorectal cancer is the leading cause of cancer death among women and third highest  cause of cancer death among men in Japan.1 Oxaliplatin, irinotecan, fluorouracil (5-FU),  and several molecular-targeting agents are key drugs in the treatment of metastatic  colorectal cancer (mCRC).2–6 Most patients receive regimens that include a combina - tion of these key drugs (such as 5-FU+leucovorin +oxaliplatin [FOLFOX], CapeOX,  or 5-FU+leucovorin +irinotecan [FOLFIRI]) plus bevacizumab, and cetuximab or  panitumumab is available if the tumor has wild-type Kirsten rat sarcoma ( KRAS ).7–14  Sequential use of the established regimens containing these key agents has been shown Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Suenaga et al Running head recto: Reintroducing oxaliplatin for advanced colorectal cancer  DOI: http://dx.doi.org/10.2147/DDDT.S85567",Non-OADS,/arxiv_data1/oa_pdf/98/e2/dddt-9-3099.PMC4476424.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/98/e2/dddt-9-3099.PMC4476424.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/e2/dddt-9-3099.PMC4476424.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/79/copd-10-1147.PMC4476425.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1147–1154International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1147OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8583 1severe hypoalbuminemia is a strong independent  risk factor for acute respiratory failure in COPD:  a nationwide cohort study Char-Wen Chen1,* Yih-Yuan Chen2,* Chin-li lu3 solomon Chih-Cheng  Chen3 Yi-Jen Chen1,4 Ming-shian lin1,4 Wei Chen1,5,6 1Division of Pulmonary and Critical  Care Medicine, Chia-Yi Christian  hospital, Chiayi, 2Department of  Internal Medicine, Chia-Yi Christian  hospital, Chiayi, 3Department of  Medical research, Ditmanson Medical  Foundation, Chia-Yi Christian  hospital, Chiayi, 4Department of  respiratory Care, Chang gung  University of science and T echnology,   Chiayi Campus; Changhua, 5College of  nursing, Dayeh University, Changhua  6Department of respiratory Therapy,   China Medical University, Taichung,   Taiwan *These authors contributed equally  to this workBackground:  Acute respiratory failure (ARF) is a life-threatening event, which is frequently  associated with the severe exacerbations of chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/71/79/copd-10-1147.PMC4476425.pdf
"Keywords:  COPD, acute respiratory failure, hypoalbuminemia Introduction Chronic obstructive pulmonary disease (COPD) is characterized by progressive,  partially reversible airflow obstruction and lung hyperinflation with significant extra - pulmonary manifestations and comorbid conditions.1–3 It is the fourth leading cause  of chronic morbidity and mortality in the US4 and is projected to rank fifth in 2020  in terms of burden of disease worldwide.5,6 The natural course of COPD includes  progressively declining lung function and a number of episodic exacerbations, which  is defined as a worsening of respiratory symptoms requiring treatment with oral corti - costeroids or antibiotics.7 Acute exacerbation (AE) is highly correlated with increased  emergency department (ED) visits, respiratory failure, hospitalizations, and deaths in  patients with COPD.8,9 Acute respiratory failure (ARF) is a common and life-threatening event, which is  frequently associated with severe AE of COPD.10 Short-term or long-term outcomes Correspondence: Wei Chen Division of Pulmonary and Critical Care  Medicine, Chia-Yi Christian hospital,  539 Jhongsiao road, Chiayi 600, Taiwan Tel +886 5 276 5041 Fax +886 5 277 4511 email peteralfa2004@yahoo.com.t w Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chen et al Running head recto: Hypoalbuminemia in COPD DOI: http://dx.doi.org/10.2147/COPD.S85831",Non-OADS,/arxiv_data1/oa_pdf/71/79/copd-10-1147.PMC4476425.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/71/79/copd-10-1147.PMC4476425.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/79/copd-10-1147.PMC4476425.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 991–1001Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  991OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7639 8Dosing of U-100 insulin and associated outcomes  among Medicare enrollees with type 1 or type 2  diabetes elizabeth l eby1 Kate Van Brunt2 Cynthia Brusko3 Bradley Curtis4 Maureen J lage5 1global Patient Outcomes and real  World evidence, eli lilly and  Co.,   Indianapolis In  UsA; 2eli lilly and  Co.,   Windlesham, UK; 3lilly UsA, llC,   Indianapolis, In , UsA; 4eli lilly  and Co., Indianapolis, In , UsA;   5healthMetrics Outcomes research,   llC, Bonita springs, Fl, UsAObjective:  To examine costs, resource utilization, adherence, and hypoglycemic events among  various doses of U-100 insulin regimens among elderly patients (age 65 years) diagnosed  with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
"Keywords:  insulin, diabetes, costs, resource utilization, adherence, hypoglycemia Introduction The US population is aging at a faster rate than at any other time in the history of the  United States,1 with one projection estimating that the number of Americans aged  65 years and older will be more than double – from 47.7 to 97.1 million persons –  between the years 2015 and 2060.2 Increasing age is a non-modifiable risk factor for  type 2 diabetes mellitus (T2DM),3 which accounts for 90%–95% of all diabetes cases,4  and the aging of the population is a major driver of the Nation’s growing diabetes  epidemic.5 As of 2012, one in four Americans 65  years of age or older has diabetes,  compared to approximately one in eight among US adults overall (25.9% vs 12.3%),4  and the prevalence of the disease among elderly individuals is increasing.6 Elderly  persons with diabetes have greater disability, a higher burden of illness, and a greater  risk of institutionalization relative to their counterparts without the disease,5,7 and among Correspondence: Maureen J lage healthMetrics Outcomes research, llC,  27576 river reach Drive, Bonita springs, Fl 34134, UsA Tel +1 860 245 0685 email lagemj@hlthmetrics.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Eby et al Running head recto: Dosing of U-100 insulin and associated outcomes DOI: http://dx.doi.org/10.2147/CIA.S76398",Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
"Available from: http://www.cdc.gov/aging/help/dph-aging/state- aging-health.htm l. Accessed April 3, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
"Available from: http://www.census.gov/population/ projections/data/national/2012/summarytables.htm l. Accessed April 3,  2014.was associated with improved adherence (ie, a PDC threshold  of at least 80%).",OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
Available from: http://www.professional.,Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
Available at http://www.cdc.gov/diabetes/pubs/statsreport14/ national-diabetes-report-we b.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
Available from:  http://www.diabetes.org/diabetes-basics/type-1 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
Available from: http://www.bd.com/us/diabetes/page.,Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
Available from: http://www.uspharmacist.com/content/s/126/ c/20822 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b7/59/cia-10-991.PMC4476426.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/d0/copd-10-1163.PMC4476427.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1163–1172International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1163OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8180 6T est-retest reliability of lower limb isokinetic  endurance in COPD: a comparison of angular  velocities Fernanda ribeiro* Pierre-alexis lépine* Corine garceau-Bolduc Valérie Coats Étienne allard François Maltais Didier saey Centre de recherche de l’Institut  Universitaire de cardiologie et de  pneumologie de Québec, Université  laval, Québec, Canada *These authors contributed equally  to this workBackground:  The purpose of this study was to determine and compare the test-retest reliability  of quadriceps isokinetic endurance testing at two knee angular velocities in patients with chronic  obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/92/d0/copd-10-1163.PMC4476427.pdf
"Muscle endurance is defined as the ability to main - tain a given task over a certain period of time, and it is determined by muscle fiber  oxidative capacity, and the oxygen supply.4 In COPD, muscle endurance is impaired  to a greater extent than strength.5,6 Impaired muscle endurance may even be present in Correspondence: Didier saey Institut Universitaire de cardiologie et de  pneumologie de Québec, 2725 Chemin  ste-Foy, Québec, Canada g1V 4g5 Tel +1 418 656 2614 Fax +1 418 656 4762 email didier.saey@rea.ulaval.c a Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ribeiro et al Running head recto: Testing muscle endurance in COPD DOI: http://dx.doi.org/10.2147/COPD.S81806",Non-OADS,/arxiv_data1/oa_pdf/92/d0/copd-10-1163.PMC4476427.pdf
"Available from:  http://www.physiotherapy.ca/getmedia/4f79b505-18ec-4ab6- 93f2 - a0c75f97711c/2004-PTC-56_2-test-retest-mathur_en.pdf.asp x.  Accessed April 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/92/d0/copd-10-1163.PMC4476427.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/92/d0/copd-10-1163.PMC4476427.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s International Journal of COPD 2015:10submit your manuscript | www.dovepress.co m Dove press Dove press 1172ribeiro et al  41.,Non-OADS,/arxiv_data1/oa_pdf/92/d0/copd-10-1163.PMC4476427.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/ac/dddt-9-3119.PMC4476428.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3119–3124Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3119Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8293 8anticancer activity of Nigella sativa  (black seed)  and its relationship with the thermal processing  and quinone composition of the seed riad agbaria adi gabarin arik Dahan shimon Ben-shabat Department of clinical Pharmacology,   school of Pharmacy, Faculty of health  sciences, Ben- gurion University  of the negev, Beer-sheva, israelAbstract:  The traditional preparation process of Nigella sativa  (NS) oil starts with roasting of  the seeds, an allegedly unnecessary step that was never skipped.",Non-OADS,/arxiv_data1/oa_pdf/a2/ac/dddt-9-3119.PMC4476428.pdf
"Although the plant is not a significant component of the human diet, in the  Middle East it is incorporated into the way of life and the daily diet1 as a spice and  preservative.2 Black seed has been widely used for thousands of years to treat a variety  of diseases and medical conditions, including asthma, high blood pressure, diabetes,  inflammation, cough, headache, eczema, fever, dizziness, and influenza.2–4 Over the  last five decades, numerous scientific studies have affirmed the pharmacological quali - ties of NS seeds, and demonstrated its anti-inflammatory, antibacterial, antihistamine,  antidiabetic, anticancer, and antihypertensive activity.2 Extracts of NS contain volatile and non-volatile oils, amino acids, proteins,  carbohydrates, alkaloids, nitrogen compounds, saponins, and minerals such correspondence: shimon Ben-shabat Department of clinical Pharmacology,  school of Pharmacy, Faculty of health  sciences, Ben-gurion University of the   negev, Beer-sheva 84105, israel Tel +972 8 647 7363 Fax +972 8 647 9303 email sbs@bgu.ac.i l Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Agbaria et al Running head recto: Thermal processing of Nigella sativa DOI: http://dx.doi.org/10.2147/DDDT.S82938",Non-OADS,/arxiv_data1/oa_pdf/a2/ac/dddt-9-3119.PMC4476428.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a2/ac/dddt-9-3119.PMC4476428.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/ac/dddt-9-3119.PMC4476428.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/79/ijn-10-3989.PMC4476429.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3989–4008International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3989RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S8395 1Multiple cues on the physiochemical, mesenchymal,  and intracellular trafficking interactions with  nanocarriers to maximize tumor target efficiency Sang-Woo Kim Dongwoo Khang Nanomedicine Laboratory,   Department of Molecular Medicine,   School of Medicine, Gachon  University, Incheon, South KoreaAbstract:  Over the past 60 years, numerous medical strategies have been employed to  overcome neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/a9/79/ijn-10-3989.PMC4476429.pdf
"Stem  cells have innate homing abilities (migration through transendothelium) to cancer cells, Correspondence: Dongwoo Khang Department of Molecular Medicine,  School of Medicine, Gachon University,  Incheon 406-840, South Korea Tel +82 32 899 1525 Fax +82 32 899 1525 email dkhang@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Kim and Khang Running head recto: Multiple cues with nanocarriers to maximize tumor target efficiency DOI: http://dx.doi.org/10.2147/IJN.S83951",Non-OADS,/arxiv_data1/oa_pdf/a9/79/ijn-10-3989.PMC4476429.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a9/79/ijn-10-3989.PMC4476429.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/79/ijn-10-3989.PMC4476429.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cia-10-979.PMC4476435.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 979–990Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  979OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8375 0Causes and predictors of hospital readmissions  in patients older than 65 years hospitalized for  heart failure with preserved left ventricular  ejection fraction in western romania Adelina Marioara Mavrea1 Tiberiu Dragomir1 Diana Aurora Bordejevic1 Mirela Cleopatra T omescu1 Oana Ancusa1 Iosif Marincu2 1Cardiology Department, 2Department  of epidemiology and Infectious  Diseases, “Victor Babes” University  of Medicine and Pharmacy, Timisoara,   romaniaBackground:  Heart failure with preserved ejection fraction (HFpEF) is more frequent in the  elderly and is associated with important economic implications because of repetitive and pro - longed hospitalizations, due to both cardiovascular and noncardiovascular causes.",Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cia-10-979.PMC4476435.pdf
"Keywords:  elderly, heart failure with preserved left ventricular ejection fraction, hospital  readmissionsCorrespondence: Mirela Cleopatra  Tomescu; Tiberiu Dragomir Cardiology Department, “Victor Babes”  University of Medicine and Pharmacy,  second eftimie Murgu square, 300041- Timisoara, romania Tel +40 7 2297 9516; +40 7 2274 1991 Fax +40 2 5622 0636 email tomescu.mirela@umft.r o;  tibidragomir@yahoo.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Mavrea et al Running head recto: Predictors of readmissions in elderly HF patients with preserved LVEF DOI: http://dx.doi.org/10.2147/CIA.S83750",Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cia-10-979.PMC4476435.pdf
"Available from: https://www.idf.org/webdata/docs/ WHO_IDF_definition_diagnosis_of_diabetes.pd f. Accessed Dec 10,  2012.",Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cia-10-979.PMC4476435.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cia-10-979.PMC4476435.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cia-10-979.PMC4476435.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1179–1189International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1179RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5415 4Profile of a fixed-dose combination of tiotropium/ olodaterol and its potential in the treatment  of COPD Sanjeevan Muruganandan1 Lata Jayaram2,3 1Department of Respiratory and Sleep  Medicine, Austin Health, 2Department  of Respiratory and Sleep Medicine,   western Health, 3University of  Melbourne, Melbourne, Victoria,   AustraliaAbstract:  Chronic obstructive pulmonary disease (COPD) is a progressive, debilitating disorder  that results in frequent exacerbations and impacts quality of life.",Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
"Bronchodilators exert their effect by smooth-muscle relaxation, resulting in improved  lung emptying, reduced thoracic gas volume and residual volume, as well as lessened  dynamic hyperinflation and improved inspiratory capacity.3Correspondence: Lata Jayaram Department of Respiratory and  Sleep Medicine, western Health,  Gordon Street, Footscray, Melbourne,  vIC 3011, Australia Tel +61 3 8354 6169 Fax +61 3 8610 2177 email lata.jayaram@wh.org.a u Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Muruganandan and Jayaram Running head recto: Role of tiotropium/olodaterol in COPD DOI: http://dx.doi.org/10.2147/COPD.S54154",Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
Available from: http://www.boehringer-ingelheim.com.,Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT20153392 2.,Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT0153393 5.,Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
Available  from: https://clinicaltrials.gov/ct2/show/NCT0208516 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
Available from:  http://clinicaltrials.gov/ct2/show/NCT02296138.,Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9d/copd-10-1179.PMC4476436.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/c6/cmar-7-175.PMC4476437.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 175–188Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  175ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CMAR.S7135 5The impact of 5-hydroxytryptamine-receptor  antagonists on chemotherapy treatment  adherence, treatment delay, and nausea   and vomiting swetha Rao Palli1 Michael grabner1 Ralph a Quimbo1 hope s Rugo2 1healthCore, Wilmington, De,  2University of California san Francisco  helen Diller Family Comprehensive  Cancer Center, san Francisco, C a, Usa Correspondence: Michael grabner   healthCore, 123 Justison street,  suite 200, Wilmington, De 19801, Usa   Tel +1 302 230 2000   Fax +1 302 230 2020   email mgrabner@healthcore.co mPurpose:  To determine the incidence of chemotherapy-induced nausea/vomiting (CINV) and  chemotherapy treatment delay and adherence among patients receiving palonosetron versus  other 5-hydroxytryptamine receptor antagonist (5-HT3 RA) antiemetics.",Non-OADS,/arxiv_data1/oa_pdf/b5/c6/cmar-7-175.PMC4476437.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/b5/c6/cmar-7-175.PMC4476437.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/c6/cmar-7-175.PMC4476437.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6d/6d/copd-10-1139.PMC4476438.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1139–1146International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1139OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8705 8effects of indacaterol versus tiotropium on  respiratory mechanics assessed by the forced  oscillation technique in patients with chronic  obstructive pulmonary disease Correspondence: naoki Inui Department of Internal Medicine,  hamamatsu University school  of Medicine, 1-20-1 handayama,  hamamatsu 431-3192, Japan Tel +81 5 3435 2263 Fax +81 5 3435 2386 email inui@hama-med.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Inui et al Running head recto: Effects of indacaterol versus tiotropium in COPD assessed by FOT DOI: http://dx.doi.org/10.2147/COPD.S87058 naoki Inui1,2 sayomi Matsushima1 shinpei Kato1 hideki Yasui1 Masato Kono1 T omoyuki Fujisawa1 noriyuki enomoto1 Yutaro nakamura1 Mikio T oyoshima3 Takafumi suda1 1second Division, Department  of Internal Medicine, 2Department  of Clinical Pharmacology and  Therapeutics, hamamatsu University  school of Medicine, handayama,   hamamatsu, Japan; 3Department  of respiratory Medicine, hamamatsu  rosai hospital, shougen-cho,   hamamatsu, JapanAbstract:  The forced oscillation technique (FOT) can measure respiratory mechanics and has  attracted attention in chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/6d/6d/copd-10-1139.PMC4476438.pdf
"Available from: http://www.goldcopd.org/guidelines-global- strategy-for-diagnosis-management.htm l. Accessed May 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6d/6d/copd-10-1139.PMC4476438.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6d/6d/copd-10-1139.PMC4476438.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/6d/copd-10-1139.PMC4476438.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/c6/copd-10-1155.PMC4476439.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1155–1161International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1155OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8099 2Bronchial hyperresponsiveness, airway inflammation,  and reversibility in patients with chronic obstructive  pulmonary disease andrea Zanini1 Francesca Cherubino1 elisabetta Zampogna1 stefania Croce2 Patrizia Pignatti2 antonio spanevello3 1Division of Pneumology, I rCCs  rehabilitation Institute of Tradate,   salvatore Maugeri Foundation  (IrCCs), Tradate, Italy; 2allergy  and Immunology Unit, salvatore  Maugeri Foundation (IrCCs), Pavia,   Italy; 3Department of Clinical and  experimental Medicine, University  of Insubria, Varese, ItalyBackground:  Bronchial hyperresponsiveness (BHR), sputum eosinophilia, and bronchial  reversibility are often thought to be a hallmark of asthma, yet it has been shown to occur in  COPD as well.",Non-OADS,/arxiv_data1/oa_pdf/09/c6/copd-10-1155.PMC4476439.pdf
"Keywords:  hyperreactivity, methacholine, exacerbations, sputum eosinophilia, COPD Introduction Bronchial hyperresponsiveness (BHR) is a common characteristic of asthmatic subjects,  but it is also present in COPD patients and in 11%–20% of healthy subjects.1 In the  “Sapaldia” study, 17% of the randomly enrolled Swiss subjects had BHR and 51% of  them were asymptomatic.2 After 11 years, some of these subjects were reevaluated,  showing that BHR is a risk factor for a rapid forced expiratory volume in 1 second  (FEV1) decline and for asthma and COPD development.2 BHR is often associated with bronchial inflammation, particularly in asthmatic  subjects,3 but different studies also demonstrated a dissociation between BHR and  airway inflammation in asthma.4 Moreover, smoking is a risk factor for BHR increas - ing over time5 and BHR improves after smoking cessation.6Correspondence: andrea Zanini Division of Pneumology, IrCCs  rehabilitation Institute of Tradate,  salvatore Maugeri Foundation (IrCCs),  Via roncaccio 16, 21049 Tradate, Italy Tel +39 0331 829 111 Fax +39 0331 829 417 email azanini67@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zanini et al Running head recto: Airway inflammation and lung function in COPD DOI: http://dx.doi.org/10.2147/COPD.S80992",Non-OADS,/arxiv_data1/oa_pdf/09/c6/copd-10-1155.PMC4476439.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/09/c6/copd-10-1155.PMC4476439.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/c6/copd-10-1155.PMC4476439.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/4e/ijn-10-4029.PMC4476456.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4029–4041International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4029OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8236 6application of nanoparticles for oral delivery of  acid-labile lansoprazole in the treatment of   gastric ulcer: in vitro and in vivo evaluations Milind alai1 Wen Jen lin1,2 1graduate Institute of Pharmaceutical  sciences, school of Pharmacy, 2Drug  research center, college of Medicine,   National Taiwan University, Taipei,   TaiwanAbstract:  The aim of this study was to develop nanoparticles for oral delivery of an acid-labile  drug, lansoprazole (LPZ), for gastric ulcer therapy.",Non-OADS,/arxiv_data1/oa_pdf/b3/4e/ijn-10-4029.PMC4476456.pdf
"The enteric delayed-release dosage form of LPZ has been reported to be unable correspondence: Wen Jen lin graduate Institute of Pharmaceutical  sciences, school of Pharmacy,  National Taiwan University, 33 lin san  south road, Taipei, 10050, Taiwan Tel +886 2 3366 8765 Fax +886 2 2391 9098 email wjlin@ntu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Alai and Lin Running head recto: Nanoparticles for oral delivery of acid-labile lansoprazole DOI: http://dx.doi.org/10.2147/IJN.S82366",Non-OADS,/arxiv_data1/oa_pdf/b3/4e/ijn-10-4029.PMC4476456.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b3/4e/ijn-10-4029.PMC4476456.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/4e/ijn-10-4029.PMC4476456.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/dddt-9-3109.PMC4476457.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3109–3118Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3109Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7932 2insulin administration: present strategies and  future directions for a noninvasive (possibly  more physiological) delivery elena Matteucci1 Ottavio Giampietro1 vera Covolan2 Daniela Giustarini3 Paolo Fanti4 Ranieri Rossi3 1Department of Clinical and  experimental Medicine, 2Department  of Chemistry and industrial  Chemistry, University of Pisa,   3Department of Life Sciences,   Laboratory of Pharmacology and  T oxicology, University of Siena,   Siena, italy; 4Division of Nephrology,   University of Texas Health Science  Center San Antonio, South Texas  veteran Health Care System, San  Antonio, T exas, USAAbstract:  Insulin is a life-saving medication for people with type 1 diabetes, but traditional  insulin replacement therapy is based on multiple daily subcutaneous injections or continuous  subcutaneous pump-regulated infusion.",Non-OADS,/arxiv_data1/oa_pdf/c5/0d/dddt-9-3109.PMC4476457.pdf
"For glucose monitoring  methods, all stakeholders prioritized rt-CGM for any patient with type 1 diabetes.2  In patients with type 2 diabetes, CSII therapy was not superior to MDI.3 Closed-loop  insulin delivery, so-called artificial pancreas, combines continuous glucose sensor with Correspondence: elena Matteucci Dipartimento di Medicina Clinica e  Sperimentale, via Roma 67, 56126 Pisa,  italy Tel +39 050 99 2090 Fax +39 050 99 3281 email elena.matteucci@med.unipi.i t Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Matteucci et al Running head recto: Noninvasive insulin delivery DOI: http://dx.doi.org/10.2147/DDDT.S79322",Non-OADS,/arxiv_data1/oa_pdf/c5/0d/dddt-9-3109.PMC4476457.pdf
"One of the major disadvantages of insulin pump therapy is  cost, which is higher than MDI ( http://www.idf.org/debate- insulin-pump-therapy-matter-choic e).",Non-OADS,/arxiv_data1/oa_pdf/c5/0d/dddt-9-3109.PMC4476457.pdf
"Physiology of insulin secretion Circulating, monomeric insulin is composed of two poly - peptide chains (the A and B chains consisting of 21 and 30  amino acids, respectively) and two disulfide bridges, which  create the quaternary assembly of the molecule ( http://www.betacell.org/content/articleview/article_id/8 /) (Accessed on  February 4, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c5/0d/dddt-9-3109.PMC4476457.pdf
Avail - able from: http://novotrials.com/website/pdf/registry/bin_20120423- 015136-79 4.pdf.,OADS,/arxiv_data1/oa_pdf/c5/0d/dddt-9-3109.PMC4476457.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c5/0d/dddt-9-3109.PMC4476457.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/dddt-9-3109.PMC4476457.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/3d/idr-8-173.PMC4476458.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 173–179Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  173ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S7878 6early-switch/early-discharge opportunities   for hospitalized patients with methicillin-resistant  Staphylococcus aureus  complicated skin and soft  tissue infections: proof of concept in the United  arab emirates ashraf el houfi1 nadeem Javed2 caitlyn T solem3 cynthia Macahilig4 Jennifer M stephens3 nirvana Raghubir5 Richard chambers6 Jim Z li7 seema haider8 1Dubai hospital, Dubai, Uae; 2Rashid  hospital, Dubai, Uae; 3Pharmerit  International, Bethesda, MD, Usa;  4Medical Data analytics, Parsippany,  nJ, Usa; 5Pfizer, new York, nY,  Usa; 6Pfizer, collegeville, P a, Usa;  7Pfizer, la Jolla, ca, Usa; 8Pfizer,  groton, cT, Usa correspondence: Jennifer M stephens   Pharmerit International,   4350 east-West highway, suite 430,   Bethesda, MD 20814, Usa   Tel +1 240 821 1290   Fax +1 240 821 1296   email jstephens@pharmerit.co mObjectives:  To describe real-world treatment patterns and health care resource use and to estimate  opportunities for early-switch (ES) from intravenous (IV) to oral (PO) antibiotics and early- discharge  (ED) for patients hospitalized in the United Arab Emirates (UAE) with  methicillin-resistant   Staphylococcus aureus  (MRSA) complicated skin and soft tissue infections.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/idr-8-173.PMC4476458.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/idr-8-173.PMC4476458.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/3d/idr-8-173.PMC4476458.pdf
"Available from: http://www.who.int/choice/country/ country_specific/en/index.htm l. Accessed February 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/idr-8-173.PMC4476458.pdf
"Available from: http://www.tradingeconomics.com/ united-arab-emirates/consumer-price-index-cp i. Accessed November 5,  2013.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/idr-8-173.PMC4476458.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/0a/kfv068.PMC4476459.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 215–220International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  215OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S7518 9a survey of French general practitioners on the  epidemiology of wounds in family practice Marianne sarazin1–3 Florence roberton4 rodolphe charles4 alessandra Falchi1,2,5 solange Gonzales chiappe1–3 Thierry Blanchon1,2 Frédéric lucht6 Thomas hanslik1,2,7,8 1InserM, UM r_s 1136, F-75012,   Paris, France;  2sorbonne Universités,   UPM c University Paris  06, UM r_s  1136, F-75012, Paris, France;  3DIM,   centre hospitalier,  42 700 Firminy,   France;  4Département de médecine  générale, Faculté de médecine Jacques  lisfranc, F-42023 saint etienne,   ce France;  5ea 7310, laboratoire  de Virologie, Université de corse,   F-20250 corte, France;  6cIc-ec3,   chU saint etienne, F-42277 saint- Priest en Jarez, ce France;  7UVsQ,   Université de Versailles saint Quentin,   F-78000 Versailles, France;  8assistance  Publique hôpitaux de Paris, service de  Médecine Interne, hôpital ambroise  Paré, F-92100 Boulogne Billancourt,   France correspondence: Marianne sarazin   Département d’information médicale,  centre hospitalier, rue de Bénaud,   42 700 Firminy, France   Tel +33 471 407 105  email msarazin@u707.jussieu.f rBackground:  To measure the frequency and nature of wounds in patients treated in general  practice and to describe the patients’ tetanus vaccination status and the sources providing  information about this status.",Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
The GP’ s French representativeness was obtained  from the French Health Research department.17 The informa - tion was obtained from the Survey of Individual Activity and  Prescription and was provided by the national French health  insurance Caisse nationale d’Assurance maladie (CNAM) for  each participating GP .18 All variables in this study were analyzed using the R®  software program ( http://www.r-project.org /).,OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
Available   from: http://www.invs.sante.fr/Publications-et-outils/BEH-   Bulletin -epidemiologique -hebdomadaire/Archives/2012/BEH-n-26- 2012.,Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
"Available from: http://www.inpes.sante.fr/ CFESBases/catalogue/pdf/1133.pd f. Accessed November  27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
"Available from: http://www.has-sante.fr/portail/upload/docs/ application /pdf/200912/mise_en_evidence_de_limmunoprotection_ antitetanique_en_contexte_durgence-note_de_cadrage.pd f. Accessed  November  27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
Available from: http://www.invs.sante.,Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
"Available  from: http://www.drees.sante.gouv.fr/les-medecins-estimations-au- 1er- janvier-2009,5182.htm l. Accessed November  27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
Available from:  http://www.ameli.fr/ professionnels-de-sante/medecins/gerer-votre-activite/votre-exercice- en-liberal /.,Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
"Available from: http://www.i-med.fr/IMG/pdf/INDeH_CountryProfile_   France.pd f. Accessed August 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/49/5d/ijgm-8-215.PMC4476466.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/37/ppa-9-803.PMC4476470.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 803–809Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  803OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8164 5exploring motivations to seek and undergo  prosthodontic care: a cross-sectional study  in a Brazilian adult sample Antonio hélio Vieira Donizete castro e silva Túlio eduardo nogueira cláudio rodrigues leles Department of Prevention and Oral  rehabilitation, school of Dentistry,   Federal University of goiás, goiânia,   goiás, BrazilAbstract:  This study explored the influence of individual and social factors regarding intentions  and behaviors related to prosthodontic treatment, using the theory of planned behavior (TPB).",Non-OADS,/arxiv_data1/oa_pdf/77/37/ppa-9-803.PMC4476470.pdf
"These barriers also make the overall demand dependent  on available treatment options and resources from both the care provider and society,  as well as several social and psychological processes that transform need into demand correspondence: cláudio rodrigues  leles Faculdade de Odontologia, Universidade  Federal de goiás, Praça Universitária,  s/n, setor Universitário, goiânia, goiás,  ceP 74.605-220, Brazil Tel +55 62 3209 6052 Fax +55 62 3209 6051 email claudio_leles@ufg.b r Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Vieira et al Running head recto: Motivations to seek and undergo prosthodontic care DOI: http://dx.doi.org/10.2147/PPA.S81645",Non-OADS,/arxiv_data1/oa_pdf/77/37/ppa-9-803.PMC4476470.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/77/37/ppa-9-803.PMC4476470.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/0a/ott-8-1499.PMC4476471.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1499–1502OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1499CASE SERIESopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8465 9Axillary and internal mammary sentinel lymph  node biopsy in male breast cancer patients: case  series and review Xiaoshan Cao1,2 Chunjian Wang1 Yanbing Liu1 Pengfei Qiu1 Binbin Cong1,2 Y ongsheng Wang1 1Breast Cancer Center, Shandong  Cancer Hospital and Institute, Jinan,   Shandong, People’s Republic of China;   2School of Medicine and Life Sciences,   Jinan University-Shandong Academy  of Medical Sciences, Jinan, Shandong,   People’s Republic of ChinaAbstract:  Male breast cancer (MBC) is considered as a rare disease that accounts for less than  1% of all breast cancers, and its treatment has been based on the evidence available from female  breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/8a/0a/ott-8-1499.PMC4476471.pdf
"Open-biopsy had been performed  1 week prior in another hospital, and invasive ductal carcinoma of 2.4 cm and grade II–III Correspondence: Yongsheng Wang Breast Cancer Center, Shandong Cancer  Hospital and Institute, No 440, Jiyan  Road, Jinan, Shandong, 250117, People’s  Republic of China Email wangysh2008@ aliyun.com Journal name: OncoTargets and Therapy Article Designation: CASE SERIES Y ear: 2015 Volume: 8 Running head verso: Cao et al Running head recto: Axillary and internal mammary SLNB in male breast cancer patients DOI: http://dx.doi.org/10.2147/OTT.S84659",Non-OADS,/arxiv_data1/oa_pdf/8a/0a/ott-8-1499.PMC4476471.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8a/0a/ott-8-1499.PMC4476471.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/0a/ott-8-1499.PMC4476471.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/66/opth-9-1077.PMC4476472.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1077–1079Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1077ShO rt repO rtopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S8285 2Microbiologic spectrum and susceptibility  of isolates in delayed post-cataract surgery  endophthalmitis Animesh Jindal1 Avinash pathengay1 Subhadra Jalali2 Annie Mathai2 rajeev reddy pappuru2 raja Narayanan2 Jay Chhablani2 Savitri Sharma3,4 taraprasad Das2,3 harry W Flynn Jr5 1L V prasad eye Institute, GM r  Varalakshmi Campus, Visakhapatnam,   India; 2Srimati Kannuri Santhamma  Centre for Vitreoretinal Diseases,    L V prasad eye Institute, KAr Campus,   hyderabad, India; 3L V prasad eye  Institute, Bhubaneswar eye Institute,   Bhubaneswar, Odisha, India; 4Jhaveri  Microbiology Centre, L V prasad eye  Institute, KAr Campus, hyderabad,   India; 5Department of Ophthalmology,   Bascom palmer eye Institute,   University of Miami, Miami, FL, USAAbstract:  The objective of this study was to evaluate the microbiological spectrum and  antimicrobial susceptibility of isolates in delayed post-cataract surgery endophthalmitis.",Non-OADS,/arxiv_data1/oa_pdf/56/66/opth-9-1077.PMC4476472.pdf
"Susceptibilities for fungal isolates were not performed.Correspondence: Avinash pathengay L V prasad eye Institute, GMr  Varalakshmi Campus, 11-113/1,  hanumanthawaka Junction,  Visakhapatnam 530040, India tel +91 891 3989 2020 Fax +91 891 398 4444 email avinash@lvpei.or g Journal name: Clinical Ophthalmology Article Designation: Short Report Y ear: 2015 Volume: 9 Running head verso: Jindal et al Running head recto: Microbiology of delayed post-cataract surgery endophthalmitis DOI: http://dx.doi.org/10.2147/OPTH.S82852",Non-OADS,/arxiv_data1/oa_pdf/56/66/opth-9-1077.PMC4476472.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/56/66/opth-9-1077.PMC4476472.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/66/opth-9-1077.PMC4476472.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pRisk Management and Healthcare Policy 2015:8 99–110Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  99Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S6892 5Perspectives on differing health outcomes by city:  accounting for Glasgow’s excess mortality Simon DS Fraser Steve George  Academic Unit of Primary Care  and Population Sciences, Faculty of  Medicine, University of Southampton,  Southampton, Hampshire, UK Correspondence: Simon DS Fraser;   Steve George   Academic Unit of Primary Care and  Population Sciences, Faculty of Medicine,  University of Southampton, South  Academic Block, Southampton General  Hospital, Tremona Road, Southampton  SO16  6YD, Hampshire, UK   Tel +44 23 8120 6530  email s.fraser@soton.ac.u k; pluto@ soton.ac.u kAbstract:  Several health outcomes (including mortality) and health-related behaviors are known  to be worse in Scotland than in comparable areas of Europe and the United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
"Available from: http://www.gcph.co.uk/ publications/238accounting_for_scotlands_excess_mortality_towards_a_synthesi s.22 Abbreviation: GCPH, Glasgow Centre for Population Health.likely to constitute a greater component of the causal pathway  than others ( Figure s 3 and 4).",Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
"Available from: http://www.gcph.co.uk/publications/238accounting_for_scotlands_excess_mortality_towards_a_synthesi s.22 Health behaviors Greater inequalities Deindustrialization Deprivation concentration Individual valuesLower social capital Family, gender, and parentingPolitical attack Sectarianism Migration Genetic differences Climatic differencesDifferent culture of substance misuseDeprivation Culture of boundlessness and alienation Culture of limited social mobility Health service supply and demand 0 123456 Number of Bradford Hill criteriaHypothesis in relation to the emergence of a Scottish effect or Glasgow effect 7Meets criteria Does not meet criteria 89 Figure  4 The number of Bradford-Hill’s viewpoints met by each hypothesis as explanatory factors in Scotland and Glasgow’s excess mortality.",Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
"Available from: http://www.gcph.co.uk/publications/238accounting_for_scotlands_excess_mortality_towards_a_synthesi s.22In considering the GCPH review, it is worth remember - ing that, though widely used in this way, the use of Brad - ford Hill “criteria” as a checklist for evaluating whether  a reported association might be causal has been criticized  in the past, particularly by Rothman, who felt that the  Bradford Hill “criteria” do not clearly distinguish causal  from noncausal relations (hence the term “viewpoints” used here, rather than “criteria”).23 In the GCPH review, they  did, however, provide a useful framework within which to  consider the different hypotheses and may help to tease  out where ongoing uncertainties remain, and the authors  recognized that their conclusions were hindered by a lack  of empirical data for many of the hypotheses that were  considered.",Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
"Available from: http://www.gcph.co.uk/publications/238accounting_for_scotlands_excess_mortality_ towards_a_synthesi s.22 Abbreviation:  GCPH, Glasgow Centre for Population Health.",Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
Available from: http://www.who.int/kobe_centre/ publications/hidden_cities2010/en /.,Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
Available  from: http://ec.europa.eu/social/main.jsp?catId=502&furtherPubs=yes&   langId=en&pubId=78&type= 2.,Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
"Available from: http://www.google.co.u k/url?sa=t&rct=j&q=&e src=s&source =web&cd=1&ved=0CCMQFjAA&url =http%3A%2F% 2Fwww.scotpho.org.uk%2Fdownloads%2Fscotphoreports%2Fscotph o061107_leonreport.doc&ei =4HrsVNSgDJHTaL2qguAC&usg =AFQ jCNEezJlEDp5Ueita0rSYbo_TAd4KNQ&bvm =bv.86475890,d.d2s.",OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
Available from: http://www.scotland.gov.,Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
Available from: http://www.gcph.,Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
"Available from:  http://www.gcph.co.uk/work_themes/synthesis_what_have_we_ learne d. Accessed March  25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2f/2c/rmhp-8-099.PMC4476473.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/04/opth-9-1099.PMC4476474.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1099–1107Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1099Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8620 8long-term (60-month) results for the implantable  miniature telescope: efficacy and safety outcomes  stratified by age in patients with end-stage  age-related macular degeneration David Boyer1 K Bailey Freund2 Carl regillo3 Marc h levy4 sumit garg5 1retina-Vitreous associates Medical  group, Beverly hills, C a, 2Vitreous- retina-Macula Consultants of  new Y ork, new Y ork, nY; 3Wills  eye institute, Philadelphia, P a,   4sarasota retina institute, sarasota,   Fl, 5The gavin herbert eye institute  (University of California, irvine)  irvine, C a, UsaBackground:  The purpose of this study was to evaluate the long-term results of an implantable  miniature telescope (IMT) in patients with bilateral, end-stage, age-related macular degenera - tion (AMD).",Non-OADS,/arxiv_data1/oa_pdf/92/04/opth-9-1099.PMC4476474.pdf
"Keywords:  end-stage age-related macular degeneration, implantable miniature telescope, low  vision Introduction Advanced age-related macular degeneration (AMD; geographic atrophy or  neovascular AMD) affects as many as 1.8 million people in the USA1,2 and is bilateral Correspondence: David Boyer retina-Vitreous associates Medical  group, 9001 Wilshire Blvd, suite 301,  Beverly hills, Ca 90211, Usa Tel +1 310 854 6201 email vitdoc@aol.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Boyer et al Running head recto: Efficacy and safety of IMT in end-stage AMD by patient age DOI: http://dx.doi.org/10.2147/OPTH.S86208",Non-OADS,/arxiv_data1/oa_pdf/92/04/opth-9-1099.PMC4476474.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/92/04/opth-9-1099.PMC4476474.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/04/opth-9-1099.PMC4476474.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/d9/ppa-9-797.PMC4476475.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 797–802Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  797OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8441 1effect of pharmaceutical care on medication  adherence of patients newly prescribed insulin  therapy: a randomized controlled study chuanwei Xin Zhongni Xia cheng Jiang Mengmeng lin gonghua li Department of Pharmacy, Tongde  hospital of Zhejiang Province,   Zhejiang Academy of Traditional  chinese Medicine, hangzhou,   People’s  republic of chinaBackground:  Poor adherence to insulin medications leads to a high rate of hospital admissions  and poor health-related quality of life in the patients with diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/1b/d9/ppa-9-797.PMC4476475.pdf
"Also, clinical outcomes support benefits associated with early initiation  and intensification of insulin therapy in patients with type 2 diabetes.3 However, poor correspondence: gonghua li Department of Pharmacy, Tongde  hospital of Zhejiang Province, Zhejiang  Academy of Traditional chinese  Medicine, gucui road, hangzhou,  Zhejiang Province, People’s  republic  of china Tel +86 571 8997 2240 email xyaoshi9@163.co mJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Xin et al Running head recto: Effect of pharmaceutical care DOI: http://dx.doi.org/10.2147/PPA.S84411",Non-OADS,/arxiv_data1/oa_pdf/1b/d9/ppa-9-797.PMC4476475.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/1b/d9/ppa-9-797.PMC4476475.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/5b/ppa-9-811.PMC4476476.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 811–820Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  811OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8134 8Older patients’ perceived burdens of their health  problems: a cross-sectional analysis in 74 german  general practices Ulrike Junius-Walker1 Birgitt Wiese1 renate Klaaßen-Mielke2 gudrun Theile1,3 christiane Annette Müller4 eva hummers-Pradier4 1institute of general Practice,   hannover Medical school, hannover,   2Department of Medical informatics,   Biometry and epidemiology, ruhr- University, Bochum, germany;   3geriatric clinic University hospital,   Zurich, switzerland; 4Department  of general Practice/Family Medicine,   University Medical center göttingen,   georg-August-University, göttingen,   germanyBackground:  Older patients often experience the burden of multiple health problems.",Non-OADS,/arxiv_data1/oa_pdf/87/5b/ppa-9-811.PMC4476476.pdf
de Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Junius-Walker et al Running head recto: Health burdens of older patients DOI: http://dx.doi.org/10.2147/PPA.S81348,Non-OADS,/arxiv_data1/oa_pdf/87/5b/ppa-9-811.PMC4476476.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/87/5b/ppa-9-811.PMC4476476.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/80/ppa-9-767.PMC4476477.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 767–775Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  767Study Protocolopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S7773 0design, construction, and implementation  of an online platform for patients with type 1  diabetes: Encodiab dácil Alvarado-Martel1,2,* Francesca cañas3,* rebeca Velasco1 Nuria Alcubierre3 laura lópez-ríos1,2 Ferran rius4 Francisco Javier Nóvoa1,2 Armando carrillo1,2 Marta Hernández3,4 Ana María Wägner1,2,* dídac Mauricio5,6,* 1department of Endocrinology and  Nutrition, complejo Hospitalario  universitario Insular Materno-Infantil  de Gran canaria, las Palmas, Spain;   2Instituto universitario de Investigaciones  Biomédicas y Sanitarias, universidad de  las Palmas de Gran canaria, las Palmas,   Spain; 3department of Endocrinology  and Nutrition, Institut de recerca  Biomèdica de lleida (IrBlleida), lleida,   Spain; 4department of Endocrinology  and Nutrition, Hospital universitari  Arnau de Vilanova, lleida, Spain; 5Hospital  universitari Germans trias i Pujol, Badalona,   Spain; 6Health Sciences research Institute  Germans trias i Pujol, Badalona, Spain *these authors contributed equally  to this workPurpose:  The purpose of this study was to develop, build, and implement a virtual platform  equipped with practical tools, relevant contents, and communication rooms, with the aim of  facilitating patients’ self-management of type 1 diabetes mellitus (T1DM).",Non-OADS,/arxiv_data1/oa_pdf/80/80/ppa-9-767.PMC4476477.pdf
"The incorporation of the Internet into our daily life has transformed the relation - ship between patients and health care professionals.7 Nowadays, “the web” is the most correspondence: Ana María Wägner department of Endocrinology and Nutrition,  complejo Hospitalario Insular Materno-Infantil  de Gran canaria, Av Marítima 35016 las  Palmas de Gran canaria, Spain tel +34 928 441 937 Email ana.wagner@ulpgc.e s  dídac Mauricio Health Sciences research Institute Germans  trias i Pujol, ctra can ruti, camí de les  Escoles, 08916 Badalona, Spain tel +34 93497 8655 Email didacmauricio@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Study Protocol Y ear: 2015 Volume: 9 Running head verso: Alvarado-Martel et al Running head recto: EncoDiab DOI: http://dx.doi.org/10.2147/PPA.S77730",Non-OADS,/arxiv_data1/oa_pdf/80/80/ppa-9-767.PMC4476477.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/80/80/ppa-9-767.PMC4476477.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/85/tacg-8-137.PMC4476478.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 137–155The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  137Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S6047 2Perspectives on the revised Ghent criteria   for the diagnosis of Marfan syndrome Yskert von Kodolitsch1 Julie De Backer2 Helke Schüler1 Peter Bannas3 Cyrus Behzadi3 Alexander M Bernhardt1 Mathias Hillebrand1 Bettina Fuisting4 Sara Sheikhzadeh1 Meike Rybczynski1 Tilo Kölbel1 Klaus Püschel5 Stefan Blankenberg1 Peter N Robinson6 1Centre of Cardiology, University  Hospital eppendorf, Hamburg,  Germany; 2Centre for Medical  Genetics, University Hospital  Ghent, Ghent, Belgium; 3Diagnostic  and interventional Radiology  Department and Clinic, 4Department  of Ophthalmology, 5Department of  Legal Medicine, University Hospital  eppendorf, Hamburg, Germany;  6institute of Medical Genetics  and Human Genetics, Charité  Universitätsmedizin, Berlin, Germany Correspondence: Yskert von Kodolitsch   German Aortic Centre Hamburg at the  University Heart Centre, University  Hospital Hamburg – eppendorf,   Hamburg, Martinistrasse 52,   20246 Hamburg, Germany   Tel +49 4074 1057 328   Fax +49 4074 1054 840   email kodolitsch@uke.d eAbstract:  Three international nosologies have been proposed for the diagnosis of Marfan  syndrome (MFS): the Berlin nosology in 1988; the Ghent nosology in 1996 (Ghent-1); and the  revised Ghent nosology in 2010 (Ghent-2).",Non-OADS,/arxiv_data1/oa_pdf/fd/85/tacg-8-137.PMC4476478.pdf
"Available from: http://www.eurordis.org/IMG/pdf/ voice_12000_patients/EURORDISCARE_FULLBOOKr.pd f. Accessed  July 2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fd/85/tacg-8-137.PMC4476478.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/fd/85/tacg-8-137.PMC4476478.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/85/tacg-8-137.PMC4476478.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/4d/jbm-6-197.PMC4476479.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 197–209Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  197Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S7246 3iron chelation therapy in transfusion-dependent  thalassemia patients: current strategies and future  directions Antoine N Saliba Afif R Harb Ali T Taher Department of internal Medicine,   Division of Hematology/Oncology,   American University of Beirut, Beirut,   Lebanon Correspondence: Ali Taher   Building 56, Naef K Basile Cancer  Institute, 5th floor, American University  of Beirut Medical Center, Cairo Street,  PO Box 11-0236, Riad el Solh 1107 2020,  Beirut, Lebanon   Tel +961 1 35 0000 ext 5392   email ataher@aub.edu.l bAbstract:  Transfusional iron overload is a major target in the care of patients with transfusion- dependent thalassemia (TDT) and other refractory anemias.",Non-OADS,/arxiv_data1/oa_pdf/93/4d/jbm-6-197.PMC4476479.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/93/4d/jbm-6-197.PMC4476479.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/4d/jbm-6-197.PMC4476479.pdf
"Available from: https://clinicaltrials.gov/ct2/show/ NCT01709032?term =Deferiprone +AND+deferasirox&rank =1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/93/4d/jbm-6-197.PMC4476479.pdf
Available from: https://clinicaltrials.gov/ct2/show/NC T01511848?term =Deferiprone +AND+deferasirox&rank =3.,Non-OADS,/arxiv_data1/oa_pdf/93/4d/jbm-6-197.PMC4476479.pdf
"A vailable  from:http://www.hbpinfo.com/ukts-standards-2008.pdf, 2015.",Non-OADS,/arxiv_data1/oa_pdf/93/4d/jbm-6-197.PMC4476479.pdf
Available from: http://thalassemia.com/treatment-guidelines-5.,Non-OADS,/arxiv_data1/oa_pdf/93/4d/jbm-6-197.PMC4476479.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02189 941?term =deferiprone&rank =5.,Non-OADS,/arxiv_data1/oa_pdf/93/4d/jbm-6-197.PMC4476479.pdf
Available from: https://clinicaltrials.gov/ct2/show/record/ NCT02274233?term =sp+420&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/93/4d/jbm-6-197.PMC4476479.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/73/ott-8-1493.PMC4476480.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1493–1497OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1493Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8025 5il-27 rs153109 polymorphism increases the risk  of colorectal cancer in chinese han population shixu lyu lechi Ye Ouchen Wang guanli huang Fan Yang Yehuan liu siyang Dong Department of surgical Oncology,   the First affiliated hospital  of Wenzhou Medical University,   Wenzhou, Zhejiang, People’s republic  of chinaAbstract:  IL-27, a new member of the IL-12 family, has been found to have antitumor  effects in colorectal cancer (CRC); therefore, polymorphisms of this protein may modulate  CRC carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/e8/73/ott-8-1493.PMC4476480.pdf
"All mice inoculated with C26 cells survived and had complete tumor  remission, indicating that IL-27 can potently induce antitumor activity and protective  immunity.10 Recently, several studies suggest the role of IL-27 polymorphisms in cancer  risk such as esophageal cancer,12 ovarian cancer,13 nasopharyngeal carcinoma,14 correspondence: Ouchen Wang Department of surgical Oncology,  the First Affiliated Hospital of Wenzhou  Medical University, Wenzhou, Zhejiang  325000, People’s republic of china Tel +86 577 5557 8527 email fl23bei124@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Lyu et al Running head recto: IL-27 polymorphism in CRC DOI: http://dx.doi.org/10.2147/OTT.S80255",Non-OADS,/arxiv_data1/oa_pdf/e8/73/ott-8-1493.PMC4476480.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e8/73/ott-8-1493.PMC4476480.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/73/ott-8-1493.PMC4476480.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/e4/ppa-9-785.PMC4476481.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 785–795Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  785OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8189 8Prevalence and risk factor analysis of lower  extremity abnormal alignment characteristics  among rice farmers Usa Karukunchit1,2 rungthip Puntumetakul1,3 Manida swangnetr1,4 rose Boucaut5 1research center in Back, neck,   Other Joint Pain and human  Performance (Bn OJPh), 2Faculty of  Associated Medical sciences, Khon  Kaen University, 3school of Physical  Therapy, Faculty of Associated  Medical sciences, Khon Kaen  University, 4Department of Production  T echnology, Faculty of T echnology,   Khon Kaen University, Khon Kaen,   Thailand; 5school of health sciences  (Physiotherapy), ic Ahe (international  centre for Allied health evidence),   sansom institute for health research,   University of south Australia,   Adelaide, sA, AustraliaBackground:  Rice farming activities involve prolonged manual work and human–machine  interaction.",Non-OADS,/arxiv_data1/oa_pdf/5a/e4/ppa-9-785.PMC4476481.pdf
"Plowing is performed using  heavy vibrating machinery on slippery and sloping walking surfaces (Figure 1A).2,4  correspondence: rungthip Puntumetakul research center in Back, neck, Other  Joint Pain and human Performance  (BnOJPh), 123 Khon Kaen University,  Mitraphab street, Muang District, Khon  Kaen 40002, Thailand Tel +66 8 3419 6186 Fax +66 4 3202 399 email rungthiprt@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Karukunchit et al Running head recto: Lower extremity abnormal alignment characteristics among rice farmers DOI: http://dx.doi.org/10.2147/PPA.S81898",Non-OADS,/arxiv_data1/oa_pdf/5a/e4/ppa-9-785.PMC4476481.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/5a/e4/ppa-9-785.PMC4476481.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/80/opth-9-1093.PMC4476482.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1093–1098Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1093Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8479 0Vitamin D deficiency and posterior subcapsular  cataract Craig J Brown1 Faical akaichi2 1The eye Center, Fayetteville, ar,   Usa; 2scotland’s rural College,   Edinburgh, UKPurpose:  To evaluate risk factors associated with posterior subcapsular cataract (PSC)  development and the relationship between vitamin D deficiency and etiology of PSC.",Non-OADS,/arxiv_data1/oa_pdf/04/80/opth-9-1093.PMC4476482.pdf
"A retrospective  examination of other risk factors was undertaken to establish any possible interactions  with vitamin D deficiency as causative mechanisms of PSC formation, supporting the  validity of the hypocalcemic animal model in humans.Correspondence: Craig J Brown The eye Center, 594 e Millsap road,  Fayetteville, ar 72073, Usa Tel +1 479 442 2020 email cjbrown1234@sbcglobal.ne t Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Brown and Akaichi Running head recto: PSC and vitamin D deficiency DOI: http://dx.doi.org/10.2147/OPTH.S84790",Non-OADS,/arxiv_data1/oa_pdf/04/80/opth-9-1093.PMC4476482.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/04/80/opth-9-1093.PMC4476482.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/80/opth-9-1093.PMC4476482.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/ee/ppa-9-777.PMC4476483.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 777–784Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  777OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8577 3Patient-reported treatment satisfaction and choice  of dosing frequency with biologic treatment  for moderate to severe plaque psoriasis Mingliang Zhang1 susan K Brenneman2 chureen T carter1 Breanna l essoi2 Kamyar Farahi1 Michael P Johnson2 seina lee1 William h Olson3 1health economics and Outcomes  research, Janssen scientific Affairs,   llc, horsham, PA, 2health economics  and Outcomes research, Optum  life sciences, eden Prairie, M n,  3research and Analysis strategy,   Janssen scientific Affairs, llc,   Titusville, nJ, UsABackground:  Moderate to severe plaque psoriasis has a serious effect on health-related quality  of life.",Non-OADS,/arxiv_data1/oa_pdf/0a/ee/ppa-9-777.PMC4476483.pdf
"Keywords:  psoriasis, biologic treatment, patient satisfaction, biologic dosing, patient choice Introduction Psoriasis is a non-contagious, chronic, systemic, immune-mediated skin disease, which  affects 2%–3% of the US population (6–8 million people).1,2 The most prevalent autoim - mune disease in the USA,1 psoriasis can present at any age, but primarily affects adult  males and females equally.3 Although the impact varies according to disease severity,  psoriasis can impose a substantial economic burden, in terms of loss of productivity,  disability, and treatment costs.4–9 In addition to economic consequences, the social correspondence: Mingliang Zhang health economics and Outcomes  Research, Immunology, Janssen Scientific  Affairs, llc, 850 ridgeview Dr, horsham,  PA 19044, UsA Tel +1 215 325 6404 email mzhang5@its.jnj.co mJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: Biologic psoriasis treatment satisfaction and frequency DOI: http://dx.doi.org/10.2147/PPA.S85773",Non-OADS,/arxiv_data1/oa_pdf/0a/ee/ppa-9-777.PMC4476483.pdf
"Available from: http://www.psoriasis.org/about- psoriasis/treatments/biologic s. Accessed March 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0a/ee/ppa-9-777.PMC4476483.pdf
Available from:  http://www.niams.nih.gov/Health_Info/Psoriasis /.,Non-OADS,/arxiv_data1/oa_pdf/0a/ee/ppa-9-777.PMC4476483.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/0a/ee/ppa-9-777.PMC4476483.pdf
"Available from: http://www2.census.gov/geo/ pdfs/maps-data/maps/reference/us_regdiv.pd f. Accessed March 27,  2015.",OADS,/arxiv_data1/oa_pdf/0a/ee/ppa-9-777.PMC4476483.pdf
"Available from: http://www.cdc.gov/nchs/icd/icd9cm.ht m. Accessed  March 27, 2015.",OADS,/arxiv_data1/oa_pdf/0a/ee/ppa-9-777.PMC4476483.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 615–624International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  615RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5080 4Critical appraisal of paroxetine for the treatment  of vasomotor symptoms Dana G Carroll1,2 Katelin M Lisenby1,2 Tracy L Carter3 1Department of Pharmacy Practice,   Harrison School of Pharmacy,   Auburn University, Auburn, AL, USA;   2Department of Family Medicine,   College of Community Health  Sciences, University of Alabama,   University Medical Center, T uscaloosa,   AL, USA; 3Department of Pharmacy,   DCH Regional Medical Center,   T uscaloosa, AL, USABackground:  Vasomotor symptoms (VMS), characterized by hot flashes and night sweats, are  the most commonly reported symptoms associated with estrogen deficiency during menopause  and occur in up to 70% of women.",Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
"Menopause is defined as  the permanent loss of menses for 1 year following ovarian failure, which results in an  estrogen- and progesterone-deficient state.2,3 This decline in estrogen and progesterone  levels is known to contribute to several signs and symptoms associated with menopause,  such as hot flashes, vaginal atrophy, dyspareunia, memory problems, mood changes,  and insomnia.2–4 These physical and psychological changes can affect the quality of  life of up to 85% menopausal women.2–4Correspondence: Dana G Carroll Department of Pharmacy Practice,  Harrison School of Pharmacy, 1327D  Walker Building, Auburn University,  AL 36849, USA   Tel +1 205 348 2891 Fax +1 205 348 2889 email dgc0001@auburn.ed u Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Carroll et al Running head recto: Paroxetine in the treatment of vasomotor symptoms DOI: http://dx.doi.org/10.2147/IJWH.S50804",Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
"Available from: http://www.micromedexsolutions.com/micromedex2/ librarian/ND_T/evidencexpert/ND_PR/evidencexpert/CS/9F9DDB/ND_App Product/evidencexpert/DUPLICATIONSHIELDSYNC/49D885/ND_PG/evidencexpert/ND_B/ evidencexpert/ND_P/evidencexpert/PFActionId/redbook.FindRedBook?navitem=topRedBoo k. Accessed December 14, 2014.34 Abbreviations:  AWP, average wholesale price; CR, controlled release; HCl, hydrochloride.",Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
"Available from: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvi - soryCommittee/UCM343175.pd f. Accessed October 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2005/17970s053lbl.pd f. Accessed February 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
"Available from: http://www.nccn.org/ professionals / physician_gls /pdf/breast.pd f. Accessed October 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
"Available from: http://www.nice.org.uk/guidance/cg80/resources/ guidance-early-and-locally-advanced-breast-cancer-pd f. Accessed  December 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
"Available from: http://www.gsk.ca/english/docs-pdf/product- monographs/Paxil-CR.pd f. Accessed October 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a5/9c/ijwh-7-615.PMC4476484.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 185–195Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  185ExpErt OpiniO nopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/JBM.S7909 1Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Or use: http://youtu.be/qFh6zJ0DNd Qissues in assessing products for the treatment   of hemophilia – the intersection between   efficacy, economics, and ethics Albert Farrugia1,2 Declan noone3 Uwe Schlenkrich4 Steffen Schlenkrich5 Brian O’Mahony3 Josephine Cassar6 1School of Surgery, QEII Medical  Centre, The University of Western  Australia (M509), Crawley, WA,   Australia;  2College of Medicine,   Medicine and Environment, Australian  National University, Canberra,   WA, Australia;  3irish Haemophilia  Society, Dublin, Ireland;  4Deutsche  Hämophiliegesellschaft (DHG),   Hamburg, Germany;  5Am Holzbiel,   Erfurt-Töttleben, Germany;  6Faculty  of Health, University of Canberra,   Canberra, WA, Australia Correspondence: Albert Farrugia   School of Surgery, QEII Medical Centre,  The University of Western Australia  (M509),  35 Stirling Highway, Crawley,  WA 6009, Australia   tel +61 4 1301 8413  Email albert.farrugia@uwa.edu.a uAbstract:  Following the obviation of the pathogen safety threats posed by previous generations  of clotting factor concentrates for the treatment of hemophilia, the principal issue facing the  patient community is timely access to adequate supplies of continuously improving therapies.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: http://www.nuffieldtrust.org.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: http://www.fda.gov/downloads/ BiologicsBloodVaccines/BloodBloodProducts/ ApprovedProducts / LicensedProductsBLAs/ FractionatedPlasmaProducts /UCM244507.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Scientific_Discussion/human/000074/ WC500030713.pd f. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available  from: http://philsci-archive.pitt.edu/4793 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_ library/ Scientific_guideline/2009/09/WC500003657.pd f. Accessed  May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://effectivehealthcare.ahrq.gov/ehc/ products/534/1844/n-1-trials-report-130213.pd f. Accessed May 25,  2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://www.fda.gov/downloads/ Drugs/ Guidances/ucm201790.pd f. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://www.cochrane.org/about-us/ our-strateg y. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://www.cochrane.org/CD009961/CF_preventing- bleeding-in-people-with-congenital-bleeding-disorders-during-and- after-surger y. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://www.cochrane.org/CD003429/ CF_regular - clotting-factor-replacement-therapy-to-prevent-joint-disease-in-people- with-severe-hemophilia-a-or- b. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from:  http://www.cochrane.org/CD007851/AIRWA YS_intravenous-alpha-1 -antitrypsin-augmentation-therapy-for-treating-patients-with-alpha-1- antitrypsin-deficiency-and-lung-diseas e. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from:  https://clinicaltrials.gov/ct2/results?term=Factor +VIII+AND+hemoph ilia&Search=Searc h. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://www.ema.europa.eu/ docs/en_GB/document_library/Report/2014/05/WC500166228.pd f.  Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://meka.thl.fi/htacore/ model/AE- table s-pharma-2.0.pd f. Accessed May 25, 2015.",OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: http://meka.thl.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://www.ispor.org/workpaper/ emea-hrql-guidance.pd f. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: https://www.g-ba.de/ downloads/39-261-2026/2014-07-03_AM-RL-XII_ Turoctocog%20 alfa_2014-01-15-D-092_BAnz.pd f. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: https://www.g-ba.de/ downloads/40-268-2871/2014-07-03_AM-RL-XII_Turoctocog%20 alfa_2014-01-15-D-092_TrG.pd f. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: http://www.rand.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from:  http://www.institutmolinari.org/economic-effects-of-germany-s,491.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available  from: http://www.fda.gov/downloads/BiologicsBloodVaccines/  BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/ FractionatedPlasmaProducts/UCM363882.pd f. Accessed May 25,  2015.",OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: http://www.fda.gov/downloads/ BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/ LicensedProductsBLAs/FractionatedPlasmaProducts/UCM373769.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available  from: https://www.clinicaltrials.gov/ct2/show/NCT01496274?term =Fa ctor+IX+CSL&rank =3.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: https://clinicaltrials.gov/ct2/show/results/NCT01233 258?term =Bayer+Factor+VIII&rank =22.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT01580293?term =BAY+94-9027&rank =3.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: https://clinicaltrials.gov/ct2/show/   NCT01736475?term =BAX+855&rank =2.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: https://clinicaltrials.gov/ct2/show/study/ NCT01125813?term =GENA-08&rank =1&sect=X0125 6.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available  from: https://clinicaltrials.gov/ct2/show/NCT01480180?term =N8- GP&rank =3.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT02172950?term =rVIII-SingleChain&rank =2.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Available from: https://www.edqm.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from:  http://www.wma.net/en/30publications/10policies/b3/17c.pd f. Accessed  May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Available from: http://www.ich.org/fileadmin/Public_Web_Site/ ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pd f. Accessed  May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/cf/jbm-6-185.PMC4476485.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/3e/ott-8-1375.PMC4476486.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 1375–1385OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1375Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8243 7a comparison of the prognostic value of   preoperative inflammation-based scores and  TnM stage in patients with gastric cancer Qun-Xiong Pan* Zi-Jian Su* Jian-Hua Zhang Chong-Ren Wang Shao-Ying Ke Department of Oncosurgery,   Quanzhou First affiliated hospital  of Fujian Medical University,   Quanzhou, Fujian, People’s Republic  of china *These authors contributed equally  to this workBackground:  People’s Republic of China is one of the countries with the highest incidence  of gastric cancer, accounting for 45% of all new gastric cancer cases in the world.",Non-OADS,/arxiv_data1/oa_pdf/0d/3e/ott-8-1375.PMC4476486.pdf
"Each year,  gastric cancer causes over 700,000 deaths worldwide.1 People’s Republic of China  is one of the countries with the highest incidence of gastric cancer, accounting for Correspondence: Qun-Xiong Pan Department of Oncosurgery, Quanzhou  First Affiliated Hospital of Fujian Medical  University, anji road, Fengze District,  Quanzhou, FuJian 362000, People’s  Republic of China Tel +86 138 0599 2255 Fax +86 0595 2314 7721 email 710262737@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Pan et al Running head recto: Prognosis of inflammation scores and TNM stage in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S82437",Non-OADS,/arxiv_data1/oa_pdf/0d/3e/ott-8-1375.PMC4476486.pdf
"Available  from: http://globocan.iarc.fr, 2011-02-20.",Non-OADS,/arxiv_data1/oa_pdf/0d/3e/ott-8-1375.PMC4476486.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0d/3e/ott-8-1375.PMC4476486.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/3e/ott-8-1375.PMC4476486.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/70/sar-6-061.PMC4476488.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2015:6 61–74Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  61Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S5080 7Clinical potential of methylphenidate   in the treatment of cocaine addiction:   a review of the current evidence Kenneth M Dürsteler1,2 eva-Maria Berger1 Johannes Strasser1 Carlo Caflisch2 Jochen Mutschler2 Marcus Herdener2 Marc vogel1 1Center for Addictive Disorders,  Psychiatric University Clinics Basel,  Basel, Switzerland;  2Center for  Addictive Disorders, Department  of Psychiatry, Psychotherapy and  Psychosomatics , Psychiatric Hospital,  University of Zurich, Zurich,  Switzerland Correspondence: Kenneth M Dürsteler   Center for Addictive Disorders,  Psychiatric University Clinics Basel,  wilhelm Klein-Strasse  27,   4012 Basel, Switzerland   Tel +41 61 325 51 25  Fax +41 61 325 53 64  email kenneth.duersteler@upkbs.c hBackground:  Cocaine use continues to be a public health problem, yet there is no proven  effective pharmacotherapy for cocaine dependence.",Non-OADS,/arxiv_data1/oa_pdf/82/70/sar-6-061.PMC4476488.pdf
Available from: http://www.emcdda.europa.eu/pub - lications/edr/trends-developments/2014.,Non-OADS,/arxiv_data1/oa_pdf/82/70/sar-6-061.PMC4476488.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/82/70/sar-6-061.PMC4476488.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/70/sar-6-061.PMC4476488.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/1c/tcrm-11-949.PMC4476489.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 949–959Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  949ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8299 5Circulating thymus and activation-regulated  chemokine/CC chemokine ligand 17 is a strong  candidate diagnostic marker for interstitial lung  disease in patients with malignant tumors: a result  from a pilot study hiromichi Yamane nobuaki Ochi T omoko Yamagishi Y oshihiro honda Masami Takeyama nagio Takigawa Department of general internal  Medicine 4, Kawasaki Medical school,   Kita-ku, Okayama, JapanIntroduction:  Serum Krebs von den Lungen-6 (KL-6) level is an established diagnostic marker  of interstitial lung disease (ILD).",Non-OADS,/arxiv_data1/oa_pdf/e4/1c/tcrm-11-949.PMC4476489.pdf
"The clinical  patterns differ depending on the patient’s illness and drug-related factors, including the  type of drug.2 Because more comprehensive insights into the mechanisms involved in  the development of drug-induced ILD, aside from our knowledge regarding the risk fac - tors, are yet to be clarified,3 the establishment of reasonable early diagnostic methods is Correspondence:  hiromichi Yamane Department of general internal Medicine  4, Kawasaki Medical school, 2-1-80  nakasange, Kita-ku, Okayama 700-8505,  Japan Tel +81 86 225 2111 Fax +81 86 232 8343 email hiromichi.ya@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Y amane et al Running head recto: TARC/CCL17 is a candidate ILD diagnostic marker DOI: http://dx.doi.org/10.2147/TCRM.S82995",Non-OADS,/arxiv_data1/oa_pdf/e4/1c/tcrm-11-949.PMC4476489.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e4/1c/tcrm-11-949.PMC4476489.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/1c/tcrm-11-949.PMC4476489.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/c2/tcrm-11-961.PMC4476490.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 961–965Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  961Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S7227 9Boussignac Cpap system for brain death  confirmation with apneic test in case of acute   lung injury/adult respiratory distress  syndrome – series of cases andrzej Wieczorek1 T omasz Gaszynski2 1Department of anesthesia and  Intensive Care, Medical University  of Lodz, Lodz, p oland; 2Department  of emergency Medicine and Disaster  Medicine, Medical University of Lodz,   Lodz, polandIntroduction:  There are some patients with severe respiratory disturbances like adult respira - tory distress syndrome (ARDS) and suspicion of brain death, for whom typical performance  of the apneic test is difficult to complete because of quick desaturation and rapid deterioration  without effective ventilation.",Non-OADS,/arxiv_data1/oa_pdf/ce/c2/tcrm-11-961.PMC4476490.pdf
"To avoid failure of brain death confirmation and Correspondence: Tomasz Gaszynski Department of emergency Medicine  and Disaster Medicine, Medical  University of Lodz, Kopcinskiego 22,  Lodz 90-153, poland Tel +48 42 678 3748 email tomasz.gaszynski@umed.lodz.p l Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Wieczorek and Gaszynski Running head recto: Boussignac CPAP for apneic test DOI: http://dx.doi.org/10.2147/TCRM.S72279",Non-OADS,/arxiv_data1/oa_pdf/ce/c2/tcrm-11-961.PMC4476490.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ce/c2/tcrm-11-961.PMC4476490.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/c2/tcrm-11-961.PMC4476490.pdf
Published by Elsevier Ireland Ltd.This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/c7/main.PMC4476546.pdf
http://dx.doi.org/10.1016/j.ijcha.2015.03.001 2352-9067/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/11/c7/main.PMC4476546.pdf
Published by Elsevier Ireland Ltd.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/c7/main.PMC4476546.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.els evier.com/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/11/c7/main.PMC4476546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/e2/main.PMC4476547.pdf
"http://dx.doi.org/10.1016/j.gendis.2015.01.002 2352-3042/Copyright ª2015, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/main.PMC4476547.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2015) 2, 133e143",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/main.PMC4476547.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/33/main.PMC4476549.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.005 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/33/main.PMC4476549.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/33/main.PMC4476549.pdf
"Avail- able:, http://www.who.int/mediacentre/factsheets/fs104/en/ (Accessed April 13 2014).",Non-OADS,/arxiv_data1/oa_pdf/aa/33/main.PMC4476549.pdf
© 2015 American Journal of Preventive Medicine This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/df/nihms-693500.PMC4476642.pdf
Oklahoma City OK: https://www.sos.ok.gov/documents/ executive/829.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/4f/df/nihms-693500.PMC4476642.pdf
2011. http://www.nigc.gov/Media/Press_Releases/ 2011_Press_Releases/PR-175_ 07-2011.aspx 11.,Non-OADS,/arxiv_data1/oa_pdf/4f/df/nihms-693500.PMC4476642.pdf
The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.,OADS,/arxiv_data1/oa_pdf/43/44/str-46-1840.PMC4476845.pdf
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.115.008841,Non-OADS,/arxiv_data1/oa_pdf/43/44/str-46-1840.PMC4476845.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/e0/afv051.PMC4476848.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Based upon these determinants, reactive species may lead to the oxidation of cysteine thiols to sulfenic, sul ﬁnic and sulfonic acids; formation of intra/intermolecular disul ﬁde bonds; S-nitrosylation;Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.05.005 2213-2317/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: DCFH-DA, dichloro-dihydro- ﬂuorescein diacetate; DHBA, dihy- droxybenzoic acid; DHE, dihydroethidium; DPI, diphenyleneiodonium; ER, en-doplasmic reticulum; HDAC, histone deacetylases; HPF, hydroxyphenyl ﬂuorescein; NE, norepineprine; 8-OH-dG, 8-hydroxy-2 ′-deoxyguanosine; PF1, peroxy ﬂuor1; ROS, reactive oxygen species; SOD, superoxide dismutase nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
Supplementary information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2015.05.005 .,OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Salmon, Revisiting an age-old question regarding oxidative stress, Free Radical Biology & Medicine 71 (2014) 368 –378, http://dx.doi.org/0 81624 364801234567mU/mgprotein- NE(2µM) NE(100µM)### ###* Time (hours)0 8162436480246810121416 Time (hours)%inhibitionofPyrogallo l autooxidation- NE(2µM) NE(100µM) ****** *### ### ### Fig.",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Figtree, Biological markers of oxidative stress: applications to cardiovascular research and practice, Redox Biology 1 (2013) 483 –491, http://dx.doi.org/10.1016/j.redox.2013.07.006 24251116 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Moens, Oxidative and nitrosative stress in the maintenance of myocardial function, Free Radical Biology & Medicine 53(8) (2012) 1531 –1540, http://dx.doi.org/10.1016/j.freeradbiomed.2012.07.010 22819981 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"American Journal of the Medical Sciences 342 (2) (2011) 120 –124, http://dx.doi.org/ 10.1097/MAJ.0b013e3182249fcd 21747279 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Santos, A.M. Shah, Redox regulation of cardiac hypertrophy, Journal of Molecular and Cellular Cardiology 73 (2014) 103 –111, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Moens, NADPH oxidase-dependent oxidative stress in the failing heart: from pathogenic roles to therapeutic ap-proach, Free Radical Biology & Medicine 52 (2) (2012) 291 –297, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Brandes, N. Weissmann, K. Schröder, Redox-mediated signal transduction by cardiovascular Nox NADPH oxidases, Journal of Molecular and Cellular Cardiology 73 (2014) 70 –79,http://dx.doi.org/10.1016/j.yjmcc.2014.02.006 24560815 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Marinho, C. Real, L. Cyrne, H. Soares, F. Antunes, Hydrogen peroxide sensing, signaling and regulation of transcription factors, Redox Biology 2 (2014) 535 –562, http://dx.doi.org/10.1016/j.redox.2014.02.006 24634836 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[11] J.-G. Lee, K. Baek, N. Soetandyo, Y. Ye, Reversible inactivation of deubiquiti- nases by reactive oxygen species in vitro and in cells, Nature Communication 4(2013) 1568, http://dx.doi.org/10.1038/ncomms2532 23463011 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[12] B. Groitl, U. Jakob, Thiol-based redox switches, Biochimica Biophysica Acta 1844 (8) (2014) 1335 –1343, http://dx.doi.org/10.1016/j.bbapap.2014.03.007 24657586 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Zweier, Cardiac mitochondria and reactive oxygen species generation, Circulation Research 114 (3) (2014) 524 –537, http://dx.doi.org/ 10.1161/CIRCRESAHA.114.300559 24481843 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Runge, Redox signaling in cardiovascular health and disease, Free Radical Biology & Medicine 61 (2013) 473 –501, http://dx.doi.org/ 10.1016/j.freeradbiomed.2013.04.001 23583330 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Heart and Circulatory Physiology 294 (6) (2008) H2879 –H2888, http://dx.doi.org/10.1152/aj- pheart.91406.2007 18441197 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Pimentel, T. Adachi, Y. Ido, T. Heibeck, B. Jiang, Y. Lee, et al., Strain-sti- mulated hypertrophy in cardiac myocytes is mediated by reactive oxygenspecies-dependent Ras S-glutathiolation, Journal of Molecular and CellularCardiology 41 (4) (2006) 613 –622, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Maier, Role of oxidants on calcium and sodium movement in healthy and diseased cardiac myocytes, Free Radical Biology & Medicine 63 (2013) 338 –349, http://dx.doi.org/10.1016/j.free- radbiomed.2013.05.035 23732518 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[19] P. Donoso, G. Sanchez, R. Bull, C. Hidalgo, Modulation of cardiac ryanodine receptor activity by ROS and RNS, Frontiers in Bioscience (Landmark Edition)16 (2011) 553 –567, http://dx.doi.org/10.2741/3705 21196188 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Schiller, A. Mai, T. Peng, Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyo- cytes during lipopolysaccharide stimulation, Journal of Biological Chemistry 285 (13) (2010) 9429 –9436, http://dx.doi.org/10.1074/jbc.M109.071274 20097764 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[21] N. Ferrara, K. Komici, G. Corbi, G. Pagano, G. Furgi, C. Rengo, et al., β-Adrenergic receptor responsiveness in aging heart and clinical implications, Frontiers inPhysiology 4 (2014) 396, http://dx.doi.org/10.3389/fphys.2013.00396 24409150 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[22] M. Ciccarelli, G. Santulli, V. Pascale, B. Trimarco, G. Iaccarino, Adrenergic re- ceptors and metabolism: role in development of cardiovascular disease, Frontiers in Physiology 4 (2013) 265, http://dx.doi.org/10.3389/ fphys.2013.00265 24106479 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Clerk, The radical balance between life and death, Journal of Molecular and Cellular Cardiology 35 (6) (2003) 599 –602, http://dx.doi.org/10.1016/S0022- 2828(03)00121-4 12788376 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[25] Y.-C. Fu, C.-S. Chi, S.-C. Yin, B. Hwang, Y.-T. Chiu, S.-L. Hsu, Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygenspecies-TNF alpha-caspase signaling pathway, Cardiovascular Research 62 (3)(2004) 558 –567, http://dx.doi.org/10.1016/j.cardiores.2004.01.039 15158148 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Steinberg, p66Shc links alpha1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphor-ylation pathway in cardiomyocytes, Circulation Research 104 (5) (2009) 660–669, http://dx.doi.org/10.1161/CIRCRESAHA.108.186288 19168439 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[27] F. Xiong, D. Xiao, L. Zhang, Norepinephrine causes epigenetic repression of PKC εgene in rodent hearts by activating Nox1-dependent reactive oxygen species production, FASEB Journal 26 (2012) 2753 –2763, http://dx.doi.org/ 10.1096/fj.11-199422 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Frontiers onPhysiology 4 (2013) 324, http://dx.doi.org/10.3389/fphys.2013.00324 24265619 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Goswami, In cardiac myoblasts, cellular redox regulates FosB and Fra-1 through multiple cis-regulatory modules, Free Radical Biology & Medi- cine 51 (8) (2011) 1512 –1521, http://dx.doi.org/10.1016/j.free- radbiomed.2011.07.008 21820506 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[30] S. Ueno, T. Kashimoto, N. Susa, K. Shiho, T. Seki, N. Ito, et al., Estimation of hydroxyl radical generation by salicylate hydroxylation method in kidney of mice exposed to ferric nitrilotriacetate and potassium bromate, Free RadicalResearch 41 (11) (2007) 1246 –1252, http://dx.doi.org/10.1080/ 10715760701644019 17907000 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[31] C. Bolin, F. Cardozo-Pelaez, Assessing biomarkers of oxidative stress: analysis of guanosine and oxidized guanosine nucleotide triphosphates by high per- formance liquid chromatography with electrochemical detection, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sci-ences 856 (1 –2) (2007) 121 –130, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[32] A. Sikora, J. Zielonka, M. Lopez, J. Joseph, B. Kalyanaraman, DiRecT oxidation of boronates by peroxynitrite: mechanism and implications in ﬂuorescence imaging of peroxynitrite, Free Radical Biology & Medicine 47 (10) (2009) 1401 –1407, http://dx.doi.org/10.1016/j.freeradbiomed.2009.08.006 19686842 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Weydert, J.J. Cullen, Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue, Nature Protocols 5 (1) (2010) 51 –66,http://dx.doi.org/10.1038/nprot.2009.197 20057381 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[36] S. Marklund, G. Marklund, Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase,European Journal of Biochemistry 47 (3) (1974) 469 –474, http://dx.doi.org/ 10.1111/j.1432-1033.1974.tb03714.x 4215654 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Biochemistry Journal 428 (2) (2010) 183 –190, http://dx.doi.org/10.1042/BJ20100208 20331437 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[38] X. Chen, Z. Zhong, Z. Xu, L. Chen, Y. Wang, 2 ′,7′-Dichlorodihydro ﬂuorescein as aﬂuorescent probe for reactive oxygen species measurement: forty years of application and controversy, Free Radical Research 44 (6) (2010) 587 –604, http://dx.doi.org/10.3109/10715761003709802 20370560 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Cotter, Hydrogen peroxide: a Jekyll and Hyde signalling molecule, Cell Death & Disease 2 (2011) e213, http://dx.doi.org/10.1038/ cddis.2011.96 21975295 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Oury, Extracellular superoxide dismutase protects cardio- vascular syndecan-1 from oxidative shedding, Free Radical Biology & Medicine50 (9) (2011) 1075 –1080, http://dx.doi.org/10.1016/j.free- radbiomed.2011.02.014 21334435 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Dranka, M. Hardy, R. Michalski, J. Zielonka, HPLC-based monitoring of products formed from hydroethidine-based ﬂuorogenic probes /C0the ultimate approach for intra- and extracellular superoxide detection, Biochimica Biophysica Acta 1840 (2) (2014) 739 –744, http://dx.doi.org/ 10.1016/j.bbagen.2013.05.008 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[42] H. Khalil, N. Rosenblatt, L. Liaudet, C. Widmann, The role of endogenous and exogenous RasGAP-derived fragment N in protecting cardiomyocytes from peroxynitrite-induced apoptosis, Free Radical Biology & Medicine 53 (4) (2012) 926 –935, http://dx.doi.org/10.1016/j.freeradbiomed.2012.06.011 22721922 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[43] H. Yin, M. Zhu, Free radical oxidation of cardiolipin: chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and humandiseases, Free Radical Research 46 (8) (2012) 959 –974, http://dx.doi.org/ 10.3109/10715762.2012.676642 22468920 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Majima, T. Nagano, Development of novel ﬂuorescence probes that can reliably detect reactive oxygen species and distinguish speci ﬁc species, Journal of Biological Chemistry 278 (5) (2003) 3170 –3175, http://dx.doi.org/10.1074/jbc.M209264200 12419811 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[45] W. Paulander, Y. Wang, A. Folkesson, G. Charbon, A. Løbner-Olesen, H. Ingmer, Bactericidal antibiotics increase hydroxyphenyl ﬂuorescein signal by altering cell morphology, PLoS One 9 (3) (2014) e92231, http://dx.doi.org/10.1371/ journal.pone.0092231 24647480 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"acid hydroxylation during in vitro experiments involving thiols, Journal of Chromatography B: Biomedical Sciences and Applications 763 (1 –2) (2001) 185–193, http://dx.doi.org/10.1016/S0378-4347(01)00396-6 11710577 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[47] J. Zielonka, A. Sikora, J. Joseph, B. Kalyanaraman, Peroxynitrite is the major species formed from different ﬂux ratios of co-generated nitric oxide and superoxide: direct reaction with boronate-based ﬂuorescent probe, Journal of Biological Chemistry 285 (19) (2010) 14210 –14216, http://dx.doi.org/10.1074/ jbc.M110.110080 20194496 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Machen, Redox-independent activation of NF-kappaB by Pseudomonas aeruginosa pyocyanin in a cystic ﬁbrosis airway epithelial cell line, Journal of Biological Chemistry 283 (40) (2008) 27144 –27153, http://dx.doi.org/10.1074/jbc.M709693200 18682396 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[49] A. Berenyiova, M. Grman, A. Mijuskovic, A. Stasko, A. Misak, P. Nagy, et al., The reaction products of sul ﬁde and S-nitrosoglutathione are potent vasorelax- ants, Nitric Oxide 46 (2015) 123 –130, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Martin, Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer re- search, Cancer Letters 327 (1 –2) (2012) 123 –133, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[52] V. Turinetto, C. Giachino, Multiple facets of histone variant H2AX: a DNA double-strand-break marker with several biological functions, Nucleic AcidsResearch 43 (5) (2015) 2489 –2498, http://dx.doi.org/10.1093/nar/gkv061 25712102 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"[54] S. Suzuki, T. Shishido, M. Ishino, S. Katoh, T. Sasaki, S. Nishiyama, et al., 8- Hydroxy-2 ′-deoxyguanosine is a prognostic mediator for cardiac event, Eur- opean Journal of Clinical Investigation 41 (7) (2011) 759 –766, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Harbison, J. Sanchez- Ramos, Comparison of base-excision repair capacity in proliferating and dif-ferentiated PC 12 cells following acute challenge with dieldrin, Free Radical Biology & Medicine 31 (10) (2001) 1272 –1278, http://dx.doi.org/10.1016/ S0891-5849(01)00715-8 11705706 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Hill, et al., Down- regulation of CuZn-superoxide dismutase contributes to beta-adrenergic re-ceptor-mediated oxidative stress in the heart, Cardiovascular Research 74 (3) (2007) 445 –455, http://dx.doi.org/10.1016/j.cardiores.2007.02.016 17362897 .",Non-OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Maf ﬁone, et al., Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats, Journal of Cellular and Molecular Medicine 11 (1) (2007) 156 –170, http://dx.doi.org/10.1111/ j.1582-4934.2007.00009.x 17367510 .",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"Gottschalk, et al., Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxida- tive stress in caco-2 cells, Toxicological Sciences: Of ﬁcial Journal of Society of Toxicology 114 (2) (2010) 193 –203, http://dx.doi.org/10.1093/toxsci/kfp309 20044591 .A.",OADS,/arxiv_data1/oa_pdf/dc/3d/main.PMC4477046.pdf
"260Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.05.003 2213-2317/ &2015 Published by Elsevier B.V.Abbreviations: ACR, acrolein; AGE, advanced glycation end product(s); ALE, advanced lipoxidation end product(s); CID, collisional induced dissociation; CHH, 7- (diethy- lamino)coumarin-3-carbohydrazide; cyPG, cyclopentenone prostaglandin(s); DNPH, 2,4-dinitrophenylhydrazine; ESI, electrospray ionization ; GO, glyoxal; 4-HHE, 4-hy- droxyhexanal; HNE, 4-hydroxynonenal; HEL, N ε-hexanoyl-lysine; MALDI, matrix assisted laser desorption/ionization; MDA, malondialdehyde; MS, mass spectrometry; NLS, neutral loss scans; ONE, 4-oxononenal; 15d-PGJ 2, 15-deoxy- Δ12,14-prostaglandin J 2; RCS, reactive carbonyl species.",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[2] R. Pamplona, Advanced lipoxidation end-products, Chemico-Biological In- teractions 192 (1 –2) (2011) 14 –20,http://dx.doi.org/10.1016/j.cbi.2011.01.007 21238437 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Maier, Protein modi ﬁcations by elec- trophilic lipoxidation products: adduct formation, chemical strategies and tandem mass spectrometry for their detection and identi ﬁcation, Mass Spectrometry Reviews 33 (3) (2014) 157 –182, http://dx.doi.org/10.1002/ mas.21389 24818247 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[6] U. Stemmer, A. Hermetter, Protein modi ﬁcation by aldehydophospholipids and its functional consequences, Biochimica Biophysica Acta 1818 (10) (2012) 2436 –2445, http://dx.doi.org/10.1016/j.bbamem.2012.03.006 22450235 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[7] E. Niki, Lipid peroxidation: physiological levels and dual biological effects, Free Radical Biology and Medicine 47 (5) (2009) 469 –484, http://dx.doi.org/ 10.1016/j.freeradbiomed.2009.05.032 19500666 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[8] F. Guéraud, M. Atalay, N. Bresgen, A. Cipak, P.M. Eckl, L. Huc, et al., Chemistry and biochemistry of lipid peroxidation products, Free Radical Research 44 (10) (2010) 1098 –1124, http://dx.doi.org/10.3109/10715762.2010.498477 20836659 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Spickett, Chemistry of phospholipid oxidation, Biochimica Bio- physica Acta 1818 (10) (2012) 2374 –2387, http://dx.doi.org/10.1016/j.bba- mem.2012.02.002 22342938 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Morrow, Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation, Cellular and Mole- cular Life Sciences 59 (5) (2002) 808 –820, http://dx.doi.org/10.1007/s00018- 002-8469-8 12088281 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Cyclopentenone prostaglandins with dienone structure promote cross-link- ing of the chemoresistance-inducing enzyme glutathione transferase P1-1,Molecular Pharmacology 78 (4) (2010) 723 –733, http://dx.doi.org/10.1124/ mol.110.065391 20631055 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Baraibar, B. Friguet, Oxidative proteome modi ﬁcations target speci ﬁc cellular pathways during oxidative stress, cellular senescence and aging,Experimental Gerontology 48 (7) (2013) 620 –625, http://dx.doi.org/10.1016/ j.exger.2012.10.007 23127722 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[16] J. Alary, F. Guéraud, J.P. Cravedi, Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways, Molecular Aspects of Medicine 24 (4 –5) (2003) 177 –187, http://dx.doi.org/10.1016/S0098-2997(03)00012-8 12892995 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Bulteau, B. Friguet, Protein modi ﬁcation and replicative senescence of WI-38 human embryonic ﬁbroblasts, Aging Cell 9 (2) (2010) 252 –272, http://dx.doi.org/10.1111/j.1474- 9726.2010.00555.x 20102351 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Oeste, B. Díez-Dacal, D. Pérez-Sala, Proteomic studies on protein modi ﬁcation by cyclopentenone prostaglandins: expanding our view on electrophile actions, Journal of Proteomics 74 (11) (2011) 2243 –2263, http://dx.doi.org/10.1016/j.jprot.2011.03.028 21459170 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Che- mical Research in Toxicology 21 (4) (2008) 824 –835, http://dx.doi.org/ 10.1021/tx700349r 18324789 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Marnett, Systems analysis of protein modi ﬁcation and cellular responses induced by electrophile stress, Accounts of Chemical Research 43(5) (2010) 673 –683, http://dx.doi.org/10.1021/ar900286y 20218676 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Ge, S. Parvez, et al., Temporally controlled targeting of 4-hydroxynonenal to speci ﬁc proteins in living cells, Journal of the American Chemical Society 135 (39) (2013) 14496 –14499, http://dx.doi.org/10.1021/ja405400k 24015839 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[23] G. Aldini, I. Dalle-Donne, G. Vistoli, R. Maffei Facino, M. Carini, Covalent modi ﬁcation of actin by 4-hydroxy-trans-2-nonenal (HNE): LC –ESI-MS/MS evidence for Cys374 Michael adduction, Journal of Mass Spectrometry 40 (7) (2005) 946 –954, http://dx.doi.org/10.1002/jms.872 15934040 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Terrón, O. Llorca, D. Pérez- Sala, Addition of electrophilic lipids to actin alters ﬁlament structure, Bio- chemical and Biophysical Research Communications 349 (4) (2006)1387 –1393, http://dx.doi.org/10.1016/j.bbrc.2006.09.005 16979589 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[25] G. Aldini, M. Carini, G. Vistoli, T. Shibata, Y. Kusano, L. Gamberoni, et al., Identi ﬁcation of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functionalapproaches to investigate the effect on cytoskeletal derangement, Bio- chemistry 46 (10) (2007) 2707 –2718, http://dx.doi.org/10.1021/bi0618565 17297918 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[26] K. Stamatakis, F.J. Sánchez-Gómez, D. Pérez-Sala, Identi ﬁcation of novel protein targets for modi ﬁcation by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton, Journalof the American Society Nephrology 17 (1) (2006) 89 –98,http://dx.doi.org/ 10.1681/ASN.2005030329 16291835 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Maier, Site- speci ﬁc protein adducts of 4-hydroxy-2(E)-nonenal in human THP-1 monocytic cells: protein carbonylation is diminished by ascorbic acid, Che- mical Research in Toxicology 23 (1) (2010) 37 –47,http://dx.doi.org/10.1021/ tx9002462 20043646 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Porter, D.C. Liebler, Quantitative chemoproteomics for site-speci ﬁc analysis of protein alkylation by 4-hydroxy-2-nonenal in cells, Analytical Chemistry 87 (5) (2015) 2535 –2541, http://dx.doi.org/ 10.1021/ac504685y 25654326 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Butter ﬁeld, T. Reed, R. Sultana, Roles of 3-nitrotyrosine- and 4-hydro- xynonenal-modi ﬁed brain proteins in the progression and pathogenesis of Alzheimer ’s disease, Free Radical Research 45 (1) (2011) 59 –72,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[31] G. Leonarduzzi, E. Chiarpotto, F. Biasi, G. Poli, 4-hydroxynonenal and cho- lesterol oxidation products in atherosclerosis, Molecular Nutrition and Food Research 49 (11) (2005) 1044 –1049, http://dx.doi.org/10.1002/ mnfr.200500090 16270277 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[33] P. Dunér, I. Gonçalves, H. Grufman, A. Edsfeldt, F. To, M. Nitulescu, et al.,Increased aldehyde-modi ﬁcation of collagen type IV in symptomatic plaques /C0a possible cause of endothelial dysfunction, Atherosclerosis 240 (1) (2015) 26–32,http://dx.doi.org/10.1016/j.atherosclerosis.2015.02.043 25746374 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Witztum, The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity, Current Opinion in Lipidology 19 (4) (2008)369 –377, http://dx.doi.org/10.1097/MOL.0b013e328308b622 18607184 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Salomon, Oxidized phospholipids, isolevuglandins, and atherosclerosis, Molecular Nutrition and Food Research 49 (11) (2005)1050 –1062, http://dx.doi.org/10.1002/mnfr.200500056 16270278 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Yang, J. Xu, S.S. Palaniyandi, Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected withlow-dose streptozotocin, Experimental Biology and Medicine 239 (5) (2014)610 –618, http://dx.doi.org/10.1177/1535370213520109 24651616 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Kurien, R. Rodgers, J. Shenoi, S. Kurono, H. Matsumoto, et al., Detection of catalase as a major protein target of the lipid peroxidationproduct 4-HNE and the lack of its genetic association as a risk factor in SLE, BMC Medical Genetics 9 (2008) 62, http://dx.doi.org/10.1186/1471-2350-9- 62 18606005 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Petersen, Cysteine modi ﬁcation by lipid peroxidation products inhibits protein disul ﬁde isomerase, Chemical Research in Toxicology 18 (8) (2005) 1324 –1331, http://dx.doi.org/10.1021/ tx050078z 16097806 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Smathers-McCullough, D. R. Petersen, Identi ﬁcation of 5 ′AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol, Jour- nal of Biological Chemistry 289 (22) (2014) 15449 –15462, http://dx.doi.org/ 10.1074/jbc.M113.543942 24722988 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Ciamporcero, M. Daga, C. Ullio, A. Arcaro, et al., Role of 4-hydroxynonenal-protein adducts in human diseases, Antioxidants and Redox Signaling (2015) , http://dx.doi.org/10.1089/ars.2014.6166 ,i np r e s s .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Stitt, Advanced glycation end products and dia- betic retinopathy, Current Medicinal Chemistry 20 (26) (2013) 3234 –3240, http://dx.doi.org/10.2174/09298673113209990025 23745547 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Regnier, Proteomic identi ﬁcation of carbonylated proteins and their oxidation sites, Journal of Proteome Research 9 (8) (2010)3766 –3780, http://dx.doi.org/10.1021/pr1002609 20521848 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Bautista, Combined pro- teomic approaches for the identi ﬁcation of speci ﬁc amino acid residues modi ﬁed by 4-hydroxy-2-nonenal under physiological conditions, Journal of Proteome Research 9 (11) (2010) 5770 –5781, http://dx.doi.org/10.1021/ pr100555v 20818828 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Weldon, N. Hubner, H. Dong, et al., Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-pros- taglandin J2 controls coronary hypoxic vasodilation, Circulation Research 108 (3) (2011) 324 –334, http://dx.doi.org/10.1161/CIRCRESAHA.110.235879 21164107 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"García-Domínguez, A. Pérez-Rodríguez, A. Prieto, F.J. Cañada, et al., Modi ﬁcation and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective, Biochemistry 46 (22)(2007) 6607 –6616, http://dx.doi.org/10.1021/bi602389p 17489560 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"de la Torre, D. Andreu, et al., The C-terminus of H-Ras as a target for the covalent bindingof reactive compounds modulating Ras-dependent pathways, PLOS One 6 (1) (2011) e15866, http://dx.doi.org/10.1371/journal.pone.0015866 21253588 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Das, W. Riedel, High-performance liquid chromatographic peak identi ﬁcation of 2,4-dinitrophenylhydrazine derivatives of lipid per- oxidation aldehydes by photodiode array detection, Journal of Chromato-graphy A 798 (1 –2) (1998) 117 –123, http://dx.doi.org/10.1016/S0021-9673G.",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Shoemaker, S.C. Wang, Ultrahigh performance liquid chromatography analysis of volatile carbonyl compounds in virgin olive oils, Journal of Agricultural and Food Chemistry 61 (50) (2013) 12253 –12259, http://dx.doi.org/10.1021/jf404368m 24279346 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[58] M. Wang, H. Fang, X. Han, Shotgun lipidomics analysis of 4-hydroxyalkenal species directly from lipid extracts after one-step in situ derivatization,Analytical Chemistry 84 (10) (2012) 4580 –4586, http://dx.doi.org/10.1021/ ac300695p 22500579 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[59] I. Milic, R. Hoffmann, M. Fedorova, Simultaneous detection of low and high molecular weight carbonylated compounds derived from lipid peroxidation by electrospray ionization-tandem mass spectrometry, Analytical Chemistry 85 (1) (2013) 156 –162, http://dx.doi.org/10.1021/ac302356z 23186270 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[61] S. Tomono, N. Miyoshi, H. Ohshima, Comprehensive analysis of the lipophilic reactive carbonyls present in biological specimens by LC/ESI-MS/MS, Journalof Chromatography B: Analytical Technologies in the Biomedical and LifeSciences 988 (2015) 149 –156, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[62] D. García-Gómez, P. Martínez-Lozano Sinues, C. Barrios-Collado, G. Vidal-de- Miguel, M. Gaugg, R. Zenobi, Identi ﬁcation of 2-alkenals, 4-hydroxy-2-alke- nals, and 4-hydroxy-2,6-alkadienals in exhaled breath condensate by UHPLC –HRMS and in breath by real-Time HRMS, Analytical Chemistry 87 (5) (2015) 3087 –3093, http://dx.doi.org/10.1021/ac504796p 25646646 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"El-Maghrabey, N. Kishikawa, K. Ohyama, N. Kuroda, Analytical method for lipoperoxidation relevant reactive aldehydes in human sera by high-performance liquid chromatography- ﬂuorescence detection, Analytical Bio- chemistry 464 (2014) 36 –42,http://dx.doi.org/10.1016/j.ab.2014.07.002 25017470 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Mohamed, H.M. Abdel-Wadood, A. M. Mahmoud, et al., Chromatographic determination of low-molecular mass unsaturated aliphatic aldehydes with peroxyoxalate chemiluminescence detection after ﬂuorescence labeling with 4-(N,N-dimethylaminosulfonyl)-7- hydrazino-2,1,3-benzoxadiazole, Journal of Chromatography B: AnalyticalTechnologies in the Biomedical and Life Sciences 953 –954 (2014) 147 –152, http://dx.doi.org/10.1016/j.jchromb.2014.02.009 24614624 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Baker, et al., Nitrated fatty acids: endogenous anti-in ﬂammatory signaling mediators, Journal of Biological Chemistry 281 (47) (2006) 35686 –35698, http://dx.doi.org/ 10.1074/jbc.M603357200 16887803 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[66] M. Colzani, G. Aldini, M. Carini, Mass spectrometric approaches for the identi ﬁcation and quanti ﬁcation of reactive carbonyl species protein adducts, Journal of Proteomics 92 (2013) 28 –50,http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Xiong, Mass spectrometric evidence of mal- onaldehyde and 4-hydroxynonenal adductions to radical-scavenging soypeptides, Journal of Agricultural and Food Chemistry 60 (38) (2012) 9727 –9736, http://dx.doi.org/10.1021/jf3026277 22946674 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[68] G. Gürbüz, M. Heinonen, LC –MS investigations on interactions between isolated beta-lactoglobulin peptides and lipid oxidation product mal- ondialdehyde, Food Chemistry 175 (2015) 300 –305, http://dx.doi.org/ 10.1016/j.foodchem.2014.11.154 25577084 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[69] H. Steen, M. Mann, The ABC ’s (and XYZ ’s) of peptide sequencing, Nature Reviews Molecular Cell Biology 5 (9) (2004) 699 –711, http://dx.doi.org/ 10.1038/nrm1468 15340378 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"StevensJr., N. Rauniyar, L. Prokai, Rapid characterization of covalent modi ﬁcations to rat brain mitochondrial proteins after ex vivo exposure to 4-hydroxy-2-nonenal by liquid chromatography –tandem mass spectrometry using data-dependent and neutral loss-driven MS3 acquisition, Journal of Mass Spectrometry 42 (12) (2007) 1599 –1605, http://dx.doi.org/10.1002/ jms.1349 18085542 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Stevens, K. Prokai-Tatrai, L. Prokai, Characterization of 4-hydroxy-2-nonenal-modi ﬁed peptides by liquid chromatography-tandem mass spectrometry using data-dependent acquisition: neutral loss-drivenMS3 versus neutral loss-driven electron capture dissociation, AnalyticalChemistry 81 (2) (2009) 782 –789, http://dx.doi.org/10.1021/ac802015m 19072288 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Bautista, Dif- ferential carbonylation of cytoskeletal proteins in blood group O ery- throcytes: potential role in protection against severe malaria, Infection, Ge- netics and Evolution 12 (8) (2012) 1780 –1787, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Petersen, 4-HNE adductstability characterized by collision-induced dissociation and electron transfer dissociation mass spectrometry, Chemical Research in Toxicology 25 (4)(2012) 965 –970, http://dx.doi.org/10.1021/tx300100w 22404378 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Facino, Mass spectrometry for detection of 4-hy- droxy-trans-2-nonenal (HNE) adducts with peptides and proteins, MassSpectrometry Reviews 23 (4) (2004) 281 –305, http://dx.doi.org/10.1002/ mas.10076 15133838 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Pitt, Use of narrow mass-window, high-resolution extracted product ion chromatograms for the sensitive and selective iden-tiﬁcation of protein modi ﬁcations, Analytical Chemistry 85 (9) (2013) 4621 – 4627, http://dx.doi.org/10.1021/ac400131f 23534669 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Domingues, P. Domingues, M. Fedorova, Heterogeneity of peptide adducts with carbonylated lipid peroxidation products, Journal of Mass Spectrometry 50 (3) (2015) 603 –612, http://dx.doi.org/10.1002/ jms.3568 25800198 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Podrez, Analysis of covalent modi ﬁcations of proteins by oxidized phospholipids using a novel method of peptide enrichment,Analytical Chemistry 86 (2) (2014) 1254 –1262, http://dx.doi.org/10.1021/ ac4035949 24350680 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[79] M. Golizeh, J. Abusarah, M. Benderdour, L. Sleno, Covalent binding of 4-hy- droxynonenal to matrix metalloproteinase 13 studied by liquid chromato- graphy –mass spectrometry, Chemical Research in Toxicology 27 (9) (2014) 1556 –1565, http://dx.doi.org/10.1021/tx5002095 25116078 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Shearn, P. Reigan, M.J. Marks, et al., Characterization of 4-HNE modi ﬁed L-FABP reveals alterations in structural and functional dynamics, PLOS One 7 (6) (2012) e38459, http://dx.doi.org/ 10.1371/journal.pone.0038459 22701647 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[81] S. Anavi, Z. Ni, O. Tirosh, M. Fedorova, Steatosis-induced proteins adducts with lipid peroxidation products and nuclear electrophilic stress in hepato- cytes, Redox Biology 4 (2015) 158 –168, http://dx.doi.org/10.1016/j.re- dox.2014.12.009 25560244 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Grif ﬁths, Analysis of protein carbonylation /C0pitfalls and promise in commonly used methods, Free Radical Research 48 (10) (2014) 1145 –1162, http://dx.doi.org/ 10.3109/10715762.2014.944868 25072785 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Bollineni, R. Hoffmann, Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies, Mass Spec-trometry Reviews 33 (2) (2014) 79 –97,http://dx.doi.org/10.1002/mas.21381 23832618 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[84] I. Dalle-Donne, M. Carini, M. Orioli, G. Vistoli, L. Regazzoni, G. Colombo, et al., Protein carbonylation: 2,4-dinitrophenylhydrazine reacts with both alde- hydes/ketones and sulfenic acids, Free Radical Biology and Medicine 46 (10) (2009) 1411 –1419, http://dx.doi.org/10.1016/j.freeradbiomed.2009.02.024 19268703 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Bollineni, M. Fedorova, R. Hoffmann, Qualitative and quantitative eva- luation of derivatization reagents for different types of protein-bound car-bonyl groups, Analyst 138 (17) (2013) 5081 –5088, http://dx.doi.org/10.1039/ c3an00724c 23833766 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Bollineni, R. Hoffmann, M. Fedorova, Proteome-wide pro ﬁling of car- bonylated proteins and carbonylation sites in HeLa cells under mild oxidative stress conditions, Free Radical Biology and Medicine 68 (2014) 186 –195, http://dx.doi.org/10.1016/j.freeradbiomed.2013.11.030 24321318 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Shearn, P. Reigan, et al., 4- hydroxynonenal inhibits SIRT3 via thiol-speci ﬁc modi ﬁcation, Chemical Re- search in Toxicology 24 (5) (2011) 651 –662, http://dx.doi.org/10.1021/ tx100355a 21449565 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Thompson, et al., The anti-in ﬂammatory effects of selenium are mediated through 15-deoxy- delta12,14-prostaglandin J2 in macrophages, Journal of Biological Chemistry282 (25) (2007) 17964 –17973, http://dx.doi.org/10.1074/jbc.M703075200 17439952 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[90] E. Cernuda-Morollón, E. Pineda-Molina, F.J. Cañada, D. Pérez-Sala, 15-Deoxy- delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding throughcovalent modi ﬁcation of the p50 subunit, Journal of Biological Chemistry 276 (38) (2001) 35530 –35536, http://dx.doi.org/10.1074/jbc.M104518200 11466314 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[91] N. Takahashi, Y. Mizuno, D. Kozai, S. Yamamoto, S. Kiyonaka, T. Shibata, et al., Molecular characterization of TRPA1 channel activation by cysteine-reactiveinﬂammatory mediators, Channels 2 (4) (2008) 287 –298, http://dx.doi.org/ 10.4161/chan.2.4.6745 18769139 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Koronowski, F. J. Schopfer, et al., Nitro-oleic acid targets transient receptor potential (TRP)channels in capsaicin sensitive afferent nerves of rat urinary bladder, Ex- perimental Neurology 232 (1) (2011) 90 –99,http://dx.doi.org/10.1016/j.ex- pneurol.2011.08.007 21867704 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[93] J. Parker, Prostaglandin A 2protein interactions and inhibition of cellular proliferation, Prostaglandins 50 (5 –6) (1995) 359 –375, http://dx.doi.org/G.",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Timms, et al., A biotinylated analog of the anti-proliferative prostaglandin A 1allows assessment of PPAR-independent effects and identi ﬁcation of novel cellular targets for covalent modi ﬁcation, Chemico-Biological Interactions 183 (1) (2010) 212 –221, http://dx.doi.org/10.1016/j.cbi.2009.09.019 19800325 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Hill, Utilization of ﬂuorescent probes for the quanti ﬁcation and identi ﬁcation of subcellular proteomes and biological processes regulated by lipid peroxidation products, Free Radical Biology and Medicine 59 (2013) 56 –68,http://dx.doi.org/10.1016/j.free- radbiomed.2012.08.014 22954622 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Marnett, Iden- tiﬁcation of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives, Chemical Research inToxicology 21 (2) (2008) 432 –444, http://dx.doi.org/10.1021/tx700347w 18232660 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[98] D. Pérez-Sala, Electrophilic eicosanoids: signaling and targets, Chemico- Biological Interactions 192 (1 –2) (2011) 96 –100, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[99] J. Gayarre, K. Stamatakis, M. Renedo, D. Pérez-Sala, Differential selectivity of protein modi ﬁcation by the cyclopentenone prostaglandins PGA1 and 15- deoxy-delta12,14-PGJ2: role of glutathione, FEBS Letters 579 (25) (2005) 5803 –5808, http://dx.doi.org/10.1016/j.febslet.2005.09.069 16223487 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Oeste, D. Pérez-Sala, Modi ﬁcation of cysteine residues by cyclopentenone prostaglandins: interplay with redox regulation of protein function, Mass Spectrometry Reviews 33 (2) (2014) 110 –125, http://dx.doi.org/10.1002/ mas.21383 23818260 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[104] F.J. Sánchez-Gómez, E. Cernuda-Morollón, K. Stamatakis, D. Pérez-Sala, Pro- tein thiol modi ﬁcation by 15-deoxy-delta12,14-prostaglandin J2 addition inmesangial cells: role in the inhibition of pro-in ﬂammatory genes, Molecular Pharmacology 66 (5) (2004) 1349 –1358, http://dx.doi.org/10.1124/ mol.104.002824 15317873 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Baraibar, R. Ladouce, B. Friguet, Proteomic quanti ﬁcation and identi ﬁ- cation of carbonylated proteins upon oxidative stress and during cellular aging, Journal of Proteomics 92 (2013) 63 –70,http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"A prostaglandin D2 metabolite generated dur- ing in ﬂammatory processes, Journal of Biological Chemistry 277 (12) (2002) 10459 –10466, http://dx.doi.org/10.1074/jbc.M110314200 11786541 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[108] Y. Kato, The formation of lipid hydroperoxide-derived amide-type lysine adducts on proteins: a review of current knowledge, Subcellular Biochem- istry 77 (2014) 21 –39,http://dx.doi.org/10.1007/978-94-007-7920-4_2 24374915 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Kodama, A. Kakizuka, H. Jingami, Alpha, beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma, Journal of Biological Chemistry 280 (14) (2005) 14145 –14153, http://dx.doi.org/10.1074/ jbc.M500901200 15695504 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Timms, C. Coderch, F. Gago, et al., Identi ﬁcation of aldo-keto reductase AKR1B10 as a selective target for modi ﬁcation and inhibition by prostaglandin A(1): implications for anti- tumoral activity, Cancer Research 71 (12) (2011) 4161 –4171, http://dx.doi.org/ 10.1158/0008-5472.CAN-10-3816 21507934 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[111] S. Gharbi, B. Garzón, J. Gayarre, J. Timms, D. Pérez-Sala, Study of protein targets for covalent modi ﬁcation by the antitumoral and anti-in ﬂammatory prostaglandin PGA 1: focus on vimentin, Journal of Mass Spectrometry 42 (11) (2007) 1474 –1484, http://dx.doi.org/10.1002/jms.1291 17960581 .",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"Lee, Rosics: chemistry and proteomics of cysteine modi ﬁcations in redox biology, Mass Spectrometry Reviews 34 (2) (2015) 184 –208, http://dx.doi.org/10.1002/mas.21430 24916017 .",OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
"[114] A. Tsapara, D. Kardassis, A. Moustakas, A. Gravanis, C. Stournaras, Expression and characterization of Cys374 mutated human beta-actin in two different mammalian cell lines: impaired micro ﬁlament organization and stability, FEBS Letters 455 (1 –2) (1999) 117 –122, http://dx.doi.org/10.1016/S0014-5793 (99)00848-0 10428484 .G.",Non-OADS,/arxiv_data1/oa_pdf/3a/71/main.PMC4477048.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/ca/main.PMC4477102.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.05.0042213-3232/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/ca/main.PMC4477102.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/ca/main.PMC4477102.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.nicl.2015.04.0242213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"Quanti- tative regional brain volumes were obtained using the parcellation method incorporated in Freesurfer 5.1 software ( http://freesurfer.net/ fswiki ) using the Desikan atlas ( Desikan et al., 2006 ).",OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"135 (1), 50 –68.http://dx.doi.org/10.1037/a001441119210053 .",Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"Histopathology 15 (1), 49 –59.http://dx.doi.org/10.1111/j.1365-2559.1989.tb03040.x2767623 .",Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1146/annurev.ne.09.030186.0020413085570 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1089/neu.2011.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1162/08989290577458927116269109 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1212/WNL.000000000000061624966406 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"15 (1), 1 –8.http://dx.doi.org/10.1017/S135561770809003619128523 .",Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1212/01.WNL.0000068008.78394.2C12771250 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"NeuroImage 5(1), 49 –62.http://dx.doi.org/10.1006/nimg.1996.02479038284 .",Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.cogbrainres.2004.06.01415511653 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.08.05617175179 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.7205/MILMED-D-12-0009823113441 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1089/ neu.2013.287724020449 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.apmr.2013.06.,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"4 (134), 134– 160. http://dx.doi.org/10.1126/scitranslmed.",Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1093/cercor/ bht22923968837 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.2466/pms.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1056/NEJMoa07297218234750 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"J. Neurotrauma 28 (9), 1783– 1801. http://dx.doi.org/10.108 9/neu.2010.172321644813 .",Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/0010-0277(94)90028-08039361 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1176/appi.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.3233/NRE-2010- 055820448312 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1682/JRRD.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"Neuron 60 (4), 543 –55  4.http://dx.doi.org/10.1016/j.neuron.2008.11.00519038213 .",OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1111/j.1460-9568.2004.03108.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"17 (1), 36 –45.http://dx.doi.org/10.1017/S135561771000120721083963 .",Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1093/brain/awn30919036762 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.apmr.2013.08.29824581909 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"24 (1), 65 –68.http://dx.doi.org/10.1097/HTR.",Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1080/ 0269905031000161737014742148 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.do  i.org/10.1097/NEN.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"136 (1), 43 –64.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.05.00621596142 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/S0926- 6410(99)00010-510407200 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1177/ 014662167700100306 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1002/jnr.2251020882564 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.2466/pms.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.apmr.2008.07.00719081444 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1002/jnr.2317923335267 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1089/neu.2008-085619317610 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1017/S135561771100143322132942 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.mehy.2013.07.,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2006.02.02416624579 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
"1 (1), 51. http://dx.doi.org/10.1186/2051-5960-1- 5124252601 .",Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1126/science.153.3736.6525939936 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1016/j.nicl.2014.05.00524936431 .,OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1017/S135561770505028915892899 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1017/S135561771000140221144101 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1021/cn300216h23590251 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1002/hbm.2235824038816 .,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
http://dx.doi.org/10.1001/ jamapsychiatry.2013.308024337530 .553 M.R.,Non-OADS,/arxiv_data1/oa_pdf/6d/56/main.PMC4477106.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1016/j.nicl.2015.05.009 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"ﬁl.ion.ucl.ac.uk/spm/ ) and DPARSF( Chao-Gan and Yu-Feng, 2010 ;http://rfmri.org/DPARSF ) toolboxes, both in MATLAB R2013a (MathWorks Inc., Natick, MA,United States), wereused for pre-processing purposes.",Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
Graph theory analysis An in-house network analysis pipeline was used implementing Matlab codes from the Brain Connectivity Toolbox (BCT: Rubinov and Sporns (2010) ; https://sites.google.com/site/bctnet/Home ).,OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"Thecomplex network model was derived from an independent dataset based on group averaged task-free fMRI data from 26 healthy control subjects ( Crossley et al., 2013 ), freely available online (BCT: GroupAverage_rsfMRI.m- https://sites.google.com/site/bctnet/datasets ).",OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1371/journal.pcbi.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"26 (1), 63 –72.http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1093/cercor/bhr38822275481 .,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.07.00717761438 .,OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1097/ 00004647-200110000-0000111598490 .,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"244, 67–74.http://dx.doi.org/10.1016/j.expneurol.2012.01.02822342991 .",OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1038/nrn321422498897 .,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"4, 13. http://dx.doi.org/10.3389/fnsys.2010.",Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1097/WCO.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"125 (1), 21 –31.http://dx.doi.org/10.1016/ j.clinph.2013.06.18223871167 .",OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4858-10.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"4, 22. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1089/brain.2011.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.4137/EBO.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1523/JNEUROSCI.6309-09.201020668192 .,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"166 (1), 1 –15  .http://dx.doi.org/10.1016/S0022- 510X(99)00107-010465493 .",OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"87 (19), 198701. http://dx.doi.org/10.1103/PhysRevLett.87.19870111690461 .",Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/ 10.1212/WNL.0b013e31822c90f221849655 .,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"Epilepsia 44, 30 –43.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"Neural Circuits 8, 101. http://dx.doi.org/10.3389/fncir.2014.0010125232306 .",OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1038/nature1318624695228 .,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1016/j.clinph.2006.12.,OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.,OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"Evolving functional network properties and synchronizability during human epileptic seizures.Chaos 18 (3), 033119. http://dx.doi.org/10.1063/1.296611219045457 .",OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.6046-11.201222973006 .,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"NeuroImage 82, 403– 415. http://dx.doi.org/10.1016/ j.neuroimage.2013.05.08123747961 .",OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1038/nrn380125186238 .,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1016/j.clinph.2012.01.,OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1006/nimg.2001.097811771995 .,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1371/journal.pone.011460625493432.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
"5, 187. http://dx.doi.org/ 10.3389/fneur.2014.0018725309507 .",Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1152/jn.00368.,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1038/309189623998 .,Non-OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
http://dx.doi.org/10.1093/cercor/bhr26921968567 .542 M. Pedersen et al.,OADS,/arxiv_data1/oa_pdf/84/70/main.PMC4477107.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.nicl.2015.04.007 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
Resting-state Connectivity analyses were performed using the CONN fMRI functional connectivity toolbox (version 12.1; http://www.nitrc.org/ projects/conn ).,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1007/s00429-007-0161- 117962979 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.chiabu.2006.09.00617412420 .,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1002/hbm.2263925224633 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1097/00004583-199704000-000189100430 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
"52, 12 –23.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
"2, 43 –49.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1037/0022-3514.67.2.319 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.chiabu.,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1002/cne.2074916254997 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/ 10.1002/mpr.34322547297 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1093/cercor/bhm17917940084 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.neuron.2006.07.02916982430 .,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1176/appi.ajp.2007.,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
"J. Psychiatry 166 (1), 64 –73.http://dx.doi.org/10.1176/appi.ajp.2008.0708133619047324 .",Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1093/cercor/bhq07120421249 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1371/journal.pone.002527821966479 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1080/02699931.2012.66620522650182 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.genhosppsych.2009.05.00319892208 .,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1002/jts.2070522144187 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1001/ archgenpsychiatry.2009.18620124111 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1176/appi.ajp.2012.1107110522535198 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1017/ S003329171200231023171514 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1162/ 089892905402118415969906 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1001/archpsyc.1995.039502400660127492257 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
"10 (1), 34 –49.http://dx.doi.org/10.3758/CABN.10.1.",Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
"7, 930. http://dx.doi.org/10.3389/fnhum.2013.0093024478665 .",Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1146/annurev.me.19.,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
"Neuroimage 83, 679–68 9. http://dx.doi.org/10.1016/j.neuroimage.2013.07.00223851324 .",OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
"Neuropsychopharmacology 40, 1250– 1258. http://dx.doi.org/10.1038/npp.2014.31125413183 .",Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.cub.2011.10.01522153160 .,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.tics.,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.tics.2013.09.,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1007/ s00429-010-0262-020512370 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
"212 (1), 38 –52.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.neubiorev.,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1007/s00213-010-2009-220865251 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1111/j.1467-8721.2008.00608.x21701602 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1037/0022-006X.52.6.9556520288 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.5587-06.200717329432 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1097/PSY.0b013e318273bf3323115342 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1002/hbm.2070519072897 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.11.08021134471 .,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1016/j.jaac.2013.04.,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1111/j.1467-7687.2010.00971.x21399712 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4465- 11.201122171056 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1152/ jn.00783.200919889849 .,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
http://dx.doi.org/10.1111/j.1601- 183X.2012.00837.x22979952 .525 H.A.,Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4477108.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/a2/main.PMC4477109.pdf
http://dx.doi.org/10.1016/j.mgene.2015.05.005 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/26/a2/main.PMC4477109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/a2/main.PMC4477109.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/2a/main.PMC4477110.pdf
http://dx.doi.org/10.1016/j.mgene.2015.06.001 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/2a/main.PMC4477110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/2a/main.PMC4477110.pdf
http://dx.doi.org/10.1155/2014/468375 .,Non-OADS,/arxiv_data1/oa_pdf/b9/2a/main.PMC4477110.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Dis eases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.05.001,Non-OADS,/arxiv_data1/oa_pdf/2c/48/main.PMC4477111.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Dis eases, NMNI ,7,2 1 –22 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/2c/48/main.PMC4477111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
ThereforeContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.06.002 2213-2317/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
Supplementary material Supplementary data associated with this article can be found in t h eo n l i n ev e r s i o na t http://dx.doi.org/10.1016/j.redox.2015.06.002 .,OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"[2] D.C. Rubinsztein, The roles of intracellular protein-degradation pathways in neurodegeneration, Nature 443 (7113) (2006) 780 –786, http://dx.doi.org/ 10.1038/nature05291 17051204 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"3 (1987) 1 –30,http://dx.doi.org/10.1146/annurev.",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"66 (17) (2009) 2819 –2833, http://dx.doi.org/10.1007/s00018-009-0048-9 19468686 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"61 (1992) 761 –807, http://dx.doi.org/10.1146/annurev.",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Yin, Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome,Autophagy 4 (2) (2008) 141 –150, http://dx.doi.org/10.4161/auto.5190 17986870 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"20 (1) (2013) 21 –30,http://dx.doi.org/10.1038/cdd.2012.72 22722335 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"[8] A. Taylor, Mechanistically linking age-related diseases and dietary carbohy- drate via autophagy and the ubiquitin proteolytic systems, Autophagy 8 (9) (2012) 1404 –1406, http://dx.doi.org/10.4161/auto.21150 22906982 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"9 (10) (2008) 759 –767, http://dx.doi.org/ 10.1038/nrn2474 18769445 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"U.S.A. 112 (4) (2015) 1071 –1076, http://dx.doi.org/10.1073/ pnas.1404059112 25583491 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"13 (6) (2011) 668 –678, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Science 299 (5611) (2003) 1342 –1346, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Clancy, et al., Dietary restriction in long-lived dwarf ﬂies, Science 296 (5566) (2002) 319, http://dx.doi.org/10.1126/science.1069366 11951037 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"11 (1) (2010) 35 –46,http://dx.doi.org/ 10.1016/j.cmet.2009.11.010 20074526 .",OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Longo, Extending healthy life span –from yeast to humans, Science 328 (5976) (2010) 321 –326, http://dx.doi.org/10.1126/B.",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Harrison, et al., Rapamycin fed late in life extends lifespan in genetically heterogeneous mice, Nature 460 (7253) (2009) 392 –395, http://dx.doi.org/ 10.1038/nature08221 19587680 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"584 (7) (2010) 1287 –1295, http://dx.doi.org/10.1016/j.febslet.2010.01.017 20083114 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"[20] P. Fabrizio, et al., Regulation of longevity and stress resistance by Sch9 in yeast, Science 292 (5515) (2001) 288 –290, http://dx.doi.org/10.1126/science.1059497 11292860 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Cells 26 (5) (2007) 663 –674, http://dx.doi.org/10.1016/j.mol- cel.2007.04.020 17560372 .",OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"[22] C. Selman, et al., Ribosomal protein s6 kinase 1 signaling regulates mamma- lian life span, Science 326 (5949) (2009) 140 –144, http://dx.doi.org/10.1126/ science.1177221 19797661 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"280 (24) (2005) 22679 –22687, http://dx.doi.org/10.1074/ jbc.M502972200 15840588 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"29 (3) (2004) 136 –142, http://dx.doi.org/ 10.1016/j.tibs.2004.01.005 15003271 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"30 (15) (2011) 3052 –3064, http://dx.doi.org/10.1038/emboj.2011.221 21730963 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"23 (16) (2009) 1929 –1943, http://dx.doi.org/10.1101/gad.532109 19684113 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"1 (2006) 3, http://dx.doi.org/10.1186/1747- 1028-1-3 16759348 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"4 (1) (2008) e13, http://dx.doi.org/10.1371/journal.pgen.0040013 18225956 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"285 (47) (2010) 37092 –37101, http://dx.doi.org/10.1074/jbc.M110.174763 20847055 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Role of Snf1 and Tor1/Sch9 ki-nases, Biochimica et biophysica acta 1833 (8) (2013) 2004 –2015, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"14 (1) (2014) 17 –32,http://dx.doi.org/10.1111/1567- 1364.12097 24102693 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"5 (4) (2007) 265 –277, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Cell 7 (7) (2008) 1127 –1135, http://dx.doi.org/10.1128/EC.00330-07 18469137 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"[37] R. Cocklin, M. Goebl, Nutrient sensing kinases PKA and Sch9 phosphorylate the catalytic domain of the ubiquitin-conjugating enzyme Cdc34, PLOS One 6(11) (2011) e27099, http://dx.doi.org/10.1371/journal.pone.0027099 22087249 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Goebl, et al., The yeast cell cycle gene CDC34 encodes a ubiquitin-con- jugating enzyme, Science 241 (4871) (1988) 1331 –1335, http://dx.doi.org/ 10.1126/science.2842867 2842867 .",OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"761 (2011) 173 –200, http://dx.doi.org/10.1007/978-1-61779-182-6_12 21755449 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"55 (3) (2005) 862 –880, http://dx.doi.org/10.1111/j.1365-2958.2004.04429.x 15661010 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"68 (1999) 1015 –1068, http://dx.doi.org/10.1146/annurev.biochem.68.1.1015 10872471 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"19 (21) (2000) 5720 –5728, http://dx.doi.org/10.1093/emboj/19.21.5720 11060023 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Cell 18 (10) (2007) 4180 –4189, http://dx.doi.org/10.1091/mbc.E07-05-0485 17699586 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"451 (2008) 1 –26,http://dx.doi.org/ 10.1016/S0076-6879(08)03201-1 19185709 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"27 (5 –6) (1999) 612 –616, http://dx.doi.org/10.1016/S0891-5849(99)00107-0 10490282 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"70 (2014) 167 –173, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"65 (2013) 541 –551, http://dx.doi.org/10.1016/j.free- radbiomed.2013.06.037 23831190 .",OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"32 (2) (2008)224 –228, http://dx.doi.org/10.1016/j.cellbi.2007.08.028 17920943 .",OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"289 (13) (2014) 8735 –8741, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Schwartz, Ubiquitin-mediated degradation of cellular proteins in health and disease, Hepatology 35 (1) (2002) 3 –6,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"[54] R. Cocklin, M. Goebl, Nutrient sensing kinases PKA and Sch9 phosphorylate the catalytic domain of the ubiquitin-conjugating enzyme Cdc34, PLOS One 6 (11) (2011) e27099, http://dx.doi.org/10.1371/journal.pone.0027099 22087249 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"52 (1) (2012) 1 –6,http://dx.doi.org/10.1016/j.freeradbiomed.2011.09.030 22027063 .",OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"182 (4) (2008) 663 –673, http://dx.doi.org/10.1083/jcb.200803022 18725537 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"[57] J. Liu, et al., Reducing sphingolipid synthesis orchestrates global changes to extend yeast lifespan, Aging Cell 12 (5) (2013) 833 –841, http://dx.doi.org/ 10.1111/acel.12107 23725375 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"[58] S. Hu, et al., A protein chip approach for high-throughput antigen identi ﬁca- tion and characterization, Proteomics 7 (13) (2007) 2151 –2161, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"8 (2) (2012) http://dx.doi.org/10.1371/ journal.pgen.1002493 22319457 ,p .e 1 0 0 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"[60] C. Liu, et al., Proteasome inhibition in wild-type yeast Saccharomyces cerevisiae cells, BioTechniques 42 (2) (2007) 158, http://dx.doi.org/10.2144/000112389 17373478 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Brachmann, et al., Designer deletion strains derived from Saccharomyces cer- evisiae S288C: a useful set of strains and plas mids for PCR-mediated gene disrup- tion and other applications, Yeast 14 (2) (1998) 115 –132, http://dx.doi.org/10.1002/ (SICI)1097-0061(19980130)14:2 o115::AID-YEA204 43.0.CO;2-2 9483801 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Kushnirov, Rapid and reliable protein extraction from yeast, Yeast 16 (9) (2000) 857 –860, http://dx.doi.org/10.1002/1097-0061(20000630)16:9 o857:: AID-YEA561 43.0.CO;2-B 10861908 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"Schmittgen, Analysis of relative gene expression data using real- time quantitative PCR and the 2(-Delta Delta C(T)) method, Methods 25 (4) (2001) 402 –408, http://dx.doi.org/10.1006/meth.2001.1262 11846609 .",OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"5 (1) (2010) 51–66,http://dx.doi.org/10.1038/nprot.2009.197 20057381 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"7 (9) (2011) http://dx.doi.org/10.1371/ journal.pgen.1002253 21931558 ,p .e 1 0 0 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
"458 (2014) 69 –71,http://dx.doi.org/10.1016/j.ab.2014.04.034 24814294 .",Non-OADS,/arxiv_data1/oa_pdf/fa/5e/main.PMC4477112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/6c/main.PMC4477118.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2015.05.001 2213-2244/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/61/6c/main.PMC4477118.pdf
All samples were collected according to the guidelines - Chimpanzee sanctuaries: guidelines and management workshop report (available at http://pages.ucsd.edu/~jmoore/courses/methp rimconsweb08/chimpsanct.pdf ; date of access to website in 2004).,Non-OADS,/arxiv_data1/oa_pdf/61/6c/main.PMC4477118.pdf
"doi:10.1136/openhrt-2015- 000269 Accepted 5 June 2015 ▸http://dx.doi.org/10.1136/ openhrt-2015-000237 Open Heart, London, UK Correspondence to Dr Rahul Bahl; rahulbahl2004@hotmail.comIt is always refreshing to read research that takes into account the views and experienceof patients, especially when it can aid shared decision-making.",Non-OADS,/arxiv_data1/oa_pdf/8d/89/openhrt-2015-000269.PMC4477146.pdf
"London: GMC, 2008. http://www.gmc-uk.org/ guidance/ethical_guidance/consent_guidance_index.asp 3.",Non-OADS,/arxiv_data1/oa_pdf/8d/89/openhrt-2015-000269.PMC4477146.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a0/3c/bmjdrc-2015-000111.PMC4477147.pdf
"doi:10.1136/openhrt-2015- 000274 Accepted 5 June 2015 ▸http://dx.doi.org/10.1136/ openhrt-2015-000238 Department of Cardiology, Charite Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany Correspondence to Dr Georg M Fröhlich; georg.froehlich@gmx.atIn this issue of Open Heart , Hoole et al1 present the IMPACT trial.",Non-OADS,/arxiv_data1/oa_pdf/7f/c1/openhrt-2015-000274.PMC4477149.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/lupus-2014-000063).,Non-OADS,/arxiv_data1/oa_pdf/b3/24/lupus-2014-000063.PMC4477150.pdf
doi:10.1136/ bmjdrc-2015-000108 Received 5 April 2015 Revised 2 June 2015Accepted 3 June 2015 ▸http://dx.doi.org/10.1136/ bmjdrc-2015-000111 For numbered affiliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/65/c2/bmjdrc-2015-000108.PMC4477152.pdf
http://www.muslimhealthservice.com/ accessed January 25th 2015 33.,Non-OADS,/arxiv_data1/oa_pdf/65/c2/bmjdrc-2015-000108.PMC4477152.pdf
http://www.idf.org/sites/default/files/Atlas-poster- 2014_EN.pdf (accessed 10 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/65/c2/bmjdrc-2015-000108.PMC4477152.pdf
Open AccessI R Wallace and others TSH-secreting pituitary adenomaID: 15-0007; June 2015 DOI: 10.1530/EDM-15-0007 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/a3/ae/edmcr-2015-150007.PMC4477234.pdf
I R Wallace and others TSH-secreting pituitary adenomaID: 15-0007; June 2015 DOI: 10.1530/EDM-15-0007 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/a3/ae/edmcr-2015-150007.PMC4477234.pdf
Time Free T 4(pmol/l) TSH (mU/l) 0 16.6 1.56 8 days 12.1 0.93 I R Wallace and others TSH-secreting pituitary adenomaID: 15-0007; June 2015 DOI: 10.1530/EDM-15-0007 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/a3/ae/edmcr-2015-150007.PMC4477234.pdf
84.2.5505 ) Received in ﬁnal form 11 May 2015 Accepted 21 May 2015 I R Wallace and others TSH-secreting pituitary adenomaID: 15-0007; June 2015 DOI: 10.1530/EDM-15-0007 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/a3/ae/edmcr-2015-150007.PMC4477234.pdf
Open AccessA Nahmias and others pNETs with transformation to insulinomaID: 15-0032; June 2015 DOI: 10.1530/EDM-15-0032 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/9c/f6/edmcr-2015-150032.PMC4477235.pdf
A Nahmias and others pNETs with transformation to insulinomaID: 15-0032; June 2015 DOI: 10.1530/EDM-15-0032 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/9c/f6/edmcr-2015-150032.PMC4477235.pdf
A Nahmias and others pNETs with transformation to insulinomaID: 15-0032; June 2015 DOI: 10.1530/EDM-15-0032 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/9c/f6/edmcr-2015-150032.PMC4477235.pdf
A Nahmias and others pNETs with transformation to insulinomaID: 15-0032; June 2015 DOI: 10.1530/EDM-15-0032 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/9c/f6/edmcr-2015-150032.PMC4477235.pdf
Everolimus has emerged as a usefultreatment for hypoglycemia in insulinoma patients andwas also proven highly effective in the patients presented A Nahmias and others pNETs with transformation to insulinomaID: 15-0032; June 2015 DOI: 10.1530/EDM-15-0032 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/9c/f6/edmcr-2015-150032.PMC4477235.pdf
( doi:10.1074/ jbc.274.46.33085 ) Received in ﬁnal form 21 May 2015 Accepted 29 May 2015 A Nahmias and others pNETs with transformation to insulinomaID: 15-0032; June 2015 DOI: 10.1530/EDM-15-0032 http://www.edmcasereports.com 6,Non-OADS,/arxiv_data1/oa_pdf/9c/f6/edmcr-2015-150032.PMC4477235.pdf
"Resistanthypertension and hyperadrenergic spells are classic features, and the main presenting symptoms include: Open AccessA Sjoeholm and others Dual-hormone secreting phaeochromocytomaID: 15-0041; June 2015 DOI: 10.1530/EDM-15-0041 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd",Non-OADS,/arxiv_data1/oa_pdf/41/09/edmcr-2015-150041.PMC4477238.pdf
"Phenoxyben- zamine was initiated at 10 mg (0.2 mg/kg) twice daily, and as tolerated was increased in 10 mg/dose increments A Sjoeholm and others Dual-hormone secreting phaeochromocytomaID: 15-0041; June 2015 DOI: 10.1530/EDM-15-0041 http://www.edmcasereports.com 2",Non-OADS,/arxiv_data1/oa_pdf/41/09/edmcr-2015-150041.PMC4477238.pdf
A Sjoeholm and others Dual-hormone secreting phaeochromocytomaID: 15-0041; June 2015 DOI: 10.1530/EDM-15-0041 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/41/09/edmcr-2015-150041.PMC4477238.pdf
A Sjoeholm and others Dual-hormone secreting phaeochromocytomaID: 15-0041; June 2015 DOI: 10.1530/EDM-15-0041 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/41/09/edmcr-2015-150041.PMC4477238.pdf
"( doi:10.1515/jpem.2010.102 ) 6 Barrett C, van Uum SH & Lenders JW 2015 Risk of catecholaminergic crisis following glucocorticoid administration in patients with an A Sjoeholm and others Dual-hormone secreting phaeochromocytomaID: 15-0041; June 2015 DOI: 10.1530/EDM-15-0041 http://www.edmcasereports.com 5",Non-OADS,/arxiv_data1/oa_pdf/41/09/edmcr-2015-150041.PMC4477238.pdf
( doi:10.1001/archderm.142.12.1568 ) Received in ﬁnal form 11 May 2015 Accepted 15 May 2015 A Sjoeholm and others Dual-hormone secreting phaeochromocytomaID: 15-0041; June 2015 DOI: 10.1530/EDM-15-0041 http://www.edmcasereports.com 6,Non-OADS,/arxiv_data1/oa_pdf/41/09/edmcr-2015-150041.PMC4477238.pdf
Available from: http://www.inctr.org/meetings/past- meetings/annual-meeting-2003/.,Non-OADS,/arxiv_data1/oa_pdf/85/63/IJMPO-36-105.PMC4477372.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/2a/dd/IJMPO-36-117.PMC4477374.pdf
Available from: http://www.uicc.org/resources/ cancer-awareness-prevention-and-control-uicc-handbook- south-asia-0 [Last accessed on 2015 May 1].,Non-OADS,/arxiv_data1/oa_pdf/c5/f2/IJMPO-36-128.PMC4477376.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/e4/9f/IJMPO-36-73.PMC4477379.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/e4/9f/IJMPO-36-73.PMC4477379.pdf
Available	 from:	 https://www.clinicaltrials.gov/ct2/show/NCT00639366.,Non-OADS,/arxiv_data1/oa_pdf/98/23/IJMPO-36-77.PMC4477380.pdf
Available	 from:	http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/54/4b/IJMPO-36-79.PMC4477381.pdf
Available from: https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/212450/ Liverpool_Care_Pathway.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/35/IJMPO-36-94.PMC4477384.pdf
Available from:  http://www.telegraph.co.uk/health/healthnews/6127514/ Sentenced-to-death-on-the-NHS.html.,Non-OADS,/arxiv_data1/oa_pdf/04/35/IJMPO-36-94.PMC4477384.pdf
Available from:  http://www.midstaffspublicinquiry.com/sites/default/files/ report/Executive%20summary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/35/IJMPO-36-94.PMC4477384.pdf
https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file/323188/One_chance_ to_get_it_right.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/35/IJMPO-36-94.PMC4477384.pdf
Available from: http://www.ambercarebundle.,Non-OADS,/arxiv_data1/oa_pdf/04/35/IJMPO-36-94.PMC4477384.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/64/e9/JHRS-8-59.PMC4477450.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/64/e9/JHRS-8-59.PMC4477450.pdf
Available from: http://www.etr.org/recapp/theories/adolescent  development/overview.htm.,Non-OADS,/arxiv_data1/oa_pdf/ca/74/JHRS-8-70.PMC4477452.pdf
Available from: http://www.census.gov/cgi‑bin/ broker.,OADS,/arxiv_data1/oa_pdf/ca/74/JHRS-8-70.PMC4477452.pdf
Availabel from: http://www.pamf.org/parenting ‑ teens/health/growth ‑development/growth.html.,Non-OADS,/arxiv_data1/oa_pdf/ca/74/JHRS-8-70.PMC4477452.pdf
Author Help: Online submission of the manuscripts Articles can be submitt ed online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/ca/74/JHRS-8-70.PMC4477452.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/50/31/JHRS-8-86.PMC4477455.pdf
Available from:  http://www.who.int/genomics/gender/en/index  6.html.,OADS,/arxiv_data1/oa_pdf/50/31/JHRS-8-86.PMC4477455.pdf
Sept 2006. https://www.rcog.org.uk/ globalassets/documents/guidelines/gtg5_230611.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a1/f7/JHRS-8-93.PMC4477456.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/ba/tov071.PMC4477519.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/f3/tov095.PMC4477520.pdf
http://cdms.net.,Non-OADS,/arxiv_data1/oa_pdf/1d/f3/tov095.PMC4477520.pdf
(http://cdms.net).,OADS,/arxiv_data1/oa_pdf/1d/f3/tov095.PMC4477520.pdf
"This observation led to an increasing interest from both pharmaceutical  companies and institutional funding agencies, as testified by the K4DD Innovative Medicines Initiative  of 2012 (http://www.imi.europa.eu/content/k4dd).",Non-OADS,/arxiv_data1/oa_pdf/72/40/srep11539.PMC4477625.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: SD, WR and AC are among the owners of BiKi Technologies s.r.l., a  high-tech start-up company which sells software supporting drug design and discovery for Biotech and Pharma industries.",Non-OADS,/arxiv_data1/oa_pdf/72/40/srep11539.PMC4477625.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/72/40/srep11539.PMC4477625.pdf
User- guide and example files for SASE-hunter are provided athttp://www.sjdlab.org/resources .,OADS,/arxiv_data1/oa_pdf/5f/18/gkv419.PMC4477653.pdf
AVAILABILITY SoftwareAvailability: http://www.sjdlab.org/resources .,OADS,/arxiv_data1/oa_pdf/5f/18/gkv419.PMC4477653.pdf
"MATERIALS AND METHODS Identification of Sox9putative enhancers We used the genome browser of the University of Califor- nia at Santa Cruz ( http://genome.ucsc.edu/ ) to identify se- quences upstream of mouse Sox9that (i) are highly con- served in vertebrate genomes, (ii) are marked with epige- neticsignaturescharacteristicofenhancersinE14.5mouse embryo limbs, as detected in chromatin immunoprecipita-tionfollowedbyhigh-throughputsequencing(ChIP-seq)by theENCODE /LICRproject,and(iii)presentDNaseIhy- persensitivity in E11.5 mouse limb buds, as detected by theENCODE project at the University of Washington.",OADS,/arxiv_data1/oa_pdf/d9/b9/gkv426.PMC4477657.pdf
"Mapped reads were collapsed to unique sequences with their associated count numbers and aligned with Lastz (one mismatch al- lowance)tomanuallycuratedreferencelibrariescontainingunambiguous sequences corresponding to mature human miRNAs downloaded from miRBase release 20 ( 28); ma- ture human tRNAs downloaded from the genomic tRNAdatabase ( http://gtrnadb.ucsc.edu/ ); and mature human ri- bosomal RNA, small nuclear RNA, small nucleolar RNA, vault RNA and YRNA sequences downloaded from Gen-Bank (http://www.ncbi.nlm.nih.gov/nuccore/ ).",OADS,/arxiv_data1/oa_pdf/05/77/gkv432.PMC4477662.pdf
Sequencingdata were submitted to the sequence read archive database (http://www.ncbi.nlm.nih.gov/sra )undertheBioProjectID: PRJNA270876 Stem-loopRTquantitativeanddropletdigitalPCR(ddPCR) We used a modification of the popular stem-loop RT miRNA quantification method ( 30) for small RNA quan- tification.,OADS,/arxiv_data1/oa_pdf/05/77/gkv432.PMC4477662.pdf
"A recent report hasshown that bacterial YRNAs mimic tRNAs and are sub- stratesofthesameprocessingmachinery( 60).Theseobser- vationsandthefindingofthesespeciesincirculation( 22,24) suggest that there may be a biological reason for cleavage of tRNAs and secretion of 5 /primehalves into the extracellular space.ACCESSION NUMBERS High throughput sequencing data will be available at the sequence read archive database ( http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/05/77/gkv432.PMC4477662.pdf
"York, UK: University of York Centre for Reviewsand Dissemination; 2009. https://http://www.york.ac.uk/inst/crd/SysRev/!SSL!/WebHelp/1_3_UNDERTAKING_THE_RE VIEW.htm.",Non-OADS,/arxiv_data1/oa_pdf/72/a1/nuu063.PMC4477700.pdf
http://www.sign.ac.uk/methodology/checklists.html.,Non-OADS,/arxiv_data1/oa_pdf/72/a1/nuu063.PMC4477700.pdf
http://www.lancaster.ac.uk/shm/research/nssr/research/dissemination/publications/NS_Synthesis_Guidance_v1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/a1/nuu063.PMC4477700.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/18/main.PMC4477704.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/18/main.PMC4477704.pdf
http://dx.doi.org/10.1016/j.eucr.2014.12.011Urology Case Reports 3 (2015) 18 e20,Non-OADS,/arxiv_data1/oa_pdf/9e/18/main.PMC4477704.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/52/main.PMC4477707.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35782 .2.,OADS,/arxiv_data1/oa_pdf/32/52/main.PMC4477707.pdf
http://dx.doi.org/10.1016/j.gdata.2015.05.037 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/32/52/main.PMC4477707.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/52/main.PMC4477707.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/32/52/main.PMC4477707.pdf
Furthermore the E-PRE-DELIRIC model will soon be integrated in theDeliriumICU app which makes it possible to use it bed-side ( http://itunes.apple.com/us/app/deliriumicu/id511306 390andhttps://play.google.com/store/apps/details?id=dots digits.deliriumicu ).,Non-OADS,/arxiv_data1/oa_pdf/d2/36/134_2015_Article_3777.PMC4477716.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d2/36/134_2015_Article_3777.PMC4477716.pdf
Available at http://www.R-project.org/ 34.,Non-OADS,/arxiv_data1/oa_pdf/d2/36/134_2015_Article_3777.PMC4477716.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/00/16/134_2015_Article_3789.PMC4477720.pdf
http://www.scp.nl/ .,Non-OADS,/arxiv_data1/oa_pdf/00/16/134_2015_Article_3789.PMC4477720.pdf
http://hdl.handle.net/1765/41382 37.,Non-OADS,/arxiv_data1/oa_pdf/00/16/134_2015_Article_3789.PMC4477720.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/0e/41/134_2015_Article_3751.PMC4477725.pdf
http://www.ascilite.org.au/ conferences/singapore07/procs/.,Non-OADS,/arxiv_data1/oa_pdf/7a/b0/ar11.PMC4477727.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).CBE Life Sci Educ June 1, 2015 14:ar12 DOI:10.1187/ cbe.14-05-0082",Non-OADS,/arxiv_data1/oa_pdf/02/cb/ar12.PMC4477728.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.14-11-0216 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ June 1, 2015 14:ar13",Non-OADS,/arxiv_data1/oa_pdf/be/34/ar13.PMC4477729.pdf
Chron  High Educ http://chronicle.com/article/PhD-Attrition-How   -Much-Is/140045 (accessed 29 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/be/34/ar13.PMC4477729.pdf
http://phdcompletion.org/information/Executive   _Summary_Demographics_Book_II.pdf (accessed 13 November 2014).,Non-OADS,/arxiv_data1/oa_pdf/be/34/ar13.PMC4477729.pdf
http://acd.od.nih.gov/Diversity   -in-the-Biomedical-Workforce-Implementation-Plan.pdf (accessed  13 November 2014).,Non-OADS,/arxiv_data1/oa_pdf/be/34/ar13.PMC4477729.pdf
"It is available to the public under an Attribu - tion–Noncommercial– Share Alike 3.0 Unported Creative Commons  License (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.14-07-0114 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.INTRODUCTION Experts within a field have rich, well-connected knowledge  structures that allow them to rapidly retrieve information  and see unexpected connections and patterns.",Non-OADS,/arxiv_data1/oa_pdf/70/3e/ar14.PMC4477730.pdf
The map can be explored by following this link: http://prezi.com/hr4u6kkhah2n/ cancer-bio-synthesis-map/?utm_campaign =share&utm_medium =copy.,Non-OADS,/arxiv_data1/oa_pdf/70/3e/ar14.PMC4477730.pdf
(A) Screenshot showing an overview of a synthesis map that used primarily spatial organization; you can explore the map  and follow the author’s suggested path by following this link: http://prezi.com/tp6jcnrnlh3a/synthesis-map-complete-version/?utm_ campaign =share&utm_medium =copy.,Non-OADS,/arxiv_data1/oa_pdf/70/3e/ar14.PMC4477730.pdf
Screenshot of a synthesis map that primarily used narrative organization; you can explore the map and follow the author’s suggest - ed path by following this link: http://prezi.com/fvvz5fpjzj_1/synthesis-map-3-and-4/?utm_campaign =share&utm_medium =copy.,Non-OADS,/arxiv_data1/oa_pdf/70/3e/ar14.PMC4477730.pdf
"Education blogs pro - vide multiple suggestions to enhance efficiency, one exam - ple being http://mssphillips.wordpress.com/2014/03/10/ giving-better-feedback-google-form-rubrics-and-autocrat.",Non-OADS,/arxiv_data1/oa_pdf/70/3e/ar14.PMC4477730.pdf
It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.14-08-0135 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.INTRODUCTION Students who reflect on their own thinking are positioned  to learn more than peers who are not metacognitive.,Non-OADS,/arxiv_data1/oa_pdf/d3/cb/ar15.PMC4477731.pdf
http://laprogram.colorado.edu/sites/ default/files/reports/la-program-10-11.pdf (accessed 10 March 2015).,OADS,/arxiv_data1/oa_pdf/07/2e/ar16.PMC4477732.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.14-10-0169 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ June 1, 2015 14:ar17",Non-OADS,/arxiv_data1/oa_pdf/4f/bd/ar17.PMC4477733.pdf
http://media.collegeboard.com/digitalServices/pdf/ap/ap-   biology-course-and-exam-description.pdf (accessed 8 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/4f/bd/ar17.PMC4477733.pdf
http://ccliconference.org/measuring-teaching-practices  (accessed 31 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/ea/75/ar18.PMC4477734.pdf
http://www.aapt.org/Conferences/newfaculty/upload/ STEM_REPORT-2.pdf (accessed 31 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/ea/75/ar18.PMC4477734.pdf
"Two months after publication it is available to the pub - lic under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/ by-nc-sa/3.0).DOI: 10.1187/cbe.14-12-0229 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.INTRODUCTION Explaining a biological phenomenon effectively is a cor - nerstone of success in biology, and curriculum policy doc - uments echo the importance of this ability (American As - sociation for the Advancement of Science [AAAS], 2011).",Non-OADS,/arxiv_data1/oa_pdf/43/cd/ar20.PMC4477736.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.14-12-0222 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.INTRODUCTION Despite the need to transform teaching and learning in the  sciences (e.g., American Association for the Advancement  CBE Life Sci Educ June 1, 2015 14:ar22",Non-OADS,/arxiv_data1/oa_pdf/c3/6f/ar22.PMC4477738.pdf
https://stemedhub.org/groups/aau (accessed  1 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/c3/6f/ar22.PMC4477738.pdf
"PORTAAL observations are completed on  an observation log (see https://sites.google.com/site/ uwbioedresgroup/research/portaal-resources) that asks  observers to record the timing, frequency, and presence/ absence of events as they occur in an activity.",OADS,/arxiv_data1/oa_pdf/db/a7/ar23.PMC4477739.pdf
"To train these four pairs of observers, we developed a train - ing manual and a set of three short practice videos (avail - able at https://sites.google.com/site/uwbioedresgroup/ research/portaal-resources).",Non-OADS,/arxiv_data1/oa_pdf/db/a7/ar23.PMC4477739.pdf
"Thus, instead of a score, instructors receive  the average frequency or duration of each element across  their three class sessions (the conversion chart can be found at  https://sites.google.com/site/uwbioedresgroup/research/ portaal-resources).",Non-OADS,/arxiv_data1/oa_pdf/db/a7/ar23.PMC4477739.pdf
"It is available to the public under an Attribu - tion–Noncommercial–Share Alike 3.0 Unported Creative Commons  License (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.14-10-0184 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ June 1, 2015 14:ar24INTRODUCTION Strong mentorship has been linked to enhanced mentee pro - ductivity, self-efficacy, and career satisfaction; it is also an  important predictor of the success of researchers in training  (Palepu et al., 1998; Garman et al., 2001; Ramanan et al., 2002;",Non-OADS,/arxiv_data1/oa_pdf/a9/98/ar24.PMC4477740.pdf
"14:ar24, 2 CBE—Life Sciences Educationcareer stages across the science, technology, engineering, and  mathematics (STEM) disciplines and in medicine and public  health (Sorkness et al., 2013; https://researchmentortraining   .org; https://mentoringresources.ictr.wisc.edu).",Non-OADS,/arxiv_data1/oa_pdf/a9/98/ar24.PMC4477740.pdf
"To date, all of the adapted curricula have been  made freely available online (https://researchmentortrain - ing.org; https://mentoringresources.ictr.wisc.edu).",Non-OADS,/arxiv_data1/oa_pdf/a9/98/ar24.PMC4477740.pdf
"Mentors also indicated  whether they would recommend the training to a colleague  and whether attending RMT was a valuable use of their time  (see Pfund et al., 2013, and https://mentoringresources.ictr   .wisc.edu/TrainingEvaluation for measures used).",Non-OADS,/arxiv_data1/oa_pdf/a9/98/ar24.PMC4477740.pdf
"Institutions  implementing the full versions of curricula varied from a  onetime implementation to implementing several times  across 2 yr. Actual curricula implemented varied across the  cohorts; however, the most commonly curriculum used was  Mentor Training for Clinical and Translational Researchers,  followed by Mentor Training for Clinical and Behavioral  Researchers, Mentor Training for Biomedical Researchers,  Mentor Training for Community Engaged Researchers, and,  finally, Mentor Training for Undergraduate Researchers  (https://mentoringresources.ictr.wisc.edu).",Non-OADS,/arxiv_data1/oa_pdf/a9/98/ar24.PMC4477740.pdf
"The need for methods  supporting implementation of evidence-based approaches  to mentoring is timely, as federal agencies have called on  training programs to include postdoctoral mentoring plans,  evidence-based mentoring, and individual development  plans into their program activities (www.nsf.gov/pubs/ policydocs/pappguide/nsf10_1/gpg_2.jsp#fn28; http:// publications.nigms.nih.gov/trainingstrategicplan/theme2   .htm; http://grants.nih.gov/grants/guide/notice-files/ NOT-OD-13-093.html).",Non-OADS,/arxiv_data1/oa_pdf/a9/98/ar24.PMC4477740.pdf
(http://grants.nih.gov/grants/ guide/notice-files/NOT-OD-14-113.html).,Non-OADS,/arxiv_data1/oa_pdf/a9/98/ar24.PMC4477740.pdf
http://nexus.od.nih.gov/all/2013/07/23/individual   -development-plans-for-nih-supported-trainees/#sthash.D8pTlEAe   .dpuf.,Non-OADS,/arxiv_data1/oa_pdf/a9/98/ar24.PMC4477740.pdf
It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/55/0d/es4.PMC4477741.pdf
"Presentation at Cognitive Science   Society, Sapporo, Japan, August 2012. http://mindmodeling.org/ cogsci2012/papers/0128/paper0128.pdf (accessed 11 November 2014).",Non-OADS,/arxiv_data1/oa_pdf/55/0d/es4.PMC4477741.pdf
"http://teachpsych.org/ebooks/asle2014/index.php (accessed 14  November 2014).Pyc MA, Rawson KA (2009).",Non-OADS,/arxiv_data1/oa_pdf/55/0d/es4.PMC4477741.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI:10.1187/ cbe.15-03-0065 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ June 1, 2015 14:fe2",Non-OADS,/arxiv_data1/oa_pdf/65/dc/fe2.PMC4477742.pdf
"This term captures the  integrated spirit and structure of these courses, which “are  instructor-designed and supervised environments that use  face-to-face and technology-mediated channels to enhance  interactive, engaging learning experiences and to improve  student learning outcomes” ( https://blendedtoolkit.wisc   .edu ).",Non-OADS,/arxiv_data1/oa_pdf/65/dc/fe2.PMC4477742.pdf
"It is available to the public under an Attribu - tion–Noncommercial–Share Alike 3.0 Unported Creative Commons  License (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.15-01-0007 “ASCB®”and“ The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ June 1, 2015 14:le1",Non-OADS,/arxiv_data1/oa_pdf/65/e3/le1.PMC4477743.pdf
"5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page659Prevalence of HBc -Ab among HBs -Ag negative healthy blood donors in south of Iran Farhad Khorami1, Seyed Alireza Sobhani2, Parivash Davoudian3, Ebrahim Khajeh4 1.Resident of pathology, Infectious and tropical diseases research center, Hormozgan Universit y of Medical Sciences, Bandar Abbas, Iran 2.Assistant professor of pathology, Hormozgan University of Medical Sciences, Bandar Abbas, Iran 3.Assistant professor of infectious diseases, Infectious and tropical diseases research center, Hormozgan Universit y of Medical Sciences, Bandar Abbas, Iran 4.General physician, Infectious and tropical diseases research center, Hormozgan University of Medical Sciences, BandarAbbas, Iran Corresponding Author: Ebrahim Khajeh, General physician, Infectious and tropical diseases research center, Hormozgan University of Medical Sciences, Tel: +989173617490, Email:ebrahim.khajeh@gmail.com Abstract: Background: The risk of infection with transfusion -transmitted viruses ,such as Hepatitis B virus (HBV) ,has been reducedmarkedly.",Non-OADS,/arxiv_data1/oa_pdf/81/46/epj-05-659.PMC4477747.pdf
"5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page660Hepatitis B core antibody (HBc Ab) is the first antibody produced afterinfection with HBV,and it is the only detectable marker in the window period.",Non-OADS,/arxiv_data1/oa_pdf/81/46/epj-05-659.PMC4477747.pdf
"5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page661Among the 83 people who tested positive for HBc Ab positive, 60 of them (72.3%) tested positive for HBs Ab positive as well, and 23 of them (27.7%) tested negative for HBs Ab negative.",Non-OADS,/arxiv_data1/oa_pdf/81/46/epj-05-659.PMC4477747.pdf
"5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page662becausethey may have sufficiently high titersof antibodies to HBsAg (anti -HBs), which a re protective in nature , and the affected individuals may actually be disease free.",Non-OADS,/arxiv_data1/oa_pdf/81/46/epj-05-659.PMC4477747.pdf
"5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page66318.Geraldine K, Adel A, Intesar A, J ameel N, Said HA.",Non-OADS,/arxiv_data1/oa_pdf/81/46/epj-05-659.PMC4477747.pdf
"5, Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page664Assessment of patient safety culture among personnel in the hospitals associated with Islamic Azad University in Tehran in 2013 FatemehMoussavi1,JavadMoghri2,Yavar Gholizadeh3,AtiyehKarami4,Sedigheh Najjari5,Reza Mehmandust6, Mehdi Asghari7,HabibAsghari8 1.Assistant Professor, PhD of Community Medicine, Faculty of Medicine, Islamic Azad Universi ty, Tehran Medical Unit, Tehran, Iran 2.Ph.D.Student in HealthPolicy, Department of Health Management and Economics, School of Public Health, TehranUniversity of Medical Sciences, Tehran, Iran 3.B.Sc.of Occupational Health,Department of Occupational health, Tehran University of Medical Sciences, Tehran, Iran 4.M.Sc.Student of health care management ,Department of Health Management and Economics ,Tehran University of Medical Sciences, Tehran, Iran 5.B.Sc.of Community Medicine, Faculty of Medicine, Islamic Azad University, Tehran Medical Unit, Tehran, Iran 6.B.Sc.ofNursing.",Non-OADS,/arxiv_data1/oa_pdf/a2/ab/epj-05-664.PMC4477748.pdf
"5, Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page665structural interventions to improve the quality of patient safety (3).",Non-OADS,/arxiv_data1/oa_pdf/a2/ab/epj-05-664.PMC4477748.pdf
"5, Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page666the Agency for HealthCare Research & Quality (AHRQ) makes assessments of the patient safety culture situation in a number of hospitals in the United States using the HSOPSC question naire.",Non-OADS,/arxiv_data1/oa_pdf/a2/ab/epj-05-664.PMC4477748.pdf
"5, Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page667Table 2.Positive scores of the dimensions of patient safety culture in studied hospitals and Benchmark study Dimension Number of questionsPresent StudyBenchmark Study 1-Frequency of event reporting 3 33 63 2-Overall perceptions of patient safety 4 37 66 3-Supervisor/manager  expectations  and  actions promoting patient safety4 42 75 4-Organizational  learning –continuous  improvement 3 46 72 5-Teamwork within units 4 48 80 6-Communication openness 3 27 62 7-Feedback and communication abou t error 3 38 64 8-No punitive response to error 3 12 44 9-Staffing 4 22 56 10-Hospital  management  support  for  patient safety 3 42 72 11-Teamwork across hospital units 4 39 58 12-Hospital handoffs and transitions 4 39 45 Total score 42 35 63 Table 3.Dimensions with the highest and lowest ratings of patient safety culture based on separate questions Questionnaire items No.Questionnaire Items Percentage of positive responses Dimension 5(Teamwork within units) 48 1 People support one anot her in this unit 45 3 When a lot of work needs to be done quickly, we work together as a team to get the work done55 4 In this unit, people treat each other with respect 56 11 When one area in this unit gets really busy, others help out 37 Dimension 4(Organizational  learning –continuous  improvement) 46 6 We are actively doing things to improve patient safety 54 9 Mistakes have led to positive changes here 35 13 After we make changes to improve patient safety, we evaluate their effectiveness49 Dimension 8(No punitive response to error) 12 8 Staff feel like their mistakes are held against them 15 12 When an event is reported, it feels like the person is being written up, not the problem13 16 Staff worry that mistakes they make are kept in their personnel file 6 Dimension 9(Staffing) 22 2 We have enough staff to handle the workload 21 5 Staff in this unit work longer hours than is best for patient care 17 7 We use more agency/temporary staff than is best for patient care 29 14 We work in ""crisis mode"" trying to do too much, too quickly 19 4.",Non-OADS,/arxiv_data1/oa_pdf/a2/ab/epj-05-664.PMC4477748.pdf
"5, Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page668these two dimensions were better than those of all of the other dimensi ons.",Non-OADS,/arxiv_data1/oa_pdf/a2/ab/epj-05-664.PMC4477748.pdf
"5, Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page669Acknowle dgements: This paper is the result of a research project approved by Islamic Azad University (Medicine Unit), number 51361911103009.",Non-OADS,/arxiv_data1/oa_pdf/a2/ab/epj-05-664.PMC4477748.pdf
"5, Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page670References 1.Sorra J, Famolaro T, Dyer N, al e. Hospital Survey on Patient Safety C ulture 2012 user comparative database report.",Non-OADS,/arxiv_data1/oa_pdf/a2/ab/epj-05-664.PMC4477748.pdf
"5, Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page67125.Leonard M, Frankel A.",Non-OADS,/arxiv_data1/oa_pdf/a2/ab/epj-05-664.PMC4477748.pdf
"5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page679Prevalence of and Factors Associated with Migraine in Medical Students at BandarAbbas, Southern Iran, in 2012 Maryam Yazdanparast1,2, Ali Asghar Abrishamizadeh3, Hamidreza Mahboobi4,5, Aria Omrani6, Mahsa Ghasemi1, Monir Ghorashi1, Milad Zahed1, AbbassMohammadi1, Zahra Karimi1 1.Student of Medicine of Hormozgan University of Medical Science (HUMS), Bandarabbass, Iran.",Non-OADS,/arxiv_data1/oa_pdf/b1/25/epj-05-679.PMC4477749.pdf
"5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page680The main risk factors include sleep disorders, high temperature, anxiety, and stress.",Non-OADS,/arxiv_data1/oa_pdf/b1/25/epj-05-679.PMC4477749.pdf
5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page681Table 1: Prevalence of migraine according to students’ characteristic Classification Migraine Non-migraine Chi-square P Value Field of education Medicine 23 (17.6%) 108 (82.4%) 8.403 0.677 Nursing 8 (21.6%) 29 (78.4%) Midwifery 3 (8.1%) 34 (91.9%) Anesthesiology 5 (23.8%) 16 (76.2%) Operation room 5 (27.8%) 13 (72.2%) Radiology 2 (9.5%) 19 (90.5%) Laboratory sciences 3 (9.7%) 28 (90.3%) Hygiene 3   (11.1%) 24 (88.9%) Entomology 2 (28.6%) 5 (71.4%) Health Information Technology (HIT)1 (14.3%) 6 (85.7%) Medical records 1 (14.3%) 6 (85.7%) Medical emergencies 1 (16.7%) 5 (83.3%) Entrance year 2004 0 (0%) 1 (100%) 12.028 0.100 2005 0 (0%) 11 (100%) 2006 3 (42.9%) 4 (57.1%) 2007 4 (19%) 17 (81%) 2008 12 (25%) 36 (75%) 2009 3   (6.5%) 43 (93.5%) 2010 17 (15.6%) 92 (84.4%) 2011 18 (16.8%) 89 (83.2%) Marital Status Single 52 (17%) 253 (83%) 0.314 0.314 Married 5    (11.1%) 40 (88.9%) Place of residence Dormitory 45 (16.1%) 235 (83.9%) 0.828 0.828 Non-dormitory 12 (17.1%) 58 (82.9%) 4.,Non-OADS,/arxiv_data1/oa_pdf/b1/25/epj-05-679.PMC4477749.pdf
5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page682Acknowledgements We want to thank to Hormozgan University of Medical Sciences (HUMS) research committee for their supports and helps for conduct ion this project and preparing the manuscript.,Non-OADS,/arxiv_data1/oa_pdf/b1/25/epj-05-679.PMC4477749.pdf
"5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page683References 1.Domingues RB, Cezar PB, Schmidt Filho J, de Moraes Filho MN, Pinheiro MN, Marchiori JG, et al.",OADS,/arxiv_data1/oa_pdf/b1/25/epj-05-679.PMC4477749.pdf
5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page684neurologia.,Non-OADS,/arxiv_data1/oa_pdf/b1/25/epj-05-679.PMC4477749.pdf
"5; Issue3 http://www.ephysician.ir [electronicphysician@gmail.com] Page685New corruption detected: Bogus impact factors compiled by fake organizations Mehrdad Jalalian1, Hamidreza Mahboobi2,3 1.Editor In-Chief, Electronic Physician, Mashhad, Iran 2.Infectious and Topical Diseases Research Center, Hormozgan University of Medi cal Sciences (HUMS), Hormozgan, Iran 3.Payam Noor University (PNU), Tehran, Iran Corresponding author: Dr. Mehrdad Jalalian, Electronic Physician, Mashhad, Iran, E -Mail:mehrdad.medic@gmail.com Keywords: Journal Impa ct Factor;Publications ;Indexing Additional Information for citing this article: Title of Journal: Electronic physician; Abbreviated title of journal: Electron.",Non-OADS,/arxiv_data1/oa_pdf/a2/99/epj-05-685.PMC4477750.pdf
"The cyber criminals used the following names for their fake met ric products: Global Impact Factor (GIF) compiled by http://www.globalimpactfactor.com , Universal Impact Factor (UIF) introduced by http://www.uifactor.org , Journal Impact Factor (JIF) measured by http://www.jifactor.com , and the so -called revolutionary metric product for evaluating scientific journals (Sjournals) at http://www.sjournals.ne t. The above -mentioned scams are all aboutthe same, andit is obvious that the GIF and Sjournals Index websites are very similar, as if they were created by the same person or that information was copied and pasted from one to the other.",Non-OADS,/arxiv_data1/oa_pdf/a2/99/epj-05-685.PMC4477750.pdf
